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General introduction
INFANT AND CHILDHOOD NUTRITION
Breastfeeding is the most desirable form of infant feeding [1, 2]. Breastmilk contains nutrients 
essential for normal growth and development but also immune-related components offering 
passive immunity in the gastrointestinal and respiratory tracts [1]. In addition, breastfeeding 
may provide maturation of the immune system in the long run [3]. Exclusive breastfeeding 
for 6 months is a global public health recommendation [4]. The primary aim of this global 
recommendation is to reduce infections in developing countries. However, problems of 
developing countries differ from those in industrialized countries and the evidence for 
the optimal duration of exclusive breastfeeding from industrialized countries is limited [5]. 
In industrialized countries, breastfeeding has been associated with a reduced risk of child 
infections, but also an reduced risk of overweight and obesity, and allergenic diseases [6]. 
Timely introduction of complementary feeding is of importance for both nutritional and 
developmental reasons such as for example neurodevelopmental, renal, and gastrointestinal 
maturation [7]. Complementary feeding comprises all solid and liquid foods other than breast 
milk or infants formula [7]. Recommendations regarding the introduction of solid foods has 
changed significantly over the past years [8]. Based on the optimal duration of exclusive 
breastfeeding, the WHO recommends complementary feeding to be introduced after 
the age of 6 months while breastfeeding continuous for up to two years of age or beyond 
[4]. However, recommendations vary between countries. Previous Dutch recommendations 
stated complementary feeding be introduced after the age of 6 months. Currently, Dutch 
youth health services recommends complementary feeding be introduced as of 4 months 
(17 weeks) of age [9]. The European Society for Pediatric Gastroenterology, Hepatology, 
and Nutrition (ESPGHAN) Committee on Nutrition recommends the introduction of 
complementary feeding be delayed after 17 weeks of age, but no later than 26 weeks [7]. 
The American Academy of Pediatrics recommends the introduction of solid foods at 4-6 
months of age [10].
After infancy the transition to ordinary foods takes place and dietary patterns emerge. 
A healthy diet by a moderate consumption of a varied diet including nutrient-dense foods 
is encouraged [11].
Diet and nutrition are increasingly recognized as modifiable risk factors for chronic 
disease development including obesity, cardiovascular disease and respiratory diseases [12, 
13]. Nutrition is a critical determinant of health at every age but especially during critical 
stages of early development. However, there is currently still much debate on optimal 
feeding recommendations in early life for the prevention of disease. Also, not all parents 
follow early life feeding recommendations. The period of nutritional transition in infancy 
and diet in early childhood may influence later health and therefore provide a window of 
opportunity for disease prevention. 
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ALLERGIC DISEASE
The prevalence of allergic disease, including asthma and eczema, has increased substantially 
over the past decades and continuous to rise [14-16]. Although it appears that the prevalence 
of asthma among children has ceased to increase, asthma prevalence remains high [17]. 
Especially children are bearing the greatest burden of allergic disease [18]. Although genetic 
factors play an important role in individual susceptibility, it has been suggested that the rise 
in prevalence could only be explained by modern environmental factors [16]. The influence 
of environmental factors on the immune system is complex. Environmental factors including 
air pollution, dietary factors and behavioral changes associated with a Western lifestyle have 
been proposed as risk factor for allergic disease [19, 20]. 
The period of transition from breastmilk or formula feeding to the introduction of solid 
foods has been suggested to influence the development of allergic disease [21]. Regular 
and early exposure to food allergens during a critical period of development seems to 
promote the development of persistent oral tolerance [21, 22]. Recently, two randomized 
controlled trials in the United Kingdom examined the role of early introduction of allergenic 
food in the development of allergic disease [23, 24]. Both studies found early introduction 
of allergenic food to prevent food allergies in children. The timing of the window for 
the prevention of allergies is still not clear. Infant feeding recommendations for allergy 
prevention have changed significantly over the past decade [8]. In 2008, on the basis of 
available data, the ESPGHAN Committee on Nutrition recommended that complementary 
foods should not be introduced before 17 weeks and that foods should be added 1 at a time. 
There was no convincing evidence that delaying or avoiding the introduction of allergenic 
foods prevents the development of allergy [7]. However, there is still much debate on 
the timing of introduction of solid foods and allergy development [25].  
After infancy a varied diet is recommended to insure sufficient intake of nutrients. 
However, dietary intakes of alpha-linolenic acid (ALA), iron and vitamin D are low in infants 
and young children in Europe [26]. Iron deficiency and vitamin D deficiency are the most 
common micronutrient deficiencies in young children, with a prevalence around 12% and 
23% respectively in Western Europe [27]. Sun exposure is the main source of vitamin D [28, 
29]. Lifestyle changes leading to decreased exposure to sunlight predispose to vitamin D 
deficiency. There are few dietary sources that naturally contain vitamin D including oily 
fish, egg yolk and nuts and some foods such as margarines and fruit juices are fortified with 
vitamin D [28, 29]. Vitamin D deficiency in childhood has been linked to adverse health 
consequences including rickets and growth failure [28, 29]. The American Academy of 
Pediatrics (AAP) recommends that all infants, children, and adolescents receive a minimum 
of 400 International Units (IU) of vitamin D daily through diet or supplementation to prevent 
rickets and vitamin D deficiency [30]. In the Netherlands it is recommended that all children 
till the age of 4 years receive 400 IU of vitamin D daily [31]. There is epidemiologic evidence 
that vitamin D deficiency may increase the risk of common chronic disease, including 
autoimmune diseases, infectious diseases, and cardiovascular disease [28, 29]. In children, 
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higher vitamin D concentrations have been linked to a reduced risk of allergic disease. 
However, a role of vitamin D in the prevention of allergic disease in children remains unclear. 
Instead of studying the effect of specific nutrients the effect of overall diet might give 
more insight on the combination of foods. Children consume various foods with complex 
combinations of nutrients that may be interactive or synergistic. Dietary patterns in childhood 
have been linked to childhood obesity and the development of respiratory disease [12, 32]. 
It has been suggested that a more healthy diet in childhood, like a traditional Mediterranean 
diet, may reduce the risk of asthma in children [33] whereas a more unhealthy diet may 
increase the risk of respiratory symptoms [34, 35]. However, studies assessing the effect of 
overall diet, including a Western diet, in early childhood on respiratory health are few.   
CELIAC DISEASE
Celiac disease is an autoimmune disorder resulting from both environmental and genetic 
factors. Permanent intolerance to gluten leads to chronic small enteropathy in genetically 
predisposed individuals. The prevalence of celiac disease has been estimated to approximate 
1% [36, 37]. Celiac disease commonly appears in early childhood with classical symptoms 
including diarrhea, abdominal distension, and failure to thrive. However, individuals may 
also present with extra-intestinal symptoms or no symptoms. Most cases are undiagnosed 
[38]. Infant nutrition including breastfeeding and the timing of introduction of gluten 
have been suggested to play a role in triggering the onset of celiac disease. It has been 
suggested that a longer duration of breastfeeding and gradual introduction of gluten while 
breastfeeding may reduce the risk of developing celiac disease [2, 39]. Gradual introduction 
has been suggested to lead to the development of oral tolerance, also the response 
of the immune system to gluten may be modified by breastfeeding [40, 41]. In addition, 
delaying the introduction of gluten might increase the risk [42, 43]. However, results were 
inconsistent [40, 42, 44-48]. Since 2008 the ESPGHAN Committee on Nutrition recommended 
to avoid early (<4 months) and late (≥7 months) introduction of gluten and to introduce 
gluten gradually while the infant is still being breastfed to reduce the risk of celiac disease [7]. 
But, clear evidence was lacking. A more recent randomized controlled dietary intervention 
reported early (16-24 weeks) introduction of gluten not to reduce the risk of celiac disease. 
In addition, breastfeeding at the time of gluten introduction did not reduce the risk of celiac 
disease [49]. In the Netherlands youth health services recommends gluten to be introduced 
from the age of 4 months in small amounts for the prevention of celiac disease [50]. Studying 
whether infant feeding practices can reduce the risk of celiac disease might give new insight 
into the mechanisms underlying the development of this disease. 
INFECTIOUS DISEASE
Infectious diseases are a leading cause of doctor visits and hospital admission in young 
children with most common reason being respiratory infection [51, 52]. Upper respiratory 
infections most often account for doctor consultations whereas lower respiratory infections 
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account for hospitalization [51, 52]. Most respiratory infections occur in infancy with a peak 
between 1 and 2 years of age [53]. Risk factors associated with respiratory infections in 
childhood are passive smoking [54], daycare attendance [55, 56], and vitamin D deficiency 
[57]. Positive health effects of breastfeeding during infancy have been reported, especially for 
infectious diseases [5]. Both the duration of breastfeeding as well as breastfeeding exclusivity 
have been found to be associated with the development of respiratory tract infections 
in infancy [2, 6, 58]. It has been suggested that breastfeeding may also have long-term 
health effects [3]. Breastfeeding may stimulate the immune system of the offspring with 
beneficial long-term effects [3]. Therefore, breastfeeding might protect against autoimmune 
diseases later in life, such as type 1 diabetes and inflammatory bowel disease, but may also 
have a positive effect on later cognitive function [2, 5]. Evidence for long-term effects of 
breastfeeding on the development of respiratory tract infections is limited [2, 5]. Studying 
the long-term health effects of breastfeeding might give more insight in the optimal duration 
of breast feeding for the long-term protection against infections after the termination 
of breastfeeding. 
AIMS OF THIS STUDY
In this thesis we aimed to study the following aspects on early life nutrition and 
the development of childhood disease:
 - Which maternal and infant factors are associated with the timing of introduction of 
complementary feeding?
 - Is the timing of introduction of complementary feeding associated with diseases 
in childhood?
 - Has breastfeeding a long-term health effect on respiratory tract infections in childhood?
 - Are nutritional determinants in childhood of influence on the development of respiratory 
and allergic disease? 
STUDY DESIGN
The Generation R Study
The studies presented in this thesis were conducted within the Generation R study. 
The Generation R study is a population based prospective cohort study from fetal life until 
young adulthood which is designed to identify early environmental and genetic determinants 
of growth, development and health during the life course. Participant eligible for this study 
were pregnant women with a delivery date from April 2002 through January 2006 living 
in Rotterdam, the Netherlands. The cohort included a total of 9778 mothers with their 
children enrolled throughout pregnancy. In each trimester during pregnancy assessments 
were conducted which included physical examinations, ultrasound measurements, and self-
administered measurements. Information on health of the children was obtained by parent-
reported questionnaires collected from birth until the child’s age of 6 years and routine visits 
to the child health care centers. From 2003 onwards, data on nutritional intake of the child 
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was implemented in the study. At the age of 14 months a total of 5088 mothers received 
a food frequency questionnaire (FFQ) for their child. At the age of 6 years, all children were 
invited to the dedicated research facility in the Erasmus MC, Sophia children’s hospital, to 
participate in different health outcome measurements. Venous serum samples were taken 
during the visit to the research center and serum 25-hydroxyvitamin D (25(OH) vitamin D) 
concentration and anti-tissue transglutaminase (anti-tTG) concentration was assessed in 
more than 4000 children.
OUTLINE OF THIS THESIS
Part I examines the timing of introduction of complementary feeding as possible risk factor 
for disease in childhood. Following the general introduction, chapter 2 of this thesis describes 
the factors associated with the timing of introduction of complementary feeding. Chapter 3 
focuses on the timing of introduction of allergenic foods on the development of wheezing 
and eczema in childhood. In chapter 4, the influence of breastfeeding and the timing of 
introduction of gluten on the development of celiac disease autoimmunity is reported. Part 
II focuses on nutritional determinants of respiratory health. In chapter 5, the influence of 
breastfeeding on the development of respiratory tract infections after infancy is described. 
Dietary patterns and the development of respiratory symptoms are discussed in chapter 6. 
Further, in chapter 7, the influence of vitamin D status in children on the development of 
asthma-related outcomes and eczema is reported. Finally, chapter 8 of this thesis provides 
an overall discussion on the main findings in the context of other studies. Also implications 
and directions for future research will be discussed. An overview of the studies described in 
this thesis is shown in Table 1. 
18
Chapter 1
Table 1: Overview of studies presented in this thesis
Chapter Study group n Study design Determinant Outcome Age
Part I The timing of introduction of complementary feeding
2 Generation R 3561 Cross-sectional Timing of 
introduction of 
complementary 
feeding
6 & 12 
months
3 Generation R 6905 Longitudinal Timing of introduction 
of allergenic foods
Wheezing and 
eczema
2-4 
years
4 Generation R 1679 Cross-sectional Duration of 
breastfeeding and 
timing of introduction 
of gluten
Anti-tissue 
transglutaminase 
antibody 
concentration
6 years
Part II Nutrition and respiratory and allergic disease
5 Generation R 5322 Longitudinal Breastfeeding Upper and lower 
respiratory tract 
infections
2-4 
years
6 Generation R 
(Dutch only)
2173 Longitudinal Dietary patterns Asthma-related 
symptoms and 
respiratory tract 
infections
2-4 
years
7 Generation R 3815 Cross-sectional 25-Hydroxyvitamin D 
concentration
Asthma-related 
outcomes and 
eczema
6 years
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ABSTRACT
Background: Many parents do not follow recommendations for the timing of introduction 
of complementary feeding. The aim of this study was to identify determinants associated 
with the timing of introduction of complementary feeding in a multiethnic birth cohort.
Methods: Subjects were 3561 mothers and infants participating in a prospective cohort 
study. The timing of introduction of complementary feeding and maternal and infant 
characteristics were obtained by parent-derived questionnaires. Regression analyses were 
performed to identify determinants for the timing of introduction of complementary 
feeding (<3, 3–6 and ≥6 months).
Results: In total, 62% of infants were introduced to complementary feeding before the age 
of 6 months. Determinants for very early (<3 months) introduction were being a single 
parent and infant day care attendance. Determinants for early (3–6 months) introduction 
were young maternal age, multiple parities, no infant family history of asthma, atopy 
and no infant history of allergy to cow’s milk. Determinants for both very early and early 
introduction were low educational level and not fully breastfeeding for 4 months. Maternal 
educational level was only significantly associated with the timing of introduction in mothers 
of Western origin.
Conclusions: This study confirmed determinants for the timing of introduction of 
complementary feeding that have been identified by previous studies, which may be 
appropriate targets for education and guidance. Moreover, mothers whose infants attend 
day care and have a family history of asthma, atopy or allergy to cow’s milk may need 
guidance to follow infant feeding recommendations.
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INTRODUCTION
The first year of life includes many transitions in food consumption.1 Appropriate nutrition 
during infancy is essential for adequate growth, development and health [2]. The World 
Health Organization (WHO) recommends breastfeeding for the first 6 months of life with 
the introduction of complementary feeding thereafter [2–4]. The primary aim of the current 
WHO infant feeding recommendations is the reduction of infections in developing countries 
[4]. Advisory committees in developed countries, including the European Society for Pediatric 
Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the American Association of 
Pediatrics (APP) recommend delaying the introduction of complementary feeding, preferably 
until the age of 6 months and at least until 4 months of age [5–7]. The ESPGHAN also 
recommends the introduction of complementary feeding no later than 26 weeks [5, 6]. Many 
studies have focused on determining the optimal time to introduce complementary feeding. 
Very early introduction of complementary feeding has been suggested to be associated 
with adverse health outcomes like obesity and celiac disease later in life [8, 9]. However, late 
introduction of complementary feeding is also not recommended as exclusive breastfeeding 
will not be sufficient to meet the infant’s nutritional needs after the age of 6 months, as well 
as for developmental reasons [5]. Many studies focused on determining factors associated 
with the initiation, duration and cessation of breastfeeding [10–12]. As both very early and 
late introduction of complementary feeding is not preferred and national studies indicate 
that many parents do not follow recommendations [7], identifying factors associated with 
the timing of introduction of complementary feeding is of importance. Several determinants 
associated with the timing of introduction of complementary feeding have been identified 
in previous studies in different countries [3, 4, 6, 13]. However, infant feeding practices have 
been found to differ between countries despite similar recommendations for the introduction 
of complementary feeding [6]. Differences in feeding practices have also been reported 
among subgroups of populations [7, 14]. Determining the factors associated with the timing 
of introduction of complementary feeding in a developed country with a multicultural 
population could give health care workers more insight and assist in identifying potential 
groups or individuals who are least likely to follow optimal feeding recommendations. 
Therefore, the aim of this study is to determine maternal and infant characteristics 
associated with the timing of introduction of complementary feeding in infancy in 
a multiethnic birth cohort.
MATERIALS AND METHODS
Participants and study design
This study was embedded in the Generation R Study, a multiethnic population-based 
prospective birth cohort study from fetal life until young adulthood [15]. The Generation R 
Study included 9778 pregnant woman living in Rotterdam, the Netherlands, with a delivery 
date from April 2002 until January 2006. Informed consent for postnatal follow-up was 
provided by 7893 participants. At the child’s age of 14 months, 5088 mothers received 
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a questionnaire about food consumption and the timing of introduction of complementary 
feeding (Supplementary Figure 2.1). Comprehensive data collection of food consumption 
was implemented in the study from 2003 onwards. The study was approved by the medical 
ethical review board of the Erasmus Medical Center, Rotterdam, the Netherlands.
Introduction of complementary feeding
At the child’s age of 14 (±2) months, parents were asked to complete a questionnaire about 
food consumption and the timing of introduction of complementary feeding. The food 
products used in the questionnaire were selected based on food items frequently consumed 
among Dutch toddlers, as described in a previous survey [16]. Parents were asked at which 
age the following products were first introduced into the infant’s diet: (full- or semi-skimmed) 
dairy products (with the exception of breastfeeding and formula-feeding), porridge, 
bread, biscuits, crackers, baby cookies, pasta, (breaded) meat products, vegetarian meat 
substitutes, fish, shellfish, vegetables, fruit, peanuts and nuts. The timing of introduction 
of complementary feeding was categorized as (I) before the age of 3 months, (II) at the age 
of 3–6 months and (III) at the age of 6 months and after. The categories are referred to as (I) 
very early, (II) early and (III) timely introduction of complementary feeding. The introduction 
of complementary feeding at the age of 6 months and after was defined as the reference 
group in accordance with the WHO recommendation which was currently followed during 
this study. Questionnaire response rate was 72% (n= 3643) and information on the timing of 
introduction of complementary feeding was available for 3603 infants.
Maternal and infants characteristics
Several maternal and infant characteristics were assessed as potential associated factors for 
the timing of introduction of complementary feeding. Data on maternal age, infant birth 
weight and gender were available from obstetric records assessed in midwife practices and 
hospital registries [15]. Prenatal questionnaires included information on maternal and infant 
ethnicity, maternal educational level, household income per month, marital status, maternal 
smoking and alcohol consumption during pregnancy, folic acid intake during pregnancy, 
multiple parities, family history of asthma or atopy and maternal body mass index at intake 
(questionnaire response rate: 91, 80 and 77% for early, mid and late pregnancy, respectively). 
Maternal educational level was defined according to the classification of Statistics Netherlands 
and categorized as follows: low (no education, primary school or <3 years of secondary 
school), mid (>3 years of secondary school, higher vocational training or bachelor’s degree) 
and high (academic education) [17]. Ethnicity of the mother and infant was also categorized 
according to the classification of Statistics Netherlands into Western (Dutch, European, 
American-Western, Asian- Western, Oceanian and Indonesian) and non-Western (American 
non-Western, Asian non-Western, African, Turkish, Cape Verdean, Moroccan, Dutch Antillean 
and Surinamese) [18]. Net household income per month (≤€2200, >€2200), marital status 
(no partner, married/living together), family history of asthma or atopy (no, yes), maternal 
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smoking (never smoked during pregnancy, smoked during pregnancy), maternal alcohol 
consumption (no alcohol consumption during pregnancy, alcohol consumption during 
pregnancy), multiple parities (no, yes) and folic acid intake (no intake, started in first 10 
weeks of pregnancy, started periconceptional) were defined into categories.
Data on breastfeeding were collected by a combination of delivery reports and postnatal 
questionnaires at the age of 2, 6 and 12 months (response rate: 82, 73 and 72%, respectively). 
Delivery reports included information on whether the infant was ever breastfed. Postnatal 
questionnaires included information on breastfeeding at the age of 2, 6 and 12 months 
and the age of breastfeeding cessation. Consequently, breastfeeding was categorized into 
the following groups: never breastfed, partial breastfeeding for at least 4 months and full 
breastfeeding for at least 4 months. Partial breastfeeding was defined as receiving both breast 
milk and infant formula and/or complementary feeding. Full breastfeeding was defined as 
receiving breastfeeding without any other infant formula, milk or complementary feeding. 
In addition, at the infant’s age of 6 and 12 months, parents were asked by the questionnaire 
whether their child had attended a doctor for allergy to cow’s milk in the first year of life 
(no, yes). At the age of 12 months, the questionnaire also included information on day care 
attendance. Day care attendance in the first year of life was defined as never, <16, 16–32 
and ≥32 h per week.
Population for analyses
Only mothers and infants who returned the questionnaire were included in the analyses 
(n= 3643). Non-response analysis revealed that mothers who filled in the questionnaire, 
relative to non-responders, had a higher educational level (33 vs 21%), were of 
Western ethnicity (78 vs 41%), were more often married or had a partner (91 vs 81%), 
had a lower BMI (24.4 vs 26.0 kg/m2), more often drank alcohol during pregnancy 
(60 vs 43%) and took adequate folic acid supplementation during pregnancy (31 vs 12%) 
(Supplementary Table 2.1). To prevent clustering, twins were excluded from the analyses 
(n= 82). Therefore, data of 3561 mother and infants were available for statistical analyses 
(Supplementary Figure 2.1).
Statistical methods
To determine the factors associated with the timing of introduction of complementary 
feeding, two regression models were built. The first model included the factors associated 
with very early (<3 months) introduction of complementary feeding relative to timely (≥6 
months) introduction of complementary feeding. The second model reflected the factors 
associated with early (3–6 months) introduction of complementary feeding relative to timely 
(≥6 months) introduction of complementary feeding. 
Univariate logistic regression analyses were performed for the timing of introduction of 
complementary feeding and various potential associated factors as independent variables. 
All independent variables with a P-value <0.20 in the univariate analyses were selected 
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as candidate determinants for the multivariate analyses. Subsequently, multiple logistic 
regression analyses with a backward stepwise elimination procedure was performed with 
P <0.10 as the end-point, keeping only the strongest determinants. The Hosmer–Lemeshow 
test was applied to test the goodness of fit of the regression model.
To diminish potential bias associated with missing data, a multiple imputation procedure 
was used [19]. The multiple imputation procedure predicts values for missing data on 
the basis of the associations between missing data and other variables. Missing values of 
maternal and infant characteristics (~2.0–45.9%) were multiple imputed (n= 5 imputed 
datasets). The results of the five imputed analyses were pooled and reported as odds 
ratios (OR) and 95% confidence interval (CI) in this paper. A P-value <0.05 was considered 
as statistically significant. Statistical analyses were conducted using Statistical Package for 
Statistical Science Software version 17.0 (SPSS Inc, Chicago, IL, USA).
RESULTS
Study population
Maternal and infant characteristics of the study population are presented in Table 2.1 and 
Supplementary Table 2.2. Out of 3561 infants, 6% was introduced to complementary feeding 
very early (<3 months), 56% early (3–6 months) and 38% timely (≥6 months).
Factors associated with the timing of introduction of complementary feeding
Descriptive information on the determinants of interest and their associations with 
the timing of introduction of complementary feeding are presented in Table 2.2 and 
Supplementary Table 2.3.
Introduction before the age of 3 months. Relative to timely introduction, very early introduction 
of complementary feeding was inversely associated with higher maternal educational level 
and full breastfeeding for 4 months, and associated with a single-parent household and 
>32h of day care attendance per week.
Introduction at 3–6 months. Relative to timely introduction, early introduction of 
complementary feeding was inversely associated with maternal age, higher maternal 
educational level, family history of asthma or atopy, allergy to cow’s milk and full 
breastfeeding for 4 months and associated with multiple parities.
Ethnicity and the timing of introduction of complementary feeding
A significant interaction was found between maternal educational level and ethnicity 
(P= 0.01 and P= 0.06 for mid- and high educational levels, respectively). Only in mothers 
of Western origin, higher maternal educational level was inversely associated with very 
early (<3 months) (OR: 0.36; 95% CI: 0.21–0.61 and OR: 0.18; 95% CI: 0.10–0.33) and early 
(3–6 months) introduction (OR: 0.52; 95% CI: 0.38–0.71 and OR: 0.41; 95% CI: 0.30–0.56) of 
complementary feeding (Table 2.3).
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Table 2.1. Characteristics of the study population according to the timing of introduction of 
complementary feeding 
n=3561
<3 months 3-6 months ≥6 months
 Very early Early Timely
n=217 %=6 P-value n=2009 %=56 P-value n=1335 %=38
Maternal characteristics
Age Mean (SD) 30.4 5.7 <0.01 31.2 5 <0.01 31.8 4.4
Ethnicity
Western 136 5 1534 56 1088 39
Non-western 81 10 <0.01 475 59 <0.01 247 31
Educational level
Low 55 10 346 63 152 27
Mid 121 7 <0.01 1060 57 <0.01 676 36
High 41 4 <0.01 603 52 <0.01 507 44
Household income per month
≤2200 euro 79 8 557 58 332 34
>2200 euro 138 5 <0.01 1452 56 0.07 1003 39
Marital status 
Married/living together 173 5 1822 56 1250 39
No partner 44 14 <0.01 187 59 0.01 85 27 
Maternal BMI Mean (SD) 24.6 4.5 0.30 24.6 4.3 0.04 24.2 4.1
Multiple parities
No 125 6 1163 55 812 39
Yes 92 6 0.04 846 58 0.08 523 36
Smoking   during pregnancy
Never 151 5 1539 55 1100 40
Smoked during pregnancy 66 9 <0.01 470 61 <0.01 235 30
Alcohol use during pregnancy
Never 108 8 794 56 510 36
Drank alcohol during 
pregnancy
109 5 0.05 1215 57 0.55 825 38
Folic acid intake
Never 69 12 339 57 187 31
Start in first 10 weeks 62 5 0.03 651 58 0.51 412 37
Start periconceptional 86 5 <0.01 1019 55 0.10 736 40 
Infant characteristics
Gender
Male 116 7 978 56 653 37
Female 101 5 0.21 1031 57 0.90 682 38
Ethnicity
Western 133 5 1520 56 1081 39
Non-western 84 10 <0.01 489 59 <0.01 254 31
Birth weight z-score Mean (SD) -0.25 1.00 <0.01 0.02 1.01 0.41 -0.01 1.06
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Table 2.1. (continued)
n=3561
<3 months 3-6 months ≥6 months
Very early Early Timely
n=217 %=6 P-value n=2009 %=56 P-value n=1335 %=38
Breastfeeding                         
Never 27 6 260 60 144 34
Non- fully for 4 months 154 7 0.60 1281 61 0.75 665 32
Fully for 4 months 36 4 0.02 468 45 <0.01 526 51
Family history of asthma or atopy
Yes 99 6 940 53 724 41
No 118 7 0.03 1069 59 <0.01 611 34
Cow’s milk allergy
Yes 10 4 108 48 108 48
No 207 6 0.11 1901 57 <0.01 1227 37
Day care attendance
Never 74 8 535 56 347 36
<16 hours 40 4 0.04 555 57 0.63 380 39
16-32 hours 81 5 0.07 845 57 0.75 566 38
≥32 hours 22 16 0.09 74 54 0.67 42 30 
Abbreviations: BMI, body mass index; s.d, standard deviation. P-values were assessed by using univariate logistic regression 
analyses. % represents proportion by row.
DISCUSSION
Out of 3562 infants, 62% was introduced to complementary feeding before the age of 6 
months. Infants with a single parent and who attended day care were more often introduced 
to complementary feeding very early (<3 months). Mothers who introduced complementary 
feeding early (3–6 months) were more often younger, had multiple parities and had an infant 
without a family history of asthma, atopy or a history of allergy to cow’s milk. Mothers with 
a low educational level and those who did not fully breastfeed for 4 months were more likely 
to introduce complementary feeding very early and early. However, the socioeconomic 
gradient in complementary feeding practices was only present in mothers of Western origin.
Comparison with other studies is difficult as most studies defined early introduction 
of complementary feeding to be before the age of 4–6 months in accordance with 
the recommendations of the ESPGHAN and the APP. This study defined early introduction of 
complementary feeding to be before the age of 6 months according to the recommendation 
of the WHO which was currently followed in the Netherlands during the study period. 
The main determinants found in this study are confirmatory. Previous studies also found 
low maternal age, low maternal educational level, not fully breastfeeding and being a single 
parent to be determinants associated with early introduction of complementary feeding 
[3, 4, 6, 13]. In addition, this study found infants with a family history of asthma, atopy or 
a history of allergy to cow’s milk to be more likely to be introduced to complementary 
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feeding after the age of 6 months. The WHO also recommends delaying the introduction of 
complementary feeding after the age of 6 months for the prevention of asthma and allergic 
disease [20]. However, recent evidence lends little support for delaying the introduction of 
complementary feeding in order to prevent allergic disease.8 Mothers whose infants have 
an increased risk of allergic disease may be more conscious and aware of the introduction of 
complementary feeding and therefore less likely to introduce complementary feeding early 
or more likely to delay the introduction of complementary feeding for too long.
This study also found day care attendance for more than 32h a week to be a determinant 
for very early (<3 months) introduction of complementary feeding independent of 
socioeconomic status. However, in agreement with previous studies, this study did not 
find day care attendance to be a determinant for early introduction (3–6 months) of 
complementary feeding [3].  As confirmed by previous studies, this study did not find 
maternal ethnicity to be an independent determinant for the timing of introduction of 
complementary feeding [4, 6, 13]. However, it has been suggested that the socioeconomic 
gradient in complementary feeding practices may vary by maternal ethnic background 
[7, 14]. In addition, this study found that educational level was only associated with 
the timing of complementary feeding in mothers of Western origin.
The findings of this study may have several implications. The maternal and child 
determinants can assist health care workers and dieticians in identifying groups or individuals 
who are less likely to comply with infant feeding recommendations. Most determinants 
were confirmed in other studies as well and may be appropriate targets for education and 
guidance. Additionally, mothers whose infants attend day care and have a family history of 
asthma, atopy or a history of allergy to cow’s milk may introduce complementary feeding 
differently. Mothers of these children may need additional guidance to follow infant 
feeding recommendations.
An important strength of this study was the large sample size and the multiethnic 
population. In addition, this study was able to examine a large number of potential factors 
Table 2.3. Ethnicity and the timing of introduction of complementary feeding
Multiple regression model
(<3 vs. ≥6 months)
Multiple regression model
(3-6 vs. ≥6 months)
OR (95% CI) OR (95% CI)
Western
Ethnicity
Non-Western 
Ethnicity
Western
Ethnicity
Non-Western
Ethnicity
Maternal educational Level
Mid vs. Low 0.36* (0.21 – 0.61) 1.01 (0.55 – 1.85) 0.52* (0.38 – 0.71) 0.98 (0.69 – 1.38)
High vs. Low 0.18* (0.10 – 0.33) 0.59 (0.21 – 1.64) 0.41* (0.30 – 0.56) 0.86 (0.51 – 1.45)
Abbreviations: CI, confidence interval; OR, odds ratio for the introduction of complementary feeding relative to at 6 months 
and after. Values are represented as OR (95% CI) *signifies P-value <0.05. Pinteraction: 0.01 and 0.06 for mid- and high educational 
level respectively for comparison between <3 and ≥6 months and Pinteraction: 0.01 and 0.06 for mid- and high educational level 
respectively for comparison 3–6 and ≥6 months.
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associated with the timing of introduction of complementary feeding. Another important 
strength of this study was that it identified determinants for both very early (<3 months) and 
early introduction (3–6 months) of complementary feeding.
A limitation of this study was that it could not specifically identify determinants for 
the introduction of complementary feeding using the recommendations of other advisory 
committees (that is, 16 weeks) [5–7]. However, this study identified determinants associated 
with the introduction of complementary feeding before the age of 6 months as recommended 
by the WHO and preferred by most advisory committees. Another limitation of this study was 
the retrospective character of the self-reported questionnaire on the timing of introduction 
of complementary feeding. Parents were asked to complete the questionnaire at the child’s 
age of 14 (±2) months, about 8–11 months after the introduction of complementary feeding. 
Therefore, maternal recall bias cannot be excluded. However, this would have only influenced 
our results if, for example, mothers with a low socioeconomic background were more likely 
to misclassify having introduced complementary feeding after the age of 6 months instead 
of before the age of 6 months.
CONCLUSION
This study identified important maternal and infant determinants for the timing of 
introduction of complementary feeding. The determinants should assist health professionals 
in identifying groups and individuals who are least likely to follow optimal feeding 
recommendations. This study confirmed determinants that have been identified by previous 
studies, which may be appropriate targets for education and guidance. Moreover, mothers 
whose infants attend day care and who have a family history of asthma, atopy or a history of 
allergy to cow’s milk may need guidance to follow infant feeding recommendations.
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Supplementary Figure 2.1 Flow chart of the participants within the Generation R 
Study 
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(n=7893) 
Children of mothers who received the food 
frequency questionnaire (n=5088) 
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Population of analysis (n=3561)  
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implementation of the food frequency 
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Exclusion: n=1445 due to missing data on 
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Exclusion: n=82 due to excluding twins 
 
Mothers included in the Generation R 
study (n=9778) 
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Supplementary Table 2.1. Non-response analysis (n=3561)
Responders Non-responders P-value
Maternal characteristics
Age Mean (SD) 31.4  (4.6) 30.1  (6.1) 0.08
Ethnicity (%)                                              
Western 78 41 <0.01
Non-western 22 59
Educational level (%)                                       
Low 15 37 <0.01
Mid 52 42
High 33 21
Household income per month (%)
≤2200 euro 27 28 0.96
>2200 euro 73 72
Marital status (%)    
Married/living together 91 81 0.02
No partner 9 19
Maternal BMI Mean (SD) 24.4  (4.24) 26.0  (3.9) 0.03
Multiple parities (%)                                             
No 59 53 0.05
Yes 41 47
Smoking during pregnancy (%)                     
Never 79 80 0.86
Smoked during pregnancy 21 20
Alcohol use during pregnancy (%)                      
Never 40 57 0.04
Drank alcohol during pregnancy 60 43
Folic acid intake (%)                                     
Never 15 36 <0.01
Start in first 10 weeks 31 12
Start periconceptional 54 52
Infant characteristics
Gender (%)                                                       
Male 49 48 0.84
Female 51 52
Ethnicity (%)                                              
Western 77 43 <0.01
Non-western 23 57
Birth weight (z-score) Mean (SD) -0.01 (1.01) -0.20  (1.11) 0.26
Breastfeeding (%)                                          
Never 9 0 0.09
Non- fully for 4 months 63 83
Fully for 4 months 28 17
Family history of asthma or atopy (%)             
Yes 49 56 0.46
No 51 44
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Supplementary Table 2.1. (continued)
Responders Non-responders P-value
Allergy to cow’s milk (%)                                     
Yes 6 0 0.15
No 94 100
Day care attendance (%)                                 
Never 23 34 0.05
<16 hours 28 20
16-32 hours 47 33
≥32 hours 3 13
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Supplementary Table 2.2. Characteristics of the study population according to the timing of introduction 
of complementary feeding – Original data
n=3521
<3 months
Very early
3-6 months
Early
≥6 months
Timely Missing
n=202 %=6 P-value n=1999 %=57 P-value n=1320 %=37 n %
Maternal characteristics
Age Mean (SD) 30.3 5.7 <0.01 31.2 5 <0.01 31.8 4.4 0 0
Ethnicity 86 2
Western 122 5 1502 56 1062 39
Non-western 65 9 <0.01 454 60 <0.01 230 31
Educational level              129 4
Low 45 9 321 64 136 27
Mid 106 6 <0.01 1022 57 <0.01 649 37
High 36 3 <0.01 589 53 <0.01 488 44
Household income  
per month
0 0
≤2200 euro 74 8 555   58 328 34
>2200 euro 128 5 <0.01 1444   56 0.06 992 39
Marital status 148 4
Married/living 
together
148 5 1743 56 1190 39
No partner 38 13 <0.01 177 61 <0.01 77 26
Maternal BMI Mean (SD) 24.5 4.6 0.37 24.5 4.3 0.05 24.2 4.1 291 8
Multiple parities 93 3
No 114 5 1134 56 788 39
Yes 81 6 0.03 815 58 0.06 496 36
Smoking   
during pregnancy
643 18
Never 117 5 1253 55 894 40
Smoked  
during pregnancy
49 8 <0.01 381 62 <0.01 184 30
Alcohol use during 
pregnancy
620 18
Never 82 7 657 57 416 36
Drank alcohol during 
pregnancy
85 5 <0.01 991 57 0.41 670 38
Folic acid intake 947 27
Never 38 10 233 59 124 31
Start in first 10 weeks 45 6 <0.01 463 58 0.21 291 36
Start 
periconceptional
62 4 <0.01 753 55 0.01 565 41
Infant characteristics
Gender                                  0 0
Male 108 6 974 56 647 38
Female 94 5 0.24 1025 57 0.87 673 38
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Supplementary Table 2.2. (continued)
<3 months
Very early
3-6 months
Early
≥6 months
Timely Missing
n=202 %=6 P-value n=1999 %=57 P-value n=1320 %=37 n %
Ethnicity                       70 2
Western 120 4 1490   56 1060 40
Non-western 71 9 <0.01 473   61  <0.01 237 30
Birth weight z-score 
Mean (SD)
-0.24 1.01 <0.01 0.01 0.99 0.77 -0.01 1.04 278 8
Breastfeeding                         363 10
Never 16 6 175 63 86 31
Non- fully for  
4 months
134 7 0.62 1219 62 0.77 624 31
Fully for 4 months 30 3 <0.01 407 45 <0.01 467 52
Family history of  
asthma or atopy
153 4
Yes 83 5 894   54 691 41
No 104 6 0.01 1013   60  <0.01 583 34
Allergy to cow’s milk 155 4
Yes 10 5 102   47 103 48
No 179 6 0.18 1803   57  <0.01 1169 37
Day care attendance 1218 35
Never 28 5 297 57 199 38
<16 hours 20 3 0.06 369 58 0.85 253 39
16-32 hours 47 4 0.40 614 57 0.96 414 39
≥32 hours 7 11 0.06 35 57 0.59 20 32
BMI: Body Mass Index; SD: standard deviation; P-values were assessed by using univariate logistic regression analyses. % 
represent proportion by row.
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3 The introduction of allergenic foods and the development of reported wheezing and eczema in childhood
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ABSTRACT
Objective: To examine whether the timing of introduction of the allergenic foods cow’s milk, 
hen’s egg, peanuts, tree nuts, soy, and gluten is associated with eczema and wheezing in 
children 4 years of age or younger.
Design: Population-based prospective cohort study from fetal life until young adulthood.
Setting: Rotterdam, the Netherlands, from April 2002 through January 2006.
Participants: A total of 6905 preschool children participating in the Generation R study.
Main Exposure: Timing of introduction of cow’s milk, hen’s egg, peanuts, tree nuts, soy, and 
gluten collected by questionnaires at 6 and 12 months of age. 
Main Outcome Measures: Information on the outcomes eczema and wheezing were 
obtained by questions from the age-adapted version of the “International Study of Asthma 
and Allergies in Childhood” core questionnaire and questionnaire data on parentally 
reported physician diagnosis for eczema.
Results: Of 6905 children, wheezing was reported in 31% at age 2 years and in 14% at ages 
3 and 4 years. Eczema was reported in 38%, 20%, and 18% of children at the ages of 2, 3, and 
4 years, respectively. The introduction of cow’s milk, hen’s egg, peanuts, tree nuts, soy, and 
gluten before the age of 6 months was not significantly associated with eczema or wheezing 
at any age after adjustment for potential confounders (P>.10 for all comparisons). The results 
did not alter after stratification according to the child’s history of cow’s milk allergy and 
parental history of atopy.
Conclusion: This study does not support the recommendation for delayed introduction of 
allergenic foods after age 6 months for the prevention of eczema and wheezing.
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INTRODUCTION
The prevalence of atopic diseases in children has been increasing over the past few decades 
[1] and varies throughout the world [2]. Atopic diseases, including atopic eczema, asthma, 
allergic rhinitis, and food allergy, are common in childhood and cause a very significant burden 
[3, 4]. Atopic diseases are complex and multifactorial, involving genetic and environmental 
factors [5]. An important environmental factor that may influence the development of atopic 
diseases is early childhood nutrition. The first year of life includes many transitions in food 
consumption [6]. Introduction of complementary feeding is essential for both developmental 
and nutritional concerns. The timing of complementary feeding is particularly important 
given the maturation of the gastrointestinal and renal systems [7]. Health risks that have 
been suggested to be associated with early complementary feeding include excessive child 
weight gain [8], increased body mass index [9], respiratory illness during childhood [10], and 
autoimmune diseases (eg, type 1 diabetes mellitus [11] and celiac disease [12]).
Recommendations for the timing of complementary feeding vary. The European 
Academy of Allergology and Clinical Immunology [13], The European Society for Paediatic 
Gastroenterology, Hepatology, and Nutrition (ESPGHAN) [14], and the American Association 
of Pediatrics [15] recommend delaying introduction of solid foods until a child is 4 to 6 
months of age. However, the ESPGHAN recommends that introduction of complementary 
feeding should not be delayed beyond the age of 6 ½ months [14]. There is no current 
convincing evidence that delayed complementary feeding beyond the age of 4 to 6 months 
is protective for the development of atopic diseases [13, 15-18]. In addition, few studies 
found early complementary feeding to be associated with an increased risk of atopic 
disorders such as eczema [16, 19, 20]. Some studies even found an increased risk for atopic 
disease in relation to delayed food introduction [21, 22].
It has been suggested that a family history of atopic disease is associated with 
a significantly increased risk for development of atopic disease in childhood [23]. However, 
avoidance or delayed introduction of potentially allergenic foods has not been convincingly 
shown to reduce allergies, either in children considered at risk for the development of allergy 
or in those not considered to be at risk [14]. Muraro et al [23] found that most children who 
develop atopic disease, particularly recurrent wheezing and asthma, during early childhood 
do not belong to high-risk groups for development of atopic disease.
Whether delayed introduction of allergenic foods could decrease the risk of atopic 
diseases is controversial. Therefore, our aim was to examine whether the timing of 
introduction of the following allergenic foods—cow’s milk, hen’s egg, peanuts, tree nuts, 
soy and gluten—is associated with eczema and wheezing in children up to 4 years of age. 
In addition, we aimed to assess whether the association differs between children with and 
those without a history of cow’s milk allergy in the first year of life and those children with 
and those without a parental history of atopy.
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METHODS
Participants and study design 
This study was embedded in the Generation R study, a population based prospective 
cohort study from fetal life until young adulthood, and has been described in detail 
previously [24, 25]. Consent for postnatal follow-up was provided by a total of 7893 mothers 
with a delivery date between April 2002 and January 2006. The study was approved by 
the medical ethical review board of the Erasmus Medical Center, Rotterdam, the Netherlands.
Eczema and Wheezing
For children aged 2, 3, and 4 years, questions from the age adapted version of the International 
Study of Asthma and Allergies in Childhood (ISAAC) core questionnaires on asthma and 
eczema were used. These questions were made suitable for younger children and have been 
used in several articles on this cohort [26]. Information was also available from questionnaire 
data on parentally reported physician diagnosis for eczema. Questionnaire response rates 
were 69%, 64%, and 63% at the ages of 2, 3, and 4 years, respectively. Eczema and wheezing 
were defined as present or absent in the child’s second, third, and fourth years of life.
Introduction of allergenic foods and gluten in the first year of life
When the child was 6 and 12 months old, parents were asked by questionnaire about 
the child’s age at first introduction of cow’s milk (4855 children), hen’s egg (4505 children), 
peanuts (4478 children), tree nuts (4431 children), soy (4658 children), and gluten (4734 
children) in their infant’s diet. Also at these times, parents were asked to complete a short 
food-frequency questionnaire about food products frequently consumed, according to 
a Dutch food consumption survey in children [27]. Subsequently, the reported food products 
introduced were crosschecked with the short food-frequency questionnaires. For example, 
if, when their child was 12 months old, the parents indicated that they had never introduced 
peanuts into their child’s diet, yet when their child was 6 months old, the parents had 
indicated that their child had consumed peanut butter more than once, the introduction 
of this allergen was considered to be at or before 6 months of age. In addition, the first 
introductions of cow’s milk and soy were also cross-checked with the type of bottle feeding 
(soy-based or based on fully hydrolyzed whey protein or not) used at the ages of 6 and 12 
months.
Covariates 
Variables possibly related to eczema and wheezing, such as sex, gestational age, and birth 
weight, were obtained from obstetric records assessed in midwife practices and hospital 
registries [25]. In addition, potential confounders and mediators were accessed through 
a combination of prenatal and postnatal questionnaires completed by both parents and 
included information on race/ethnicity; maternal socioeconomic status (SES); maternal 
smoking; parity; and family history of asthma, eczema, hay fever or allergic rhinitis, and 
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allergy to house dust. The race/ethnicity of the child was defined as follows: if both parents 
were born in the Netherlands, the race/ethnicity of the child was defined as Dutch; if one of 
the parents was born in a country other than the Netherlands, that country applied; if parents 
were born in countries other than the Netherlands, the country of the mother applied [28]. 
Maternal SES was defined according to educational level as follows: low level was defined 
as no education, primary school, or less than 3 years of secondary school; midlevel as more 
than 3 years of secondary school, higher vocational training, or a bachelor’s degree; and high 
level as an academic education [29]. Postnatal questionnaires completed by the mothers at 
6, 12, and 24 months included information on the general health of the child (ie, medication 
use, comorbidity), day care attendance, and the consumption of food products. Data on 
breastfeeding were collected by delivery reports and postnatal questionnaires at the ages 
of 2, 6, and 12 months. Breastfeeding was classified as (1) never; (2) exclusively for 6 months; 
(3) exclusively for 4 months and partially at 6 months; (4) exclusively for 4 months, with no 
breastfeeding at 6 months; (5) partially for 6 months; or (6) partially for 4 months, with no 
breastfeeding at 6 months. In addition, information on the presence of cow’s milk allergy 
was obtained by questionnaire at the ages of 6 and 12 months by asking parents whether 
their child had been seen by a physician because of cow’s milk allergy. When the child was 
24 months old, parents were asked about the number of physician-attended respiratory 
tract infections acquired by the child and use of antibiotics during the past 12 months. 
Information on gastroenteritis was obtained by asking parents about their child’s bowel 
movements and defined as any episode of diarrhea accompanied by fever. Body mass index 
(BMI) at 24 months was calculated from the child’s weight and height available from child 
health centers. Being overweight was defined according to age- and sex-dependent BMI 
thresholds for young children from Cole et al [30].
Population for analyses
To avoid the influence of metabolic disorders and clustering, the following children 
were excluded in the analyses for this study: twinborn (238 children); siblings within 
the Generation R cohort (343 children); those with presence of a congenital heart 
condition (47 children); those with anemia between the ages of 12 and 24 months (58 
children); and those with growth retardation, defined as height for age minus 2 standard 
deviations based on the Netherlands growth curves of children 12 to 24 months old 
(163 children) [31]. The presence of a congenital heart condition and anemia were defined 
according to parentally reported physician diagnosis obtained by questionnaire. Children 
whose parents did not provide informed consent for the use of questionnaire data 
were also excluded (135 children). To prevent bias associated with missing data, variables 
with missing values were multiple imputed (5 imputations) based on the correlation 
between the variable with missing values with other patient characteristics [32, 33] 
according to the Markov Chain Monte Carlo method. Consequently, data for 6905 children 
were available after multiple imputation for statistical analyses.
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Statistical analysis 
Logistic regression analyses were performed with eczema and wheezing at ages 2, 3, and 4 
years separately as dependent variables. Introductions of allergenic foods in the first year 
of life were analyzed as independent variables and adjusted for potential confounders and 
mediators (ie, sex, maternal SES, race/ethnicity, maternal smoking, gestational age, birth 
weight, parity, breastfeeding, use of any antibiotics, day care attendance, gastroenteritis, 
number of respiratory tract infections, overweight, parental history of atopy). The selection 
of potential confounders and mediators was performed by the alteration in odds ratios 
(ORs). The potential confounder or mediator was kept in the multivariate model in case of 
an alteration of 10% or greater in OR. To assess whether the association between the timing 
of allergenic food introduction and wheezing and eczema was different among children 
with a history of cow’s milk allergy and parental history of atopy vs those without, statistical 
interaction was evaluated by adding the product term of the independent variable and 
subgroup (independent variable×subgroup) as covariate to the univariate model. Stratified 
analyses by history of cow’s milk allergy or parental history of atopy were performed when 
the statistical interaction was significant. The pooled results of the 5 imputed data sets are 
reported in this article as ORs and 95% confidence intervals (CIs). P <.05 was considered as 
statistically significant. The statistical analyses were performed using SPSS software (version 
17.0 for Windows; SPSS Inc, Chicago, Illinois).
RESULTS
Study population
Maternal and child characteristics of the study population are presented in Table 3.1. Of 6905 
children, 31% had reported wheezing at age 2 years and 14% at ages 3 and 4 years. Eczema 
was reported in 38%, 20%, and 18% of children at the ages of 2, 3, and 4 years, respectively.
Introduction of allergenic foods and gluten
The introduction of tree nuts before the age of 6 months was significantly associated with 
wheezing at 2 years of age (OR, 2.69; 95% CI, 1.25-5.73). However, this association was 
explained by sex, maternal SES, race/ethnicity, maternal smoking, gestational age, birth 
weight, parity, breastfeeding, use of any antibiotics, day care attendance, gastroenteritis, 
number of respiratory tract infections, overweight, and parental history of atopy (Table 3.2). 
No significant association was found between early introduction to tree nuts and wheezing 
at age 3 years (OR, 1.24; 95% CI, 0.70-2.20) or 4 years (OR, 1.30; 95% CI, 0.79-2.13) (Table 
3.2). In addition, no significant association was found between early introduction to tree 
nuts and eczema up to age 4 years (Table 3.3). The introduction of cow’s milk, hen’s egg, 
peanuts, soy, and gluten to an infant’s diet before the age of 6 months was not significantly 
associated with wheezing (Table 3.2) or eczema (Table 3.3) at any age. These results were 
independent of sex, maternal SES, race/ ethnicity, maternal smoking, gestational age, birth 
weight, parity, breastfeeding, use of any antibiotics, day care attendance, gastroenteritis, 
number of respiratory tract infections, overweight, and parental history of atopy. Additional 
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adjustment for potential mediator history of cow’s milk allergy did not alter the results for 
wheezing or eczema (data not shown).
Parental history of atopy and infants history of cow’s milk allergy
A history of cow’s milk allergy in the first year of life was more frequently found in 
children with reported wheezing and eczema than in children without reported wheezing 
and eczema (P ≤.05 for difference in history of cow’s milk allergy at the ages of 2, 3, and 
Table 3.1. Maternal and child characteristics in 6905 preschool children participating in the Generation 
R study
Characteristics No. %
Mother
Socioeconomic status
Low 766 11
Mid 4746 69
High 1393 20
Ever smoked during pregnancy
No 5064 73
Yes 1841 27
Parents with a history of atopy 3274 47
Parity 2899 42
Child
Male sex 3496 51
Race/ethnicity
Dutch/Western 4380 63
Non- Western 2525 37
Gestational age at delivery, mean (SD), months 39.9 1.6
Birth weight, mean (SD),g 3431 540
History of cow’s milk allergy in first year of life 846 12
Breast-feeding
Never 781 11
6 months exclusive 345 5
4 months exclusive, partially at 6 months 1296 19
4 months exclusive, no breastfeeding at 6 months 357 5
6 months partially 795 12
4 months partially, no breastfeeding at 6 months 3331 48
Use of any antibiotics * 2839 41
Overweight * 1755 25
Respiratory tract infections, No.*
0 3322 48
1-3 times 2369 34
≥4 times 1213 18
Day care attendance* 5137 74
Gastro-enteritis* 4599 67
* From ages 12 to 24 months. 
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4 years). A parental history of atopy was also more frequently found in children with 
reported wheezing (P=.24, P <.01, and P=.11 for difference in parental history at the ages 
of 2, 3, and 4 years, respectively) and eczema (P <.05 for difference in parental history at 
the ages of 2, 3, and 4 years) (Supplementary Table 3.1). Although a significant interaction 
was found with a history of cow’s milk allergy for the introduction of peanuts and gluten 
(Supplementary Table 3.2), no significant association was found after stratification by 
history of cow’s milk allergy (Supplementary Table 3.3). No interaction was found 
between the timing of introduction of food allergens and parental history of atopy 
(Supplementary Table 3.4).
COMMENT
This population-based prospective birth cohort study failed to demonstrate that the timing 
of introduction of allergenic foods (cow’s milk, hen’s egg, peanuts, tree nuts, soy, and gluten) 
was associated with eczema and wheezing in children 4 years or younger. The results did not 
alter after stratification for history of cow’s milk allergy or parental history of atopy.
Various current feeding guidelines recommend complementary feeding to be 
introduced when a child is older than 4 to 6 months [13-15]. However, there is no current 
convincing evidence that delayed complementary feeding until a child is older than 4 to 6 
months is protective for the development of atopic disease [13, 15-18]. Few previous studies 
found earlier complementary feeding, before a child is 4 months of age, to be positively 
associated with atopic diseases as eczema and wheezing [10, 19, 34]. In a birth cohort in 
the Christchurch Child Development Study in New Zealand, eczema rates were found to 
be significantly higher in infants who were introduced to solid foods before 4 months of 
age [19, 34]. A study of a cohort of children in Dundee, Scotland, found solid feeding before 
15 weeks to be associated with an increased probability of wheezing during childhood 
[10]. However, these studies did not assess whether a longer delay of complementary 
feeding, until a child is older than 6 months, had a additional protective effect on eczema 
and wheezing.
The results of this study are in agreement with the findings of other birth cohort studies. 
The Influences of Lifestyle-related Factors on the Immune System and the Development of 
Allergies in Childhood (LISA) birth cohort study found no evidence supporting a delayed 
introduction of solid foods beyond age 6 months for the prevention of eczema at age 2 
years [35] and no evidence supporting a delayed introduction beyond ages 4 or 6 months 
for the prevention of asthma at age 6 years [17]. Filipiak et al [18] also did not find evidence 
supporting delayed introduction of solid foods beyond 4 months of age or delayed 
introduction of the most potentially allergenic solids beyond 6 months for the prevention 
of eczema. In addition, a birth cohort study in the United Kingdom found no evidence for 
a protective effect of late introduction for the development of eczema or wheezing at ages 
5 to 5 1⁄2 years [22]. Conversely, this last study found a significantly increased risk of eczema 
in relation to late introduction of the allergenic foods egg and milk. The KOALA birth cohort 
study [21]. found that a delayed introduction of cow’s milk was associated with a higher risk 
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of eczema in the first 2 years of life. The latter association could possibly be explained by 
reverse causation since parents with a family history of atopy or infants with early symptoms 
of allergy may delay complementary feeding. Possible distortion by reverse causality has 
been suggested previously [35].
An important strength of this study is the large study population drawn from the general 
population. Several other studies selected children of atopic parents who are at higher risk 
of developing atopic diseases, which might have led to selection bias since atopic parents 
are more likely to introduce allergenic foods later in the infant’s diet. An additional strength 
is the use of multiple imputation for missing data. Consequently, attrition bias was of 
minimum concern [32, 33].
Some limitations of the study have to be considered in the interpretation of the results. 
Information on the timing of allergenic food introduction was asked retrospectively when 
the child was 6 and 12 months old; therefore, minor misclassification because of recall bias 
cannot be excluded. However, this would have influenced our results only if parents of 
children with wheezing or eczema tended to misclassify having introduced allergenic foods 
after 6 months of age instead of before 6 months of age. Eczema and wheezing were 
diagnosed on the basis of parent-reported questionnaires. This could have led to 
misclassification of the outcome since physician diagnosis provides more accurate outcome 
diagnosis. Yet, we do not expect this misclassification to have influenced the effect of 
timing of food allergen introduction in particular, given that the outcome was measured 
after the introduction period. Another limitation of this study was that it could not examine 
the effect of allergenic food introduction before the age of 4 months in relation to eczema 
and wheezing. Thus, our study precludes conclusions on the effect of very early introduction 
of allergenic foods. However, Zutavern et al [17] found no evidence supporting a delayed 
introduction of solid foods beyond 4 or 6 months of age for the prevention of asthma 
at the age of 6 years. For eczema any effect of a delayed introduction of solids could not 
be excluded.
Asthma assessment among young children is based on asthmalike symptoms, such as 
wheezing, often reported by parents through self-administered written questionnaires. Early 
wheezing in infancy is, however, not a very strong and independent predictor of childhood 
asthma. Diagnosis of asthma is difficult in young children, owing to the nonspecificity of 
the symptoms and the fact that conventional lung function tests cannot be performed 
at such a young age [36]. Therefore, our results do not allow for conclusions regarding 
the introduction of allergenic foods and later development of asthma. However, previous 
studies found that an infant’s diet has a greater effect on short-term outcomes of atopic 
diseases than on long term-outcomes [7]. Therefore, we do not expect the effect of 
the introduction of allergenic foods to influence the results for eczema and wheezing 
differently at ages older than 4 years.
We considered confounding and reverse causality in our analysis by adjusting for 
potential confounders and by evaluating statistical interaction for history of cow’s milk 
allergy and parental history of atopy. However, residual confounding and residual reverse 
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causality cannot be fully excluded. Reverse causation may occur if a delayed introduction of 
allergenic foods is truly protective for wheezing and eczema and parents of high-risk infants 
were more likely to delay the introduction of allergenic foods after 6 months of age, which 
may cancel out the effect.
In conclusion, the results presented in this study do not support a delayed introduction 
of allergenic foods at an age older than 6months for the prevention of atopic diseases 
eczema and wheezing. Further studies in our cohort should focus on asthma and eczema at 
later ages in order to elucidate whether late introduction of food allergens delays the onset 
of atopic disease.
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Supplementary Table 3.1. History of cow’s milk allergy and parental history of atopy in children with 
wheezing and eczema (n=6905)
Children  
with wheezing
Children 
without 
wheezing P value
Children 
with eczema
Children 
without 
eczema P value
History of cow’s milk allergy
Year 2 16% 11% <0.01 17% 10% <0.01
Year 3 15% 12% 0.05 19% 11% <0.01
Year 4 17% 12% <0.01 18% 11% <0.01
Parental history of atopy 
Year 2 49% 47% 0.24 49% 46% <0.05
Year 3 52% 47% <0.01 53% 46% <0.01
Year 4 50% 47% 0.11 51% 47% <0.05
Supplementary Table 3.2. Statistical interaction between the introduction of allergenic foods and history 
of cow’s milk allergy
Allergenic food introduced at 
age ≤6 months
Eczema Wheezing
Year 2 Year 3 Year 4 Year 2 Year 3 Year 4
P value P value P value P value P value P value
Cow’s milk 0.60 0.33 0.28 0.70 0.73 0.34
Henn’s egg 0.80 0.99 0.91 0.48 0.46 0.42
Peanut 0.24 0.63 0.53 0.03 0.49 0.38
Tree nut 0.27 0.43 0.13 0.99 0.61 0.50
Soy 0.09 0.31 0.21 0.54 0.33 0.39
Gluten 0.36 0.10 0.13 0.91 0.12 0.04
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Supplementary Table 3.4. Statistical interaction between the introduction of allergenic foods and 
parental history of atopy
Allergenic food introduced  
at age ≤6 months
Eczema Wheezing
Year 2 Year 3 Year 4 Year 2 Year 3 Year 4
P value P value P value P value P value P value
Cow’s milk 0.87 1.00 0.81 0.63 0.74 0.14
Henn’s egg 0.79 0.85 0.85 0.72 0.81 0.98
Peanut 0.25 0.85 0.71 0.98 0.78 0.75
Tree nut 0.87 1.00 0.09 0.99 0.70 0.46
Soy 0.73 0.93 0.24 0.84 0.87 0.53
Gluten 0.29 0.64 0.70 0.72 0.25 0.30

4 Infant feeding and anti-tissue transglutaminase antibody concentrations
IIM Tromp, MAE Jansen, JC Kiefte-de Jong, VWV Jaddoe, 
A Hofman, JC Escher, H Hooijkaas and HA Moll. 
Am J Clin Nutr. 2014;100:1095–101
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ABSTRACT
Background: Celiac disease (CD) has emerged as a common, but largely undiagnosed health 
problem. Numerous studies examined the influence of infant nutrition on the development 
of diagnosed CD. However, results are still inconsistent. In addition, the effect of infant 
feeding practices on the development of potential forms of CD might be different.
Objective: The objective was to examine whether the timing of gluten introduction and 
breastfeeding duration are associated with CD autoimmunity (CDA) in children at the age 
of 6 y.
Design: This study was embedded in the Generation R Study, a population-based 
prospective cohort study. Participants included 1679 Dutch children who were positive for 
human leukocyte antigen (HLA) DQ2/DQ8. Data on the timing of gluten introduction (<6 mo 
compared with ≥6 mo) and duration of breastfeeding (<6 mo compared with ≥6 mo) were 
obtained by questionnaire. Serum samples were analyzed for anti-tissue transglutaminase 
(anti-tTG) concentrations at age 6 y. Anti-tTG concentrations were categorized into negative 
(<7 U/mL) and positive (≥7 U/mL) values. Positive anti-tTG concentrations were further 
categorized based on ≥10 times the upper limit of normal (ULN) values of the test kit (≥7–70 
and ≥70 U/mL). Multivariable logistic regression analyses were performed. 
Results: Positive anti-tTG concentrations were found in 43 children, 26 of whom had 
concentrations ≥10 times the ULN (≥70 IU/mL). The introduction of gluten from the age of 
6 mo onward and breastfeeding for ≥6 mo were not significantly associated with positive 
anti-tTG concentrations. In addition, the timing of gluten introduction and duration of 
breastfeeding were not significantly associated with positive anti-tTG concentrations below 
or above 10 times the ULN.
Conclusions: Delayed introduction of gluten beyond the age of 6 mo does not increase 
the risk of CDA. In addition, breastfeeding for ≥6 mo does not decrease the risk of CDA in 
children at 6 y of age.
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INTRODUCTION
Celiac disease [CD] has emerged as a common, but largely undiagnosed, health problem 
[1, 2]. Untreated CD is associated with excess morbidity in children and adults [3]. CD is 
characterized by an adaptive T cell–mediated response against gluten, classically resulting 
in chronic inflammation of the small intestinal mucosa and gastrointestinal complaints [4, 5]. 
However, the clinical presentation of CD has changed over the past few decades to include 
milder, nonclassic forms [6, 7]. Therefore, diagnosed CD only represents the more visible 
tip of the iceberg, ie, children having clinical symptoms, whereas asymptomatic or atypical 
cases are often missed [6].
Both human leukocyte antigen (HLA) DQ2/DQ8 carrier status and gluten exposure 
are prerequisites to develop CD. Breastfeeding and the timing of gluten exposure might 
influence the risk of CD. Underlying mechanisms remain uncertain but might involve 
a complex interplay between innate and adaptive immune responses, gut colonization, 
intestinal membrane permeability, genetic predisposition, and environmental factors such 
as infections and infant feeding habits [8–10].
Numerous studies examined the influence of infant nutrition, including breastfeeding 
and the timing of gluten introduction, on the development of diagnosed CD. On the basis 
of current literature, the European Society for Pediatric Gastroenterology, Hepatology, and 
Nutrition (ESPGHAN) Committee on Nutrition recommends to avoid both early (<4 mo) 
and late (>7 mo) introduction of gluten and to introduce gluten gradually while the child is 
still being breastfed [11]. However, results are still inconsistent in this respect [7, 9, 12–19]. 
The lack of consistency between studies may be due to the majority of these studies being 
retrospective (ie, comparing history of infant feeding practices in CD cases compared with 
controls) [13, 17, 18, 20] or ecological (ie, linking incidence rates of diagnosed CD to national 
infant feeding practices) [1]. These latter studies were mainly based on clinical CD. However, 
because subclinical, silent, or latent forms of CD might exist [4], it could be speculated that 
these forms have different etiologies, but these are not fully understood. Therefore, the effect 
of infant feeding practices on the development of subclinical, silent or latent forms of CD 
might be different [17, 21]. For example, a Swedish study found a decreased prevalence of 
symptomatic CD after new infant feeding recommendations were introduced but did not 
find any difference in the prevalence of undiagnosed (screening detected) CD [21]. However, 
a later replication within the same cohort study did not support these findings [19]. The aim 
of the current study was to examine whether breastfeeding duration and the timing of 
gluten introduction were associated with CD autoimmunity (CDA) in a population-based 
prospective cohort study in 6-y-old children.
SUBJECTS AND METHODS
Participants and study design
This study was embedded in the Generation R Study, a prospective population-based cohort 
study from fetal life onward, and has been described in detail previously [22]. A total of 8305 
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mothers with a delivery date from April 2002 through January 2006 provided consent for 
school age follow-up. Ethical approval for the study was obtained from the Medical Ethical 
Committee of the Erasmus MC, University Medical Center Rotterdam. 
Duration of breastfeeding
Information with regard to breastfeeding was obtained by a combination of delivery reports 
and postnatal questionnaires at the ages of 2, 6, and 12 mo [22]. Mothers were asked by 
questionnaire whether they had ever breastfed their child and, if yes, at what age (in mo) 
they had stopped breastfeeding. Breastfeeding duration was categorized as reported by 
Størdal et al [14] but later dichotomized as <6 mo and ≥6 mo because only 1 infant still 
received breast milk at the age of 13 mo. Questionnaire response rates were 82%, 73%, and 
72% at age 2, 6, and 12 mo, respectively.
Introduction of gluten in the first year of life
At the child’s age of 6 and 12 mo, parents were asked by questionnaire the age of first-
time introduction of gluten in their infant’s diet. In addition, parents were asked to complete 
a short food-frequency questionnaire consisting of food products frequently consumed 
according to a Dutch food consumption survey in infants [23]. The timing of gluten 
introduction was cross-checked with the consumption of bread and biscuits and type of 
porridge (based on wheat or oats instead of rice) at the age of 6 and 12 mo, as described 
previously [24]. The timing of the introduction of gluten was categorized as <6 mo or ≥6 mo.
Anti-tissue transglutaminase concentrations
Anti-tissue transglutaminase (anti-tTG) concentrations were assessed in venous serum 
samples by using fluorescence enzyme immunoassay (ELiA Celikey IgA, PhadiaImmunocap 
250; Phadia AB) at the Department of Immunology, Erasmus MC- University Medical 
Center Rotterdam, The Netherlands. The intra- and interassay CVs were below 10% and 
15%, respectively. Of 8305 children participating at the age of 6 y, serum anti-tTG was 
available in 53% of children. We excluded 20 children in whom IgA concentrations were 
low, possibly indicating IgA deficiency. None of the participants were aware of tTG-IgA 
determination. The median anti-tTG concentration in the study population was 0.25 U/mL, 
varying from 0.10 to 125 U/mL. Anti-tTG concentrations were categorized into negative 
and positive by using the cutoff for clinical practice of 7 U/mL (Figure 4.1). Positive anti-tTG 
concentrations were further categorized into 2 categories based on ≥10 times the upper 
limit of normal (ULN) values of the test kit (cutoffs for positive anti-tTG: ≥7–70 and ≥70 U/mL) 
(Figure 4.1) [25].
Detection of HLA risk alleles
To capture whether the children carried the HLA-DQ risk type DQ2 or DQ8, a tag nucleotide 
polymorphism (single nucleotide polymorphism) approach was used as was described in 
detail previously [26, 27]. Children were genotyped for these single nucleotide polymorphisms 
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for HLA-DQ2 (rs2187668, rs2395182, rs4713586, and rs7775228) and DQ8 (rs7454108) [26] 
by using genome-wide Illumina 610 Quad Array. Genotype and allele frequencies were in 
Hardy-Weinberg equilibrium (rs2187668, P= 0.71; rs2395182, P= 0.85; rs4713586, P= 0.57; 
rs7775228, P= 0.92; and rs7454108, P= 0.76).
Covariates
Data on potential confounders such as fetal sex, gestational age, birth weight, and cesarean 
section (no differentiation was made between planned and unplanned) were obtained 
from obstetric records assessed in midwife practices and hospitals [22]. Maternal anti-tTG 
concentrations were measured during pregnancy. Data on other sociodemographic and 
lifestyle factors were obtained by a combination of pre- and postnatal questionnaires 
completed by both parents. This included information on ethnicity (Western or non-Western) 
[28], parity, maternal smoking during pregnancy, maternal educational level (low or high) 
[29], and household income per month (≤€2200 or ≥€2200) [30]. Postnatal questionnaires 
included information on vitamin D supplementation, gastrointestinal and respiratory tract 
infections, and day care attendance in the first year.
 
Figure 4.1 Flowchart of participants in the Generation R Study . anti-tTG, anti-tissue 
transglutaminase; HLA, human leukocyte antigen; ULN, upper limit of normal.  
 
  
Visit to research center age 6 years  
(n=6690) 
Serum collection  
(n=4593) 
Serum anti-tTG concentrations available 
(n=4442) 
HLA-DQ2/DQ8 carrier 
(n=1679) 
Excluded: random sample 
within siblings (n=373), 
children with diagnosed 
celiac disease (n=8) and no 
HLA-DQ2/DQ8 carrier 
(n=2382)  
Negative anti-tTG 
(n=1636) 
Positive anti-tTG 
(n=43) 
<10 times ULN 
(n=17) 
≥10 times ULN 
(n=26) 
Figure 4.1. Flowchart of participants in the Generation R Study. anti-tTG, anti-tissue transglutaminase; 
HLA, human leukocyte antigen; ULN, upper limit of normal.
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Population for analyses
Of all children with anti-tTG data available (n= 4442), we excluded from the analysis those 
with diagnosed CD (n= 8) at the age of 6 y and children who were HLA-DQ2/DQ8 negative 
(n= 2382). To prevent clustering, only one child per family within the Generation R cohort was 
included by random selection (n= 373). In total, 1679 children were available for statistical 
analyses (Figure 4.1).
Statistical analysis
First, independent Student’s t test and chi-square tests were performed to test for differences 
in characteristics between groups of anti-tTG concentrations. Second, logistic regression 
analysis was performed with anti-tTG concentration at the age of 6 y as a dependent 
variable. Breastfeeding and the timing of gluten introduction were analyzed separately as 
independent variables and adjusted for major confounders. Because of the small numbers 
in the positive anti-tTG group, the selection of potential confounders in the multivariate 
model was restricted to those with an alteration of ≥10% in ORs [31]. To assess whether 
the association between breastfeeding or the timing of gluten introduction and anti-tTG 
concentrations differed by ethnicity and children with and without gastrointestinal 
infections during infancy, statistical interactions were evaluated by adding the product term 
of independent variable and subgroup (independent variable 3 subgroup) as covariates 
to the univariate model. To reduce attrition bias, multiple imputation of the exposures 
(ie, breastfeeding and timing of gluten introduction) and covariates was performed (n= 5 
imputations). The multiple imputation procedure was based on the correlation between 
each variable with missing values with other subject characteristics [32]. The pooled 
results of the 5 imputed data sets are reported in this article as ORs and 95% CIs. A P value 
<0.05 was considered significant. The statistical analyses were performed in SPSS 20.0 
for Windows (SPSS, Inc).
RESULTS
Maternal and child characteristics of the study population are shown in Table 4.1. In all 1679 
HLA-DQ2/DQ8–positive children, 2.6% had positive anti-tTG concentrations and 97.4% had 
negative anti-tTG concentrations (Table 4.1 and Figure 4.1). Of children with positive anti-tTG 
concentrations (n= 43), 60% (n= 26) had values ≥10 times the ULN (≥70 IU/mL) (Table 4.1 
and Figure 4.1). Breastfeeding for ≥6 mo was reported in 47% of children with positive and 
negative anti-tTG concentrations (Figure 4.2). The introduction of gluten from the age of 6 
mo onward was reported in 56% and 64% of children with positive and negative anti-tTG 
concentrations, respectively (Figure 4.2).
Breastfeeding and anti-tTG concentrations
Relative to breastfeeding for <6 mo, breastfeeding for ≥6 mo was not significantly 
associated with positive anti-tTG concentrations (Table 4.2). In addition, breastfeeding 
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Table 4.1. Maternal and child characteristics according to anti-tTG concentration1
Negative anti-tTG Positive anti-tTG
n=1636 (97.4%)
≥7-70 IU/ml 
n=17 (1%)
≥70 IU/ml 
n=26 (1.6%)
n % n % n %
Maternal characteristics
Educational level
Low 369 23 6 35 2 8
Mid 854 52 7 41 15 58
High 413 25 4 24 9 34
Household income per month
≤2200 euro 732 45 9 53 5 19
>2200 euro 904 55 8 47 21 812
Smoking during pregnancy
Never 1203 74 13 76 20 77
Smoked during pregnancy 433 26 4 24 6 23
Caesarean section 213 13 2 12 2 8
Parity 711 43 7 41 10 38
Maternal anti-tTG during pregnancy3
Negative 1242 99 12 100 20 100
Positive 6 1 0 0 0 0
Child characteristics
Male 843 52 4 242 8 312
Ethnicity
Western 1107 68 11 65 25 962
Non-Western 529 32 6 35 1 4
Birth weight z-score4 -0.04 0.99 0.16 1.13 -0.28 1.14
Breastfeeding
0 to <3 months 461 28 3 18 9 35
3 to <6 months 402 25 3 18 8 30
≥6 months 773 47 11 64 9 35
Introduction of gluten
<6 months 586 36 5 29 14 542
≥6 months 1050 64 12 71 12 46
Gastrointestinal tract infections first year 1072 66 11 65 18 69
Respiratory tract infections first year 893 55 10 59 18 69
Vitamin D supplementation age 6-12 months 874 53 10 59 12 46
Day care attendance first year 1099 67 12 71 24 922
1 n= 1679. Anti-tTG, anti-tissue transglutaminase.
2 Significantly different from negative anti-tTG concentrations, P < 0.05.
3 Was not multiple imputed.
4 Values are means ± SDs.
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for ≥6 mo was not significantly associated with positive anti-tTG concentrations below 
or above 10 times the ULN (≥70 IU/mL) (Table 4.3). In comparison with breastfeeding 
for <3 mo, breastfeeding between 3 and 6 mo and for ≥6 mo was not significantly 
associated with anti-tTG concentrations (data not shown). No significant interaction was 
found between breastfeeding and ethnicity or gastrointestinal infections during infancy 
(P-interaction > 0.50).
Timing of gluten introduction and anti-tTG concentrations
In comparison with the introduction of gluten before the age of 6 mo, the introduction 
of gluten from the age of 6 mo onward was not significantly associated with positive 
anti-tTG concentrations (Table 4.4). In addition, the introduction of gluten from the age of 
 
Figure 4.2 Duration of breastfeeding and timing of gluten introduction according to anti-tTG concentration. A: Proportion of 
children breastfed for ≥6 mo according to anti-tTG concentration [<7 U/mL (n = 1636) or ≥7 U/mL (n = 43)]. B: Proportion of 
children introduced to gluten from the age of 6 mo onward according to anti-tTG concentration [<7 U/mL (n = 1636) or ≥7 U/mL (n 
= 43)]. anti-tTG, anti-tissue transglutaminase. 
 
  
Figure 4.2. Duration of breastfeeding and timing of gluten introduction according to anti-tTG 
concentration. A: Proportion of children breastfed for ≥6 mo according to anti-tTG concentration 
[<7 U/mL (n= 1636) or ≥7 U/mL (n= 43)]. B: Proportion of children introduced to gluten fro  the age 
of 6 mo onward according to anti-tTG concentration [<7 U/mL (n= 1636) or ≥7 U/mL (n= 43)]. anti-tTG, 
anti-tissue transglutaminase.
Table 4.2. Association between breastfeeding duration and positive anti-tTG concentrations1
Breastfeeding n (%) Crude model Multivariate model2
<6 months 885 (53) Reference Reference
≥6 months 794 (47) 1.07 (0.52-2.22) 1.20 (0.56-2.59)
1 n= 1679. Values for the crude model are ORs (95% CIs), and values for the multivariate model are aORs. 
2 Adjusted for smoking during pregnancy, cesarean section, parity, day care attendance in first year, respiratory tract 
infections in first year, vitamin D supplementation at age 6–12 mo, household income per month, and maternal educational 
level. Additional adjustment for sex, ethnicity, birth weight z score, timing of gluten introduction, gastrointestinal tract 
infections in the first year, and maternal anti-tTG concentration did not provide an alteration of ≥10% in ORs.
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Table 4.3. Association between breastfeeding duration and positive anti-tTG concentrations below and 
above 10 times ULN1
Breastfeeding n (%)
≥7-70 IU/ml  
n=17
≥70 IU/ml  
n=26
Crude model Multivariate model2 Crude model Multivariate model2
<6 months 885 (53) Reference Reference Reference Reference
≥6 months 794 (47) 2.57 (0.56-11.75) 2.52 (0.59-10.84) 0.64 (0.24-1.73) 0.78 (0.27-2.27)
1 n= 1679. Values for the crude model are ORs (95% CIs), and values for the multivariate model are aORs (95% CIs). anti-tTG, 
anti-tissue transglutaminase; aOR, adjusted OR; ULN, upper limit of normal.
2 Adjusted for smoking during pregnancy, cesarean section, parity, day care attendance in first year, respiratory tract 
infections in first year, vitamin D supplementation at age 6–12 mo, household income per month, and maternal educational 
level. Additional adjustment for sex, ethnicity, birth weight z score, timing of gluten introduction, gastrointestinal tract 
infections in the first year, and maternal anti-tTG concentration did not provide an alteration of ≥10% in ORs.
6 mo onward was not significantly associated with positive anti-tTG concentrations below 
or above 10 times the ULN (≥70 IU/mL) (Table 4.5). No significant interaction was found 
between the timing of gluten introduction and ethnicity or gastrointestinal infections 
during infancy (P-interaction > 0.69). 
Table 4.4. Association between the introduction of gluten and positive anti-tTG concentrations1
Gluten introduction n (%) Crude model Multivariate model2
<6 months 605 (36) Reference Reference
≥6 months 1074 (64) 0.68 (0.34-1.35) 0.64 (0.31-1.31)
1 n= 1679. Values for the crude model are ORs (95% CIs), and values for the multivariate model are aORs (95% CIs). anti-tTG, 
anti-tissue transglutaminase; aOR, adjusted OR.
2 Adjusted for ethnicity and household income per month. Adjustment for sex, birth weight z score, smoking during 
pregnancy, breastfeeding, parity, cesarean section, day care attendance, vitamin D supplementation, gastrointestinal and 
respiratory tract infections in the first year, maternal educational level, and maternal anti-tTG concentration did not provide 
an alteration of ≥10% in ORs.
DISCUSSION
In this population-based prospective birth cohort, we did not find an association with 
breastfeeding duration and the timing of gluten introduction and positive anti-tTG 
concentrations in children with CDA at the age of 6 y.
The ESPGHAN Committee on Nutrition recommends that both early and late introduction 
of gluten should be avoided. In addition, it is recommended to introduce gluten in small 
amounts into the diet when the infant is still being breastfed [11]. However, evidence for 
avoiding very early and late introduction of gluten for the prevention of CD is inconsistent. 
We did not find a relation between the timing of gluten introduction and the risk of CD in 
childhood, which is in accordance with other studies [13, 15, 17]. In contrast, findings of 2 
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other prospective studies support a role for the timing of gluten introduction [9, 14]. Norris 
et al [9] found an increased risk of biopsy-confirmed CD in CDA-positive children for both 
early (≤3 mo) and late (≥7 mo) introduction of gluten [9]. Strikingly, before restricting their 
analyses to biopsy-confirmed CD, Norris et al did not find late introduction to increase the risk 
of CDA. This suggests that the timing of gluten introduction may be differentially associated 
with biopsy-confirmed and non–biopsy-confirmed CD. However, diagnosed CD is subject to 
bias, depending on the awareness of the pediatricians to make the diagnosis. In addition, 
Norris et al focused on high-risk children defined as having a firstdegree relative with type 
1 diabetes or having HLA genotypes associated with CD and type 1 diabetes. Therefore, 
the results cannot be directly extrapolated to our study. Very recently, the Norwegian 
Mother and Child Cohort Study [14] found late (≥7 mo) but not early (≤4 mo) introduction 
to be borderline associated with an increased risk of CD (adjusted OR: 1.27; 95% CI: 1.01, 
1.65). We could not confirm these results in our study, nor did we find the effect estimates 
in the same direction (adjusted OR: 0.64; 95% CI: 0.31, 1.3). However, the Norwegian Mother 
and Child Cohort Study included children with clinical CD instead of CDA, which may explain 
the different results.
The results of our study on breastfeeding and the development of CDA are in line with 
the findings of other prospective studies [9, 15, 33]. Størdal et al [14] also did not find 
breastfeeding for ≥6 mo (6–12 mo) to be associated with CD but found breastfeeding 
beyond 12 mo to be associated with an increased risk of CD. The majority of children in our 
cohort did not breastfeed after the age of 12 mo; therefore, we were unable to replicate this 
analysis [14]. Several studies did find breastfeeding to reduce the risk of CD [12, 17], especially 
breastfeeding at the time of [13, 34, 35] and beyond [12, 13, 19, 35] the introduction of gluten, 
as well as with gradual introduction of gluten while breastfeeding [12, 13, 19]. However, 
most of these studies were based on retrospectively collected data, which may lead to 
recall bias (ie, differential reporting on infant feeding practices in those with and without 
CD diagnosis) [13, 17, 18, 20, 35]. In addition, it remains unclear whether the protective 
Table 4.5. Association between the introduction of gluten and positive anti-tTG concentrations below 
and above 10 times ULN1
Gluten 
introduction n (%)
≥7-70 IU/ml  
n=17
≥70 IU/ml  
n=26
Crude model Multivariate model2 Crude model Multivariate model2
<6 months 605 (36) Reference Reference Reference Reference
≥6 months 1074 (64) 1.27 (0.37-4.37) 1.30 (0.38-4.41) 0.47 (0.19-1.13) 0.42 (0.17-1.02)
1 n= 1679. Values for the crude model are ORs (95% CIs), and values for the multivariate model are aORs (95% CIs). anti-tTG, 
anti-tissue transglutaminase; aOR, adjusted OR; ULN, upper limit of normal.
2 Adjusted for ethnicity and household income per month. Additional adjustment for sex, birth weight z score, smoking 
during pregnancy, breastfeeding, parity, cesarean section, day care attendance, vitamin D supplementation, gastrointestinal 
and respiratory tract infections in the first year, maternal educational level, and maternal anti-tTG concentration did not 
provide an alteration of ≥10% in ORs.
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effect of breastfeeding is persistent or only delays the onset of symptoms and therefore CD 
diagnosis [12, 20, 34, 35]. For example, previous studies found longer breastfeeding [35] and 
breastfeeding exclusivity [18] only to delay the onset of CD in infancy. This may explain why 
we did not find any association between breastfeeding duration and CDA. Although we did 
not find breastfeeding duration and the timing of gluten introduction to be associated with 
CDA, we do not exclude the role of infant feeding in the development of CD. Breastfeeding 
and the timing of gluten introduction might not be protective for the development of 
subclinical, silent, or latent forms of CD but could protect against developing symptomatic 
CD. Also, gluten introduction while breastfeeding and the amount of gluten could be more 
important than the duration of breastfeeding and the timing of gluten introduction, as 
suggested by Ivarsson et al [13].
An important strength of this study is, first, the assessment of serum anti-tTG 
concentrations and HLA testing in the general pediatric population, which are good 
methods to detect clinically silent CD [6]. Previous studies selected children with diagnosed 
CD [17], or with symptomatic CD leading to CD diagnosis [13, 5], or focused on high-risk 
children [9]. Second, we subdivided positive anti-tTG concentrations (≥7 U/mL) into 2 groups 
based on 10 times the ULN value (≥70 IU/mL), because positive antitTG concentrations ≥10 
times the ULN show high diagnostic accuracy [25]. Of all anti-tTG–positive children in our 
study population, >60% had anti-tTG concentrations ≥10 times the ULN, suggesting that 
these children likely have CD. Third, our study design provided information on a broad 
range of potential confounders, including ethnicity, socioeconomic status, smoking during 
pregnancy, and infections.
Some limitations should be taken into account in the interpretation of the results. 
Information on breastfeeding duration and the timing of gluten introduction was obtained 
by parental self-report. Nevertheless, only if misclassification of infant feeding practices 
were related to CD diagnosis would it have influenced our results, which is unlikely because 
questionnaires on feeding practices were completed before anti-tTG measurement at 6 y 
of age. In addition, participants in our study were unaware of tTG IgA determination, so 
a response bias is therefore highly unlikely. Also, it may be questioned whether our study 
had sufficient power to detect small differences in gluten introduction practices between 
children with and without CDA development. Our study had a power of 80% (at an α of 
0.05) to detect at least a 22% difference in gluten at ≥6 mo to be significant between 
children with and without CDA. A recent study [19] (n= 13,279) found a difference of 2.5% 
in gluten at >6 mo to be significant, whereas Norris et al [9] found a difference of 12% to be 
significant (n= 1560). Although the sensitivity and specificity of anti-tTG are high [25, 36], 
only when anti-tTG concenetrations are ≥10 times the ULN in combination with symptoms 
and positive anti-endomysial antibody can (clinical) CD be diagnosed without duodenal 
biopsy [25]. According to the ESPGHAN, clinically diagnosed CD concerns children who 
visit the pediatrician because of symptoms, whereas subclinical CD is found by screening 
and must be verified by biopsy specimens. However, because our study did not have 
biopsy specimens, we examined the development of CDA. Therefore, final conclusions 
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concerning (subclinical) CD diagnosis should be made with caution. Furthermore, we 
adjusted for potential confounders in our analysis, but residual confounding cannot be fully 
excluded. Another limitation of this study is that our study cannot examine the effect of 
gluten introduction before the age of 4 mo, as well as the amount of gluten introduced 
in relation to anti-tTG concentrations. Although a previous study in Dutch infants showed 
that the majority of children receive gluten between 3 and 6 mo of age and not before 
that time [37], a window of opportunity in which gluten introduction might prevent CDA 
cannot be fully ruled out. In relation to breastfeeding, this study cannot examine the effect 
of breastfeeding at the time of and beyond gluten introduction. Hence, our study precludes 
conclusions on the effect of very early introduction of gluten, gradual introduction of gluten, 
and the introduction while breastfeeding.
In conclusion, the results suggest that a delayed introduction of gluten beyond the age 
of 6 mo does not increase the risk of CDA. In addition, breastfeeding for ≥6 mo does not 
decrease the risk of CDA in children at 6 y of age. Our study precludes conclusions on 
the timing of gluten introduction while breastfeeding.
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Part II
Nutrition and respiratory and allergic disease

5 Breastfeeding and the risk of respiratory tract infections after infancy
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ABSTRACT
Background: The protection of breastfeeding against respiratory tract infections in the first 
year of life has often been suggested. Few studies examined the effect of breastfeeding on 
respiratory tract infections after infancy.
Objective: To examine the association between breastfeeding with lower respiratory tract 
infections (LRTI) and upper respiratory tract infections (URTI) after infancy up to 4 years of 
age (n= 5322).
Methods: This study was embedded in The Generation R study, a Dutch population-based 
prospective cohort study from fetal life until young adulthood. Information on breastfeeding 
duration (never; <3 months; 3-6 months; ≥6 months) and dose (never; partially until 4 months; 
predominantly until 4 months) were collected by questionnaire at 2, 6, and 12 months of 
age. Information on doctor attendance for LRTI and URTI were obtained by questionnaire at 
2, 3, and 4 years of age.
Results: Breastfeeding for 6 months or longer, but not for less than 6 months, was significantly 
associated with a reduced risk of LRTI up to 4 years of age (aOR: 0.71; 95% CI: 0.51-0.98). 
Compared to never being breastfed, any breastfeeding duration was not associated with URTI 
after infancy. Partial and predominant breastfeeding until 4 months was not significantly 
associated with LRTI or URTI after infancy up to 4 years of age.
Conclusion: Breastfeeding duration for 6 months or longer is associated with a reduced risk 
of LRTI, but not URTI, in pre-school children whereas predominant breastfeeding until 4 
months was not associated with respiratory tract infections. These findings are compatible 
with the hypothesis that the protective effect of breastfeeding for respiratory tract infections 
persist after infancy therefore supporting current recommendations for breastfeeding for at 
least 6 months.
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INTRODUCTION
Infectious diseases, including respiratory tract infections, are a leading cause of morbidity 
and hospitalization in infants and children [1, 2]. There is much epidemiological evidence for 
the benefits of breastfeeding against a wide range of infections and illnesses [3, 4]. Breast 
milk contains various antimicrobial substances, anti-inflammatory components and factors 
that promote immune development [4, 5]. It enhances the immature immune system of 
the infant and strengthens defense mechanisms against infectious and other agents during 
the breastfeeding period [4-7]. Exclusive breastfeeding for the first 6 months of life with 
breastfeeding along with complementary feeding thereafter is recommended by the World 
Health Organization (WHO) [8]. The benefits have been found to be dose-dependent and 
related to the duration of breastfeeding [3, 4]. The protection of exclusive and prolonged 
breastfeeding against respiratory tract infections in the first year of life has often been 
suggested and also found in The Generation R Study [3, 4, 9, 10]. But, not all studies found 
breastfeeding exclusivity and duration to reduce the occurrence of respiratory tract infections 
[11, 12]. It is suggested that the influences of breast milk on the infant’s immune system 
may persist beyond the breastfeeding period, as it not only provides passive immunity 
but also maturation of the immune system in the long run [13, 14]. Since breastfeeding 
might protect against diseases in adulthood such as type 1 diabetes and inflammatory 
bowel disease [3, 4, 15] a prolonged protection against respiratory tract infections after 
the first year of life seems plausible. However, only few studies have examined the effect 
of breastfeeding on respiratory tract infections after infancy and reported inconsistent 
results [16-21].
The aim of this study was to examine the association between breastfeeding and lower 
and upper respiratory tract infections after infancy up to 4 years of age.
SUBJECTS AND METHODS
Participants and study design
This study was embedded in the Generation R study, a population-based prospective cohort 
study from fetal life until young adulthood and has been described in detail previously 
[22]. In total, 9778 mothers with a delivery date from April 2002 through January 2006 
enrolled in the study. Consent for postnatal follow-up was provided by 7893 participants 
(Supplementary Figure 5.1). The study was approved by the medical ethical review board of 
the Erasmus Medical Center, Rotterdam, the Netherlands.
Respiratory tract infections
Data on respiratory tract infections was obtained by postal parent-reported questionnaires 
at the age of 2, 3 and 4 years. Parents were asked whether their child had suffered from 
a respiratory tract infection in the previous year and had visited a doctor for the infectious 
disease. Upper respiratory tract infections were defined as having either a serious cold, 
ear infection or throat infection and lower respiratory tract infections by the presence 
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of pneumonia or bronchitis as described in our previous study [10]. Upper and lower 
respiratory tract infections were defined as present or absent in the second, third and 
fourth year of life. Questionnaire response rates were 76%, 69% and 73% at the age of 2, 3 
and 4 years respectively.
Breastfeeding
Data on breastfeeding were collected by a combination of delivery reports and postnatal 
postal questionnaires at the age of 2, 6 and 12 months. By questionnaire the mothers were 
asked whether they had ever breastfed their child and at which age (in months) the child 
had stopped receiving breast milk. The duration of breastfeeding was categorized as (I) 
never breastfed, (II) breastfed for less than 3 months, (III) breastfed for 3-6 months, and 
(IV) breastfed for 6 months and longer. The majority of infants had stopped receiving 
breast milk before the age of 12 months, only 3 infants thereafter. An approximation of 
breastfeeding exclusivity was defined on the basis of parent reports of the child’s age at 
which solid foods were first introduced, including the introduction of formula feeding. 
Predominant breastfeeding was defined as receiving breastfeeding without any other infant 
formula, milk or solid foods [23]. Breastfeeding dose was categorized as (I) never breastfed, 
(II) partially breastfed until 4 months, and (III) predominantly breastfed until 4 months. 
Partial breastfeeding was defined as receiving both breast milk and infant formula and/or 
solid foods. Questionnaire response rates were 82%, 73% and 72% at the age 2, 6 and 12 
months respectively.
Covariates 
Information on potential confounders, including mode of delivery, gender and gestational 
age, were obtained from obstetric records assessed in mid-wife practices and hospital 
registries [22]. Additional information was obtained by a combination of prenatal and 
postnatal questionnaires completed by both parents. The questionnaires included 
information on maternal age, maternal educational level, maternal marital status, maternal 
ethnicity, household income per month, maternal BMI before pregnancy, any maternal 
smoking during pregnancy, any maternal alcohol use during pregnancy, parity and parental 
history of atopy. Ethnicity of the mother was defined as follows: if both parents were born in 
The Netherlands, the ethnicity of the mother was defined as Dutch; if one of the parents was 
born in another country than The Netherlands, that country applied; if parents were born 
in different countries other than The Netherlands, the country of the mother applied [24]. 
Ethnicity of the mother was categorized into Western (Dutch, European, American-Western, 
Asian-Western) and non-Western (American non-Western, Asian non Western, African, 
Turkish, Cape Verdean, Moroccan, Dutch Antillean, Surinamese, Oceania, and Indonesian). 
Maternal educational level was defined as follows; low: no education, primary school or 
less than 3 years of secondary school, mid: more than 3 years of secondary school, higher 
vocational training or bachelor’s degree, and high: academic education [25]. Household 
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income per month was categorized into two income-groups using the approximate monthly 
general labour income during the inclusion period of this study as cut off point (≤€2200 
and >€2200) [26]. Postnatal questionnaire completed by the mother at the child’s age of 6 
months included information on smoke exposure of the child inside and outside the home. 
Postnatal questionnaires completed by the mother at age 12 months included information 
on vitamin D supplementation in the previous 6 months and questionnaires at age 12 and 
24 months included information on day care attendance.
Population for analyses
Children whose parents did not provide informed consent for the use of postnatal 
questionnaire data (n= 1885) and children without information on respiratory tract infections 
at ages 2 to 4 years (n= 2015) were excluded from the analysis. To prevent clustering, only 
one child per family within the Generation R cohort was included by random selection 
(n=556 excluded). To reduce attrition bias, variables with missing values were multiple 
imputed (20 imputations) based on the correlation between the variable with missing values 
with other maternal and child characteristics (Supplementary Table 5.1) [27]. Consequently 
data of 5322 children were available after multiple imputation for statistical analyses 
(Supplementary Figure 5.1).
Statistical methods  
First, independent Student’s t test and chi-square test were performed to test for differences 
in characteristics between the 4 groups of breastfeeding duration. Second, logistic regression 
analyses by using generalized estimating equations (GEE) were performed. Regression 
analysis by GEE assesses the association between two variables by correction for the within 
subject’s dependence as a result of the repeated observations on lower and upper respiratory 
tract infections (age 2, 3 and 4 years) since repeated measurements within one individual are 
frequently correlated [28]. An unstructured working correlation structure was used in the GEE 
analyses as adjustment for the dependency between the repeated measurements, since 
the within-subject correlation coefficient for lower and upper respiratory tract infections 
between the three time points were different (r= 0.13-0.32). Logistic regression analysis 
with GEE was performed with lower respiratory tract infections and upper respiratory 
tract infections as dependent variables and breastfeeding as independent variable. All 
analyses were adjusted for the age (time) at which observations of illness were assessed to 
account for potential confounding by age as well as clustering of repeated measurement. 
The selection of potential confounders was performed by the alteration in odds ratio (OR) 
and kept in the multivariable model in case of an alteration of ≥10% in OR [29]. The pooled 
results of the 20 imputed datasets were reported in this paper as odds ratio’s (OR’s) and 
95% confidence intervals (95% CIs). A P-value <0 .05 was considered as statistically 
significant. The statistical analyses were carried out by using SPSS 22.0 for Windows 
(SPSS Inc, Chicago, IL).
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STUDY POPULATION
Maternal and child characteristics are presented in Table 5.1 and Supplementary Table 
5.1. Out of 5322 children, 14% had suffered from at least one episode of lower respiratory 
tract infection in the second year of life, 8% in the third year and 6% in the fourth year of 
life (Table 5.2). At least one episode of upper respiratory tract infection was reported for 
44% of children in the second year of life, 36% in the third year and 31% in the fourth year 
of life (Table 5.2).
Table 5.1. Maternal and child characteristics (n=5322)
Breastfeeding duration
Never
n=893 (17%)
<3 months
n=1602 (30%)
3-6 months
n=1093 (21%)
≥6 months
n=1734 (32%)
Number - %  
or mean ± SD
Number - %  
or mean ± SD
Number - %  
or mean ± SD
Number - %  
or mean ± SD
Maternal characteristics
Maternal age - Mean (SD)
30.7* 5.1 30.3* 4.9 31.5 4.6 31.8 4.8
Educational level – n (%)
Low 230* 26 384* 24 129 12 262 15
Mid 496 55 881 55 566 52 856 49
High 167 19 337 21 398 36 616 36
Ethnicity – n (%)
Western 623* 70 1057 66 786 72 1186 68
Non-Western 270 30 545 34 307 28 548 32
Household income per month – n (%) 
≤2200 euro 385 43 648 40 332* 30 710 41
>2200 euro 508 57 954 60 761 70 1024 59
Marital status – n (%) 
No partner 105 12 185* 12 88 8 157 9
Married/ Living together 788 88 1417 88 1005 92 1577 91
Maternal BMI before pregnancy  
(kg/m2) - mean (SD)
23.9* 4.3 23.9* 4.4 23.1 3.6 23.1 3.6
Child exposure to smoke – n (%) 
Never 471* 53 929* 58 699* 64 1224 70
Prenatal smoking, no 
environmental smoking
51 6 115 7 77 7 113 7
Prenatal smoking and 
environmental smoking
198 22 340 21 154 14 160 9
Environmental smoking, no 
prenatal smoking
173 19 218 14 163 15 237 14
Alcohol use during pregnancy – n (%)
Never 454* 51 724 45 356* 33 741 43
Drank alcohol during pregnancy 439 49 878 55 737 67 993 57
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Table 5.1. (continued)
Never
n=893 (17%)
<3 months
n=1602 (30%)
-6 months
n=1093 (21%)
≥6 months
n=1734 (32%)
Number - %  
or mean ± SD
Number - %  
or mean ± SD
Number - %  
or mean ± SD
Number - %  
or mean ± SD
Parental history of atopy – n (%)
No 462 52 833* 52 581* 53 840 48
Yes 432 48 769 48 512 47 894 52
Parity – n (%)
0 468* 52 1037* 65 677* 62 947 55
≥1 426 48 565 35 416 38 787 45
Caesarean section – n (%)
No 742* 83 1357* 85 943* 86 1547 89
Yes 152 17 245 15 150 14 186 11
Child characteristics
Male – n (%)
464 52 818 51 554 51 832 48
Gestational age at birth – n (%) 
<37 weeks 52* 6 88* 5 61* 6 72 4
≥37 weeks 842 94 1514 95 1032 94 1662 96
Vitamin D supplementation age 6-12 
months – n (%) 
No 450 50 941* 59 657* 60 786 45
Yes 444 50 661 41 436 40 948 55
Day care attendance first 2 years – n (%) 
No 248 28 369* 23 213* 19 423 24
Yes 646 72 1233 77 880 81 1311 76
* Significantly different from breastfeeding ≥6 months , P< 0.05
¶ Missing data for breastfeeding duration before multiple imputation n: 1083 (20%)
Table 5.2. Prevalence of lower and upper respiratory tract infections (n=5322)
Outcome
Age 2 Age 3 Age 4
Original data
Multiple 
imputed Original data
Multiple 
imputed Original data
Multiple 
imputed
n (%) n (%) n (%) n (%) n (%) n (%)
LRTI
No 4019 87 4591 86 3952 93 4884 92 4071 95 5011 94
Yes 594 13 732 14 316 7 438 8 201 5 311 6
Missing 709 13 1054 20 1050 20
URTI
No 2598 57 2954 56 2788 66 3412 64 3073 72 3666 69
Yes 1970 43 2368 44 1442 34 1910 36 1211 28 1656 31
Missing 754 14 1092 21 1038 20
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Duration of breastfeeding and respiratory tract infections
Compared to children who were never breastfed, breastfeeding for 6 months or longer was 
significantly associated with decreased risk of lower respiratory tract infections after infancy 
up to 4 years of age (aOR: 0.71; 95% CI: 0.51-0.98) (Table 5.3) (Supplementary Table 5.2). 
Breastfeeding for less than 3 months and breastfeeding for 3-6 months was not significantly 
associated with lower respiratory tract infections after infancy (Table 5.3) (Supplementary 
Table 5.2). Also, no significant association was found between breastfeeding for less than 3 
months and 3-6 months, and upper respiratory tract infections (Table 5.3) (Supplementary 
Table 5.2). Compared to children who were never breastfed, breastfeeding for 6 months or 
longer was significantly associated with upper respiratory tract infections (OR: 0.78; 95% CI: 
0.62-0.98). However, after correction for confounding variables the same trend was found, 
although non-significant (aOR:0.85; 95% CI: 0.69-1.05) (Table 5.3). The effects of the duration 
of breastfeeding on respiratory tract infections did not differ between the ages of 2, 3 and 4 
years (pinteraction >0.23 for lower and upper respiratory tract infections).
Dose of breastfeeding and respiratory tract infections
Partial breastfeeding until 4 months was significantly associated with a decreased risk of 
lower respiratory tract infections after infancy up to age 4 years (OR: 0.76; 95% CI: 0.59-0.99). 
However, the association did not remain significant after adjustment for confounders (aOR: 
0.78; 95% CI: 0.59-1.02) (Table 5.4) (Supplementary Table 5.3). The same trend was found 
for predominant breastfeeding but not statistically significant (Table 5.4). Before multiple 
Table 5.3. Association between breastfeeding duration and lower and upper respiratory tract infections 
up to age 4 years (n= 5322)
Breastfeeding n (%)
Lower respiratory  
tract infections
Upper respiratory  
tract infections
Univariate 
model
OR (95 % CI)
Multivariable  
model 1
aOR (95 % CI) a
Univariate 
model
OR (95 % CI)
Multivariable 
model 1
aOR (95 % CI) a
Never 893 (17) Reference Reference Reference Reference
<3 months 1602 (30) 0.75
(0.56-1.02)
0.75
(0.56-1.00)
0.87
(0.71-1.06)
0.86
(0.70-1.04)
3-6 months 1093 (21) 0.72
(0.48-1.06)
0.78
(0.53-1.13)
0.80
(0.64-1.00)
0.91
(0.73-1.12)
≥6 months 1734 (32) 0.63
(0.46-0.87)
0.71
(0.51-0.98)
0.78
(0.62-0.98)
0.85
(0.69-1.05)
OR: Odds Ratio; 95% confidence interval. OR’s are compared to never-breastfed.
a Adjusted for caesarean section, maternal age, marital status, maternal ethnicity, maternal educational level, household 
income per month, maternal BMI before pregnancy, smoke exposure child, alcohol use during pregnancy, gender child, 
vitamin D supplementation age 6-12 months, day care attendance in the first two years of life, gestational age at birth, parity 
and parental history of atopy.
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imputation, predominant breastfeeding was associated with lower respiratory tract 
infections (Supplementary Table 5.3). Partial breastfeeding until 4 months and predominant 
breastfeeding until 4 months was not significantly associated with upper respiratory tract 
infections after infancy (Table 5.4) (Supplementary Table 5.3). The effects of breastfeeding 
dose on respiratory tract infections did not differ between the ages of 2, 3 and 4 years 
(pinteraction >0.59 for upper and lower respiratory tract infections).
Table 5.4. Association between exclusive breastfeeding and lower and upper respiratory tract 
infections up to age 4 years (n= 5322)
Breastfeeding n (%)
Lower respiratory tract 
infections
Upper respiratory tract 
infections
Univariate  
model 
OR (95 % CI)
Multivariable   
model 1 
aOR (95 % CI) a
Univariate  
model 
OR (95 % CI)
Multivariable   
model 1 
aOR (95 % CI) a
Never 862 (16) Reference Reference Reference Reference
Partially until 4 months 2870 (54) 0.76
(0.59-0.99)
0.78
(0.59-1.02)
0.87
(0.72-1.05)
0.89
(0.72-1.10)
Predominantly until  
4 months
1590 (30) 0.66
(0.44-1.00)
0.72
(0.48-1.09)
0.84
(0.65-1.08)
0.93
(0.72-1.20)
OR: Odds Ratio; 95% confidence interval. OR’s are compared to never-breastfed.
a Adjusted for caesarean section, maternal age, marital status, maternal ethnicity, maternal educational level, household 
income per month, maternal BMI before pregnancy, smoke exposure child, alcohol use during pregnancy, gender child, 
vitamin D supplementation age 6-12 months, day care attendance in the first two years of life, gestational age at birth, parity 
and parental history of atopy.
DISCUSSION
In this population-based prospective birth cohort study we found children who were 
breastfed for 6 months or longer to have a reduced risk of lower respiratory tract infections 
after infancy. Predominant breastfeeding until 4 months showed the same trend but this 
was not statistically significant. Also, similar direction of the effect estimates were found for 
the association between the duration and dose of breastfeeding and upper respiratory tract 
infections but not significant.
Various studies, including a previous study within our cohort, found exclusive 
breastfeeding for 6 months to be protective for the development of respiratory tract 
infections in infancy, thereby supporting the recommendation of the WHO [10, 19, 30]. 
Our study found breastfeeding for 6 months or longer to be associated with a reduced 
risk for lower respiratory tract infections after infancy till the age of 4 years. Contrary to 
our findings, a prospective longitudinal study found that breastfeeding duration, including 
breastfeeding longer than 6 months, was not associated with pneumonia or lung infection 
in 6 year old children [17]. However, the association was only examined in children who 
initiated breastfeeding whereas we also included children who were never breastfed. In 
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agreement with our findings on breastfeeding dose, Li et al [17] did not find breastfeeding 
exclusivity to be associated with lower respiratory tract infections. As for upper respiratory 
tract infections, we did not observe a significant association among children who were 
breastfed (duration and dose) compared to those who were never breastfed. Similarly, 
Chantry et al [19] found full breastfeeding for less than 6 months not to be associated with 
an increased risk of recurrent upper respiratory tract infections and recurrent otitis media in 
children 6-72 months of age. Li et al [17] also found no association between breastfeeding, 
including duration and exclusivity, and colds or upper respiratory tract infections among 6 
year old children. The possibility that the protective effect of breastfeeding might wear off 
after breastfeeding cessation has previously been suggested [31-33]. Other studies that did 
find breastfeeding to be associated with a reduced risk of upper respiratory tract infections 
after infancy mainly focused on otitis media and mostly before the age of 3 years [20, 34, 
35]. Some studies examined the effect of breastfeeding on respiratory tract infections in 
general. A Japanese study reported breastfeeding duration for 6-7 months to be borderline 
significantly associated with a reduced risk of hospitalization for respiratory tract infections 
between the age of 18-30 months [21]. Respiratory tract infections for which hospitalization 
is needed are often more serious and mainly infections of the lower respiratory tract [2, 
36] which might explain the discrepancy between these latter results and those from our 
study. Conversely, another study did not find a protective effect of breastfeeding for all acute 
respiratory illness in children 1-6 years [20] which might be due to an overrepresentation of 
upper respiratory tract infections since these symptoms are more common in childhood [2]. 
The WHO definition of exclusive breastfeeding allows for ORS, drops and syrups but 
no other food or drink, not even water [23]. Therefore, this study examined the effect of 
predominant breastfeeding defined as no infant formula, milk or solid foods. This study 
cannot examine the effect of predominant breastfeeding per month neither for the duration 
of 6 months or longer due to small group size. The majority of mothers in the Netherlands 
do not continue breastfeeding after the age of 4 months [37]. Thus, our study precludes 
conclusions on the effect of exclusive breastfeeding for 6 months as defined by the WHO. In 
line with our findings, a birth cohort study from Hong Kong did not find exclusive and partial 
breastfeeding for 3 months to be associated with a reduced risk for hospital admissions 
for respiratory tract infections after the age of 6 months up to age 8 years [16]. However, 
Yamakawa et al.[21] did find exclusive breastfeeding at 6-7 months of age to be significantly 
associated with hospitalization for respiratory tract infections between the age of 18-42 
months. Also, Li et al.[17] reported exclusive breastfeeding for 6 months and longer, compared 
to breastfeeding between 0 to 4 months, to be significantly associated with a reduced 
odds for ear, throat, and sinus infection at age 6 years. We performed multiple imputation 
to account for bias associated with missing data. Children with and without questionnaire 
data differed in socioeconomic background, ethnicity, and a selection towards a relative 
more healthy study population seems to be present [22]. However, this would only affect 
the interpretation of our results if the association between breastfeeding and respiratory 
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infections was different for children without questionnaire data compared with those with 
questionnaire data, which is unlikely. For the analyses on breastfeeding duration ≥ 6 months 
and lower respiratory tract infections, results were comparable in the original data (aOR: 
0.56; 95% CI: 0.32-0.99) and after the multiple imputation procedure (aOR: 0.71; 95% CI: 0.51-
0.98). However, for the analyses on predominant breastfeeding and lower respiratory tract 
infections the estimate in the original data analysis (aOR: 0.53; 95% CI: 0.30-0.93) slightly 
weakened after the imputation procedure (aOR: 0.72; 95% CI: 0.48-1.09). This would suggest 
that the missing data was not completely random and affected the uncertainty of the effect 
estimates for predominant breastfeeding.
An important strength of this study is the large study population drawn from the general 
population. On the basis of previous findings in our cohort, respiratory illnesses are socially 
patterned and related to several mother and child characteristics [38]. Our study design 
provided information on multiple potential confounders and allowed for follow-up into 
childhood. However, due to the observational nature of our study, residual confounding 
cannot be fully excluded. In addition, the prospective design made it possible to obtain 
information on breastfeeding at multiple time points during infancy therefore limiting recall 
bias. Whereas other studies examined the effect of respiratory tract infections in general, or 
focused on specific infections [20, 21, 34, 35], we examined the effect of breastfeeding on 
the development of lower and upper respiratory tract infections separately. 
A weakness may be that the diagnosis of respiratory tract infection was obtained by 
parent-reported questionnaires at yearly intervals. The questions used to obtain information 
on respiratory infections were comparable to other studies. Parents were asked whether their 
child had suffered from a respiratory tract infection and whether they had visited a doctor 
for this infection since physician diagnosis is more accurate. However, this could have led to 
misclassification of the outcome as parents may not be able to distinguish between lower 
and upper respiratory tract infections and children who had not visited a doctor may even so 
have suffered from a respiratory tract infection. However, since the outcome was measured 
after the breastfeeding period we do not expect such misclassification to be differential and 
to have influenced the effect of the duration or dose of breastfeeding. Also, our study did 
not have information on the number of episodes of infection. Li et al.[17] found a relation 
between two or more visits to the physician and breastfeeding duration and exclusivity.
Several long-term effects of breastfeeding on the offspring have been reported [3-5, 15]. 
Different mechanisms for the stimulation of the immune response by breastfeeding have 
been suggested, among others transfer of anti-idiotypic antibodies and lymphocytes [6, 
13]. However, the mechanism by which breastfeeding might add to a long-term protection 
remain unclear.
In conclusion, this study showed that breastfeeding duration for 6 months or longer is 
associated with a reduced risk of lower respiratory tract infections, but not upper respiratory 
tract infections, in pre-school children. Predominant breastfeeding until 4 months was not 
associated with a reduced risk for respiratory tract infections in childhood. These findings are 
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compatible with the hypothesis that the protective effect of the duration of breastfeeding 
for respiratory tract infections persist after infancy therefore supporting current WHO 
recommendations for breastfeeding for at least 6 months also in industrialized countries.
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Supplementary Figure 5.1 Flowchart of the participants within the Generation R 
Study 
  
Mothers enrolled in the Generation R 
study (n=9778) 
Provided consent for postnatal follow-up 
(n=7893) 
Population of analysis 
(n=5322) 
 
Excluded: n=2015 due to no 
data available on RTI at age 
2,3 or 4 years.  
Excluded: n=556 random 
sample within siblings. 
 
Excluded: n=1885 due to no 
consent for postnatal follow-
up. 
Data on upper respiratory tract 
infection 
Age 2: n=4568 
Age 3: n=4230 
Age 4: n=4284 
 
Data on lower respiratory tract 
infections 
Age 2: n=4613 
Age 3: n=4268 
Age 4: n=4272 
 
Multiple imputed (see S1 
table & table 2) 
Multiple imputed (see S1 
table & table 2) 
Supplementary Figure 5.1. Flowchart of the participants within the Generation R Study
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Supplementary Table 5.1. Maternal and child characteristics (n=5322)
Original data Multiple imputed
n % n %
Maternal characteristics
Maternal age Mean (SD) 31.1 4.9 31.1 4.9
Missing 0 0
Educational level
Low 901 18 1004 19
Mid 2638 53 2799 52
High 1471 29 1519 29
Missing 312 6
Ethnicity
Western 3534 69 3652 69
Non-Western 1566 31 1670 31
Missing 222 4
Household income per month 
≤2200 euro 1556 37 2075 39
>2200 euro 2704 64 3247 61
Missing 1062 20
Marital status
Married/ Living together 4538 90 4788 90
No partner 497 10 534 10
Missing 287 5
Maternal BMI before pregnancy Mean (SD) 23.5 4.1 23.5 4.0
Missing 1325 25
Smoking during pregnancy
Never 3290 78 4114 77
Smoked during pregnancy 952 22 1208 23
Missing 1080 20
Smoking in presence of child
Smoking mother 543 16 912 17
Missing 1885 35
Smoking in the home 174 5 392 7
Missing 1884 35
Smoking in other places 448 13 802 15
Missing 1901 36
Alcohol use during pregnancy
Never 1803 42 2275 43
Drank alcohol during pregnancy 2466 58 3047 57
Missing 1053 20
Parental history of atopy 2459 49 2606 49
Missing 322 6
Multiparity 2111 41 2195 41
Missing 166 3
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Supplementary Table 5.1. (continued)
Original data Multiple imputed
n % n %
Caesarean section 660 14 733 14
Missing 538 10
Breastfeeding
Never 398 9 893 17
<3 months 1466 35 1602 30
3-6 months 860 20 1093 21
≥6 months 1515 36 1734 32
Missing 1083 20
Breastfeeding
Never 406 10 862 16
Partially until 4 months 2647 64 2870 54
Predominantly until 4 months 1056 26 1590 30
Missing 1213 23
Child characteristics
Male 2667 50 2667 50
Missing 0 0
Preterm birth1 268 5 272 5
Missing 25 1
Vitamin D supplementation age 6-12 months 1873 45 2489 71
Missing 1112 21
Day care attendance first 2 years 3140 95 4070 76
Missing 2013 38
1Preterm birth is defined as <37 weeks.
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Supplementary Table 5.2. Association between breastfeeding duration and lower and upper respiratory 
tract infections up to age 4 years (ORIGINAL DATA)
Breastfeeding
n
(%)
Lower respiratory  
tract infections
Upper respiratory  
tract infections
Univariate  
model
OR (95 % CI)
Multivariable   
model 1
aOR (95 % CI) a
Univariate  
model
OR (95 % CI)
Multivariable   
model 1
aOR (95 % CI) a
Never 398
(9)
Reference Reference Reference Reference
<3 months 1466
(35)
0.73
(0.55-0.96)
0.71
(0.41-1.21)
0.97
(0.81-1.15)
0.79
(0.56-1.14)
3-6 months 860
(20)
0.68
(0.50-0.92)
0.59
(0.34-1.04)
0.87
(0.73-1.05)
0.95
(0.66-1.37)
≥6 months 1515
(36)
0.59
(0.45-0.79)
0.56
(0.32-0.99)
0.86
(0.72-1.02)
0.91
(0.63-1.31)
OR: Odds Ratio; 95% confidence interval. OR’s are compared to never-breastfed.
a Adjusted for caesarean section, maternal age, marital status, maternal ethnicity, maternal educational level, household 
income per month, maternal BMI before pregnancy, smoke exposure child, alcohol use during pregnancy, gender child, 
vitamin D supplementation age 6-12 months, day-care attendance in the first two years of life, gestational age at birth, 
parity and parental history of atopy.
Supplementary Table 5.3. Association between breastfeeding dose and lower and upper respiratory 
tract infections up to age 4 years (ORIGINAL DATA)
Breastfeeding n (%)
Lower respiratory  
tract infections
Upper respiratory  
tract infections
Univariate  
model
OR (95 % CI)
Multivariable   
model 1
aOR (95 % CI) a
Univariate  
model
OR (95 % CI)
Multivariable   
model 1
aOR (95 % CI) a
Never 406
(10)
Reference Reference Reference Reference
Partially until 4 months 2647
(64)
0.71
(0.54-0.92)
0.66
(0.39-1.11)
0.93
(0.79-1.10)
0.86
(0.61-1.21) 
Predominantly until  
4 months
1056
(26)
0.52
(0.39-0.71)
0.53
(0.30-0.93)
0.84
(0.70-1.01)
0.95
(0.66-1.37)
OR: Odds Ratio; 95% confidence interval. OR’s are compared to never-breastfed.
a Adjusted for caesarean section, maternal age, marital status, maternal ethnicity, maternal educational level, household 
income per month, maternal BMI before pregnancy, smoke exposure child, alcohol use during pregnancy, gender child, 
vitamin D supplementation age 6-12 months, day-care attendance in the first two years of life, gestational age at birth, 
parity and parental history of atopy.
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ABSTRACT
Background: Overall diet in early childhood may affect the development of respiratory 
symptoms. This study examined whether childhood dietary patterns are associated with 
respiratory symptoms in Dutch pre-school children, and whether this association could be 
explained by energy intake.
Methods: A prospective cohort study was performed in 2,173 children aged ≤4 yrs. Data 
on asthma-related symptoms were obtained by questions from the age-adapted version 
of the “International Study of Asthma and Allergies in Childhood” questionnaires. Data on 
respiratory tract infections, defined as episodes of physician attended fever with respiratory 
symptoms, was obtained by questionnaire. Principal components analysis was used to 
develop dietary patterns at 14 months of age.
Results: Compared with low adherence, high adherence to the ‘‘Western’’ dietary pattern 
was significantly associated with frequent wheeze at 3 yrs of age (relative risk (RR) 1.39, 95% 
CI 1.02–1.89) and frequent shortness of breath (RR 1.44, 95% CI 1.03–2.01) and respiratory 
tract infections (RR 1.54, 95% CI 1.08–2.19) at 4 yrs of age. However, this association was 
partially explained by energy intake.
Conclusion: A ‘‘Western’’ diet may increase the risk of frequent respiratory symptoms at 3 
and 4 yrs of age. In some measure, this association was explained by energy intake.
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INTRODUCTION
Atopic diseases are common in children and have been increasing in prevalence. Asthma 
is the most common chronic disease in childhood [1]. Infectious diseases, particularly of 
the respiratory tract are a leading cause of morbidity and hospitalisation in infants and 
children in industrialised countries [2]. Both asthma and infectious disease cause significant 
burden of disease in childhood [3], and identifying risk factors for the development of these 
diseases is of interest. The immune system undergoes substantial maturation from fetal life 
until childhood. The adequacy of this maturation process depends on environmental factors 
of which nutrition is suggested to play a role [4]. Diet during pregnancy has been suggested 
to be associated with asthma-related symptoms in the offspring [5, 6]. Duration and 
exclusiveness of breastfeeding has been found to be related to asthma and respiratory tract 
infections in infancy and childhood [2, 7, 8]. In addition, nutrition beyond the weaning period 
may also be of importance [4]. Relatively little attention has been paid to the influence of 
diet beyond the weaning period on respiratory symptoms. Traditional analyses in nutritional 
epidemiology often examine disease in relation to specific nutrients or foods [9]. Intake of 
specific nutrients and foods during childhood has a relationship with the development of 
asthma and respiratory tract infections [10, 11]. In addition, intake of calorie-rich foods has 
been associated with a higher prevalence of asthma [12]. However, children eat a variety of 
foods with complex combinations of nutrients that are likely to be interactive or synergistic 
[9]. Therefore, dietary pattern analysis examining the association of overall diet may be more 
predictive of disease risk. So far, studies examining the effect of overall diet in childhood 
mainly focused on a traditional Mediterranean diet. These studies found a Mediterranean 
diet in early life to be associated with the development of asthma-related symptoms in 
childhood [13, 14]. No studies have examined the effect of a Western diet in childhood on 
the development of respiratory symptoms in children. However, a Western diet has been 
found to be associated with an increased risk of frequent asthma attacks in adult females 
[15]. The aim of this study was to examine whether different childhood dietary patterns are 
associated with respiratory symptoms in Dutch children up to 4 yrs of age. A second aim was 
to examine whether this association could be explained by total energy intake.
SUBJECTS AND METHODS
Participants and study design
This study was embedded in the Generation R study, a population-based prospective cohort 
study from fetal life until young adulthood and has been described in detail previously 
[16]. In total, 9,778 mothers with a delivery date from April 2002 through to January 2006 
enrolled in the study. Consent for post-natal follow-up was provided by 7,893 participants. 
Data collection on nutritional intake of the child was implemented in the study from 2003 
onwards. In total, 5,088 mothers received a food-frequency questionnaire (FFQ) for their 
child at the age of 14 months (Figure 6.1). The study was approved by the medical ethical 
review board of the Erasmus Medical Center, Rotterdam, the Netherlands.
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Respiratory symptoms
Asthma-related symptoms
Data on asthma-related symptoms were obtained by questions adapted from 
the “International Study of Asthma and Allergies in Childhood” (ISAAC) core questionnaires 
on asthma at the age of 2, 3 and 4 yrs. These questions were made suitable for younger 
children and have been previously used in other studies [17]. Asthma symptoms, including 
wheezing and shortness of breath, were categorised according to frequency as follows: 
never, 1–3 times and ≥4 times [17]. Questionnaire response rates were 69%, 64% and 63% at 
the age of 2, 3 and 4 yrs, respectively.
Respiratory tract infections
Data on respiratory tract infections were obtained by parent-reported questionnaires at 
the age of 2, 3 and 4 yrs. Respiratory tract infections were defined by the number of parent-
reported physician visit(s) for fever with respiratory symptoms; coughing, runny or blocked 
nose, or earache. Subsequently, respiratory tract infections were categorised according to 
frequency as follows: never, 1–2 times and ≥3 times [17].
 
Figure 6.1 Flow chart summarising the participants of the Generati on R study 
 
  
Provided consent for post-natal follow-
up (n=7893)  
Children of mothers who received food-
frequency questionnaire (n=5088) 
Children of mothers who returned the 
food-frequency questionnaire (n=3643) 
Population of analysis (n=2173) 
 
Exclusion: n=1885 due to no 
consent for post-natal follow-up 
 
Exclusion: n=2805 due to no 
implementation of food-
frequency questionnaire 
Exclusion: n=1445 due to 
missing information on food-
frequency questionnaire 
Exclusion: n=1200 due to non-
Dutch ethnicity and n=270 
random sample within siblings 
Mothers enrolled in the Generation  
R study (n=9778) 
Figure 6.1. Flow chart summarising the participants of the Generation R study
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Dietary patterns
At the child’s age of 14 months (±2 months) parents were asked to complete a FFQ. The FFQ 
was developed in cooperation with the division of Human Nutrition of Wageningen University, 
Wageningen, the Netherlands, and based on an existing validated food questionnaire 
described in detail previously [18], and adapted with food products frequently consumed 
according to a Dutch food consumption survey in infants [19]. The FFQ was validated against 
3-day, 24-h recalls in Dutch children at the age of 14 months. The intra-class correlation 
coefficients for macronutrients were as follows: total energy, 0.4; total protein, 0.7; total fat, 
0.4; carbohydrates, 0.4; and dietary fibre, 0.7. The frequency of consumption of a food item 
was to be recorded per day, per week, or per month over the past 4 weeks. Subjects were 
asked to report their regular portion size relative to the standard portion size according to 
the Dutch table of regular portion sizes and household units [20]. Total nutrient content was 
calculated per item according to the Dutch Nutrient Composition table [21]. Response rate 
was 72% (n= 3,643) (Figure 6.1).
Covariates
Variables possibly related to the outcomes such as sex, gestational age and birthweight 
were obtained from obstetric records assessed in midwife practices and hospital registries 
[16]. Additional potential confounders were assessed by a combination of pre- and post-
natal questionnaires completed by both parents. The questionnaires included information 
on maternal age, maternal socioeconomic status, maternal smoking during pregnancy, 
multiple parities and parental history of atopy. Maternal socioeconomic status was 
defined according to educational level as follows. Low: no education, primary school or 
<3 yrs of secondary school; mid: >3 yrs of secondary school, higher vocational training or 
bachelor’s degree; and high: academic education. Data on breastfeeding were collected by 
a combination of delivery reports and post-natal questionnaires at the age of 2, 6 and 12 
months. Breastfeeding was classified as (I) never, (II) exclusively for 6 months, (III) exclusively 
for 4 months and partially at 6 months, (IV) exclusively for 4 months, with no breastfeeding 
at 6 months, (V) partially for 6 months, (VI) partially for 4 months, with no breastfeeding at 
6 months. Cow’s milk allergy in the first year of life was assessed by questionnaire at the age 
of 6 and 12 months by asking parents whether their child had attended a doctor for cow’s 
milk allergy. At the age of 12 months parents were asked about vitamin D supplementation 
during the past 6 months. Post-natal questionnaires completed by the mother at age 12 and 
24 months included information on daycare attendance.
Population for analyses
To avoid the influence of culture differences in the definition of the dietary patterns, 
only children of Dutch origin were included in the analyses (n= 2,443). Siblings within 
the Generation R cohort were randomly selected and excluded (n= 270). To prevent bias 
associated with missing data, variables with missing values were multiple imputed (five 
imputations) based on the correlation between the variable with missing values with other 
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patient characteristics [22]. Consequently, n= 2,173 were available after multiple imputation 
for statistical analyses (Figure 6.1).
Statistical methods
The FFQ included 211 food items which were grouped into 21 different food groups. 
The 21 food groups were subjected to principal components analysis (PCA). The scree plot 
from the PCA showed a clear break in the curve after the second component revealing 
the presence of two dietary patterns with Eigen values of 3.4 and 1.7. The percentage of 
variance explained by the dietary patterns was 16.3% and 8.2%. In the PCA, varimax rotation 
was used to obtain uncorrelated factors. For reasons of interpretability, the population of 
analysis was categorised into tertiles according to their score for the dietary pattern as 
follows: low, moderate and high (using ‘‘low’’ score as reference category).
Log-binomial regression analyses were performed with the primary outcome variables; 
wheezing, shortness of breath and respiratory tract infections separately at the age of 2, 3 
and 4 yrs. The defined dietary patterns at the age of 14 months were analysed as primary 
exposure and adjusted for potential confounders. The selection of potential confounders 
was performed by the alteration in relative risks and kept in the multivariate model in 
case of an alteration of ≥10% (multivariate model 1). To assess whether the association 
between the dietary patterns and respiratory symptoms was explained by total energy 
intake additional analysis were performed with adjustment for total energy intake resulting 
in a separate multivariate model (multivariate model 2). The pooled results of the five 
imputed datasets were reported in this paper as relative risks and 95% confidence intervals. 
A p-value <0.05 was considered as statistically significant. The statistical analyses were 
performed using Stata Statistical Software for Windows, release 11 (Stata Corp., College 
Station, TX, USA).
RESULTS
Study population
Maternal and child characteristics of the study population are presented in table 6.1 and 
the prevalence of the outcomes of interest in supplementary table 6.1.
Dietary patterns
The factor loadings of the food groups in the two dietary patterns present are shown in 
supplementary table 6.2. The individual factor loading scores for the food groups are 
correlation coefficients between the food products and the specific dietary pattern. Dietary 
pattern 1 was associated with starchy foods, fruit, vegetables, potatoes, vegetable oils, 
fish, legumes and meat. This pattern is referred to here as the ‘‘Health conscious’’ dietary 
pattern. Dietary pattern 2 was associated with refined grains, soups and sauces, savoury and 
snacks, other fats, sugar-containing beverages and meat. This pattern will be referred to as 
the ‘‘Western’’ dietary pattern.
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Table 6.1. Maternal and child characteristics
Characteristics Original data
After multiple 
imputation procedure 
Mother
Maternal age yrs 31.8 ±4.25 31.8 ±4.25
Missing 0 0 - -
Socioeconomic status %
Low 230 10 232 11
Mid 1151 53 1157 53
High 777 36 784 36
Missing 15 1 - -
Maternal smoking during pregnancy % 385 18 461 21
Missing 371 17 - -
Multiple parities % 732 34 760 35
Missing 54 3 - -
Parental history of atopy % 1121 52 1141 53
Missing 36 2 - -
Child
Male % 1082 50 1082 50
Missing 0 0 - -
Standard deviation score birthweight 0.06 ±1.01 0.06 ±1.03
Missing 178 8 - -
Breastfeeding %
Never 213 10 229 11
6 months exclusive 33 2 49 2
4 months exclusive, 
partially at 6 months
371 17 387 18
4 months exclusive, 
no breastfeeding at 6 months
153 7 161 7
6 months partially 172 8 185 9
4 months partially, 
no breastfeeding at 6 months
1008 46 1161 53
Missing 223 10 - -
History of cow’s milk allergy first year % 124 6 237 11
Missing 444 20 - -
Vitamin D supplement use 6-12 months % 750 35 801 37
Missing 127 6 - -
Day care attendance first 2 yrs % 1493 69 1807 83
Missing 575 27 - -
Total energy intake at 14 months 1276 ±351 1276 ±351
Missing 0 0 - -
Data are presented as mean±SD or n (%). n= 2,173.
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Dietary patterns and respiratory symptoms
High adherence to the ‘‘Western’’ dietary pattern was significantly associated with frequent 
shortness of breath (≥4) (RR 1.43, 95% CI 1.01–2.03) at age 2 yrs (table 6.2). High adherence 
to the ‘‘Western’’ dietary pattern was also significantly associated with frequent wheeze (≥4) 
(RR 1.39, 95% CI 1.02–1.89) and frequent shortness of breath (≥4) (RR 1.66, 95% CI 1.24–2.21) 
at age 3 yrs (tables 6.2 and 6.3). However, the association between the ‘‘Western’’ dietary 
pattern and frequent shortness of breath (≥4) at the age of 2 and 3 yrs was mainly explained 
by maternal age, maternal socioeconomic status, maternal smoking during pregnancy, 
parental history of atopy, multiple parities, standard deviation score (SDS) birthweight, sex, 
breastfeeding, vitamin D supplementation, daycare attendance and history of cow’s milk 
allergy (table 6.2). High adherence to the ‘‘Western’’ dietary pattern was also significantly 
associated with frequent wheeze (≥4) (RR 1.70, 95% CI 1.22–2.36) and shortness of breath 
(≥4) (RR 1.44, 95% CI 1.03–2.01) at age 4 yrs (tables 6.2 and 6.3). However, the association 
between the ‘‘Western’’ dietary pattern and frequent wheeze (≥4) at age 4 yrs was mainly 
explained by the variables mentioned previously (table 6.3). Adherence to the ‘‘Western’’ 
dietary pattern was not significantly associated with frequent wheeze at age 2 yrs, or short-
term wheeze (1–3 times) or shortness of breath (1–3 times) up to 4 yrs of age. High adherence 
to the ‘‘Western’’ diet was significantly associated with frequent respiratory tract infections 
(≥3) (RR 1.54, 95% CI 1.08–2.19) at 4 yrs of age (table 6.4). Adherence to the ‘‘Western’’ diet 
was not significantly associated with respiratory tract infections at 2 and 3 yrs of age or 
short-term respiratory tract infections (1–2 times) at 4 yrs of age. Adherence to the ‘‘Health 
conscious’’ diet was not significantly associated with respiratory symptoms up to 4 yrs of age 
(tables 6.2, 6.3 and 6.4).
Influence of total energy intake
After adjustment for total energy intake, high adherence to the ‘‘Western’’ dietary pattern 
remained significantly associated with frequent wheeze (≥4) (aRR 1.47, 95% CI 1.04–2.07) at 
3 yrs of age and frequent respiratory tract infections (≥3) (aRR 1.46, 95% CI 1.00–2.13) at 4 
yrs of age (tables 6.3 and 6.4). After additional adjustment for total energy intake adherence 
to the ‘‘Western’’ dietary pattern was no longer significantly associated with shortness of 
breath up to 4 yrs of age (table 6.2). Adherence to the ‘‘Western’’ dietary pattern remained 
not significantly associated with any respiratory symptom at age 2 yrs or short-term 
respiratory symptom up to 4 yrs of age. Adherence to the ‘‘Health conscious’’ dietary pattern 
remained not significantly associated with any respiratory symptom up to 4 yrs of age 
(tables 6.2, 6.3 and 6.4).
DISCUSSION
In this population-based prospective birth cohort study, we observed a higher risk of 
frequent respiratory symptoms among children at the age of 3 and 4 yrs who had a greater 
adherence to a ‘‘Western’’ diet in early childhood. However, this association was partially 
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explained by total energy intake. No association was found between a ‘‘Health conscious’’ 
diet and respiratory symptoms up to 4 yrs of age.
Comparison with other studies of childhood dietary patterns and respiratory outcomes 
is difficult as most studies did not use PCA to obtain dietary patterns. However, our ‘‘Health 
conscious’’ dietary pattern (including starchy foods, fruit, vegetables, potatoes, vegetable 
oils, fish, legumes and meat) has some similarities with a Mediterranean diet. A study in 
Mexico found a Mediterranean dietary pattern to have a protective effect on asthma and 
asthma-related symptoms in children aged 6–7 yrs [23]. A Greek study found adherence 
to a Mediterranean diet to be modest protective for wheezing symptoms in children aged 
7–18 yrs [24]. Two Spanish studies additionally found a Mediterranean diet in childhood to 
be protective for symptoms of asthma in children aged 4 and 6–7 yrs [25, 26]. However, these 
studies were of cross-sectional design and recall bias and reverse causality might be a serious 
concern. To our knowledge only one prospective cohort study examined the association 
between a dietary pattern in childhood and atopic disease, and also found childhood 
adherence to a Mediterranean diet not to be significantly associated with asthma-related 
symptoms [14].
It has been suggested that the increase in prevalence of asthma is related to adoption 
of a Western lifestyle including a Western diet [27]. The ‘‘Western’’ diet in this study was 
characterised by high intake of refined grains, soups and sauces, savoury and snacks, other 
fats, sugar-containing beverages and meat. Although no other studies examined the overall 
effect of a ‘‘Western-like’’ diet in childhood on the development of asthma-related symptoms 
in children, a French study did find a ‘‘Western’’ dietary pattern to be associated with an 
increased risk of frequent asthma attacks in adult females [15]. Individual food components 
of a ‘‘Western’’ diet in childhood have been found to be associated with asthma symptoms in 
children. Sugar consumption during the perinatal period was associated with severe asthma 
symptoms in 6- and 7-yr-old children [28]. An increased intake of saturated fatty acids was 
also found to be related to the risk of asthma in children [29].
Adjustment for energy intake is a standard procedure in nutritional epidemiology for 
standardising food and nutrient intake according to total food intake. However, most studies 
on dietary patterns and respiratory symptoms do not adjust for energy intake and found 
a Mediterranean diet to be protective for asthma-related symptoms [23, 25]. CHATZI et al. 
[14] did adjust for total energy intake and found childhood adherence to a Mediterranean 
diet not to be significantly associated with asthma-related symptoms. An association 
found between a dietary pattern consisting of high energy foods and a disease outcome 
may not be the effect of the foods themselves, but the effect of high calorie intake. It has 
been suggested that high calorie foods are associated with asthma [12]. Nevertheless, 
a Cochrane review showed only a small effect of calorie reduction on asthma [30]. Indeed, 
after adjustment for total energy intake the ‘‘Western’’ dietary pattern remained significantly 
associated with wheeze and respiratory tract infections. Therefore, the association between 
the ‘‘Western’’ dietary pattern and respiratory symptoms was only partially explained by total 
energy intake and needs further elucidation.
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Our large study population drawn from the general population is an important strength 
of this study. An additional strength is the use of dietary patterns instead of single or 
few nutrients or food items. The effect of single nutrients may be too small to detect as 
the cumulative effects of multiple nutrients in a dietary pattern may be sufficiently large. 
Dietary patterns identified by PCA has the advantage of reducing a large number of 
correlated dietary measurements down to a small number of overall dimensions of diet that 
are uncorrelated [9].
The time window of exposure is becoming a key aspect in the study of diseases 
involving systems such as the immunological and respiratory systems [13]. Atopic disease 
often becomes manifest in early life, and it could be that the processes leading to atopic 
disease are initiated early in the immune development. This study assessed the effect of diet 
at the early age of 14 months, whereas most studies examined the effect of diet at school 
age. An additional strength of this study is that it examined the effect of dietary patters 
prior to the outcome of disease, contrary to other studies examining the effect of diet and 
outcome during the same time period, which may lead to recall bias and reverse causality in 
these studies.
Some limitations have to be considered in the interpretation of our results. Information 
on the outcomes was obtained by parent-reported questionnaires. This could have led to 
misclassification of the outcome, as physician diagnosis provides more accurate outcome 
diagnosis. However, we do not expect this misclassification to have influenced the effect of 
adherence to the dietary patterns, given that the outcome was measured after the FFQ was 
filled out and thus it will be unlikely that the misclassification was related to the child’s diet. 
Several arbitrary decisions are involved in identifying dietary patterns by PCA. Decisions 
on combining food items into food groups, the number of factors to extract, the method 
of rotation, and the labelling of the components may influence the reproducibility of 
the findings [9]. Although we adjusted for potential confounders, residual confounding 
cannot be fully excluded, thereby precluding final conclusions regarding the causality of 
the study results.
Diagnosis of asthma is difficult in young children, due to the nonspecificity of the symptoms 
and the fact that conventional lung function tests cannot be carried out at pre-school age 
[17]. Therefore, asthma assessment among young children is still mainly based on asthma-
related symptoms. Because the diagnosis of asthma is difficult in pre-school children, our 
results preclude us from making conclusions regarding the presence of asthma later in life. 
However, CAUDRI et al. [17] found wheezing and serious respiratory tract infections to be 
predictive for the development of asthma; in particular, frequent wheezing (≥4 times per 
year) and frequent respiratory tract infections (≥3 times per year) were predictive of asthma 
at the age of 7 to 8 yrs.
In conclusion, our findings suggest that a ‘‘Western’’ diet may increase the risk of 
respiratory symptoms at the age of 3 and 4 yrs. However, this association was moderately 
explained by total energy intake. This study does not support a protective effect of a ‘‘Health 
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conscious’’ diet on respiratory outcomes in children younger than 4 yrs of age. Further 
studies on respiratory outcomes to determine the association between diet and respiratory 
symptoms and the influence of total energy intake are worthwhile.
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SUPPLEMENT CHAPTER 6
Supplementary Table 6.1. Prevalence of outcomes 
Outcome Age 2 Age 3 Age 4
n % n % n %
Wheeze
Never 1654 76 1660 76 1689 78
1-3 times 346 16 184 9 199 9
≥4 times 174 8 329 15 286 13
Shortness of breath 
Never 1414 65 1618 75 1705 78
1-3 times 369 17 198 9 164 8
≥4 times 390 18 357 16 304 14
Respiratory tract infections
Never 1097 50 1443 66 1409 65
1-2 times 491 23 388 18 396 18
≥3 times 586 27 342 16 367 17
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Supplementary Table 6.2. Factor loadings of the food items in the “Health conscious” and “Western” 
dietary pattern in children aged 14 months (r >0.2)
Food group Mean intake g/d
Factor loading
Health conscious 
dietary pattern
Pearson’s 
correlation 
coefficient
Western dietary 
pattern
Pearson’s 
correlation 
coefficient
Refined grains 14.9 - 0.57
Whole grains 61.9 - -
Starchy foods 22.9 0.62 -
Dairy 626.0 - -
Fruit 162.2 0.32 -
Soy substitutes 4.4 - -
Vegetables 51.8 0.74 -
Potatoes 34.0 0.61 -
Soups and sauces 9.4 - 0.23
Savoury and snacks 3.9 - 0.59
Confectionary 27.8 - 0.72
Vegetable oils 0.56 0.50 -
Other fats 10.6 - 0.58
Fish 8.2 0.22 -
Shellfish 0.30 - -
Meat 25.5 0.21 0.27
Eggs 1.9 - -
Legumes 4.0 0.59 -
Sugar containing beverages 197.5 - 0.59
Non-sugar containing beverages 56.4 - -
Composite dishes 102.3 - -
Eigen value* 3.4 1.7
Variance explained (%) 16.3 8.2
Total energy intake 0.36 0.54
PCA was used as an extraction method in which the Pearson’s correlation coefficients represent the relative contribution of 
that food group to the identified dietary pattern. 
* The eigenvalue was used as indicator of the amount of variation explained by each dietary pattern.
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ABSTRACT
Background & Aims: A role of vitamin D in the development of respiratory and allergic 
disease in children remains unclear. It may be likely that vitamin D has an effect on airway 
inflammation, but only few studies examined the effect in children. We aimed to examine 
whether serum 25-hydroxyvitamin D (25(OH) vitamin D) concentrations are associated with 
the fraction of exhaled nitric oxide (FeNO), airway interrupter resistance (Rint), physician 
diagnosed asthma ever, wheezing and eczema in a population-based cohort study in 6 year 
old children.
Methods: Serum 25(OH) vitamin D concentration was assessed in 3815 children. 25(OH) 
vitamin D concentrations ≥75nmol/L were considered as sufficient, between 50-75nmol/L 
as insufficient, and <50nmol/L as deficient. FeNO and Rint were measured at the research 
center. Data on physician diagnosed asthma, wheezing, and eczema were obtained by 
parent-reported questionnaires. 
Results: In comparison with sufficient 25(OH) vitamin D concentration, deficient 
concentrations were associated with elevated FeNO of ≥25ppb (OR: 2.54; 95% CI: 1.34-4.80). 
In addition, deficient and insufficient 25(OH) vitamin D concentrations were associated with 
a lower Rint (Z-score: -1.26; 95% CI: -1.66 to -0.85) (ß: -0.75; 95% CI: -1.08 to -0.42), and increased 
risks of eczema (OR: 1.65; 95% CI: 1.13-2.41) (OR: 1.44; 95% CI: 1.06-1.95). Insufficient 25(OH) 
vitamin D concentration were associated with a decreased risk of physician diagnosed 
asthma ever (OR: 0.59; 95% CI: 0.38-0.94). 
Conclusions: Our results indicate that lower 25(OH) vitamin D levels are associated with 
elevated FeNO levels, but lower Rint values. Lower 25(OH) vitamin D levels are also associated 
with a decreased risk for asthma diagnoses but an increased risk for eczema. 
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INTRODUCTION
In the past decades the prevalence of allergic disease has increased and has therefore 
become a major public health problem [1]. The development of allergic disease might be 
influenced by exposures including diet and behavioral changes associated with a Western 
lifestyle [2]. Vitamin D may be another important environmental factor and the prevalence of 
vitamin D insufficiency has increased [3]. Potential extra-skeletal functions of vitamin D may 
play a role in the risk of asthma and allergic disease [4-9]. Sun exposure and dietary intake 
are the main source of vitamin D [7]. Changes in lifestyle, such  as decreased exposure to 
sunlight, increased time spent indoors, and physical inactivity, are important determinants of 
vitamin D deficiency [6,10]. There is at present no universally accepted definition for optimal 
25-hydroxyvitamin D (25(OH) vitamin D) concentrations [9]. The Institute of Medicine defined 
25(OH) vitamin D concentration of <50 nmol/L as deficient [11]. However, the definition of 
vitamin D sufficiency by the Institute of Medicine is controversial since the recommendation 
was primarily based on the effects on bone health whereas it has been argued that extra-
skeletal effects of vitamin D are as important [12]. Vitamin D has immunomodulatory effects 
[13]. The effect of vitamin D on immune function in relation to respiratory and allergic 
disease have been examined [13]. Epidemiological studies have shown inconsistent results. 
Different studies found low and high levels of vitamin D in children to be associated with 
and increased risk of asthma and allergy outcomes [14-18]. Other studies did not find an 
association [19, 20]. For the prevention of respiratory and allergic disease in children a role 
of vitamin D remains unclear [13, 21, 22]. Higher vitamin D levels have been associated with 
lower level of biomarkers of inflammation [23] and oxidative stress [24] in children. Therefore, 
it may be likely that vitamin D has an influence on airway inflammation. However, only 
few studies examined the effect in children as by measuring the fraction of exhaled nitric 
oxide (FeNO), which is a biomarker of airway inflammation [25, 26]. We aimed to examine 
the cross-sectional association between serum 25(OH) vitamin D concentrations and FeNO, 
Rint, physician diagnosed asthma ever, wheezing and eczema in a population-based cohort 
study in 6 year old children.
SUBJECTS AND METHODS
Participants and study design
These analyses were part of the Generation R study, which is a population-based prospective 
cohort study and has been described in detail previously [27]. All children were born from 
April 2002 through January 2006. The study was approved by the medical ethical review 
board of the Erasmus Medical Center, Rotterdam, the Netherlands. At the start of each phase 
of the study both parents were asked for written informed consent.
Asthma-related outcomes and eczema
Fractional exhaled  nitric oxide (FeNO), which is a biomarker of eosinophilic airway 
inflammation, was measured at 6 years of age using the NIOX chemiluminescence analyzer 
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during a visit to the research center. Airway resistance (interrupter resistance (Rint), MicroRint, 
Micromedical, Rochester, Kent, UK) was measured during tidal breathing, with occlusion of 
the airway at tidal peak expiratory flow. To calculate Z-scores median values for no less than 
5 acceptable measurements were calculated. The Z-scores were adjusted for the device that 
was used and for the child’s height. Lung function measurements were obtained following 
the European Respiratory Society and American Thoracic Society guidelines [28]. Parents 
were asked to temporarily cease medication for respiratory conditions in children without 
symptoms 24 hours before the visit to the research center. Data on physician diagnosed 
asthma ever since birth was obtained by annual parent-reported questionnaires. Data on 
current wheezing was collected by parent-reported questionnaires at the age 6 years using 
questions from the International Study of Asthma and Allergies in Childhood (ISAAC) [29]. 
Also, data on current eczema was collected by parent-reported questionnaires at 6 years 
of age.
25-Hydroxyvitamin D concentration
25(OH) vitamin D concentration was assessed in thawed venous serum samples at 
the Endocrine Laboratory of the VU University Medical Center, Amsterdam. Serum 25(OH) 
vitamin D was measured using isotope dilution online solid phase extraction liquid 
chromatography-tandem mass spectrometry (ID-XLC-MS/MS) and has been described 
in detail previously [30]. Serum 25(OH) vitamin D was taken during a visit to the research 
center at the age of 6 years and available in 4167 children. Serum 25(OH) vitamin D was 
not available for children who expressed anxiety for blood sampling, whose parents did not 
provide informed consent for blood sampling, and when blood sample was not possible 
for logistic reasons (i.e. time constraints). The median 25(OH) vitamin D concentration in 
the study population was 64 nmol/L, varying from 4 to 211. On the basis of previous studies 
in the pediatric population, serum 25(OH) vitamin D concentrations ≥75nmol/L were 
considered as vitamin D sufficient, concentrations between 50-75 nmol/L were considered 
as vitamin D insufficient, and <50 nmol/L as deficient [15, 25, 30].
Covariates
Information on potential confounders including sex, gestational age, birth weight and 
mode of delivery were collected from obstetric records evaluated in mid-wife practices and 
hospital registries [27]. Further information on potential confounders was obtained using 
a combination of pre-and postnatal questionnaires completed by both parents. These 
questionnaires included information on ethnicity [31], maternal educational level, maternal 
marital status, household income per month  (≤€2200 and >€2200), folic acid intake during 
pregnancy, maternal alcohol use during pregnancy, maternal smoking during pregnancy, 
multiparity and parental history of atopy. Ethnicity of the child was categorized into Western 
(Dutch, American, European, and Oceanian) and non-Western (Moroccan, Turkish, Dutch 
Antillean, Surinamese, Asian, Indonesian, African and Cape Verdean). Data on breastfeeding 
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were collected by questionnaires at 2, 6 and 12 months of age. Information on the presence 
of cow’s milk allergy in the first year was obtained by questionnaire at the ages of 6 and 12 
months. Questionnaires completed by the mother at age 12 months included information 
on vitamin D supplementation in the previous 6 months and questionnaires at the age of 12 
and 24 months included information on day-care attendance in the first 2 years. Information 
on the time the child spent playing outside during daytime, walking or biking to school 
and the time spend watching television was assessed by parent-reported questionnaires at 
the age of 6 years. Also, data on respiratory tract infections in the previous year was obtained 
by questionnaire at the same time point. During a visit to the research center at the age of 
6 years total body fat mass was measured using a Dual-energy X-ray absorptiometry (DXA) 
scanner (iDXA, GE-Lunar, 2008, Madison, WI, USA), which analyzed fat, lean and bone mass of 
the total body using enCORE software v.13.6. We calculated age- and sex-specific z-scores for 
body fat percentage based on the total Generation R Study sample with body composition 
measurements available the age of 6 years.
Population for analyses
All children with 25(OH) vitamin D concentrations available (n= 4167) were included in 
the analyses. To prevent clustering, only one child per family within the Generation R 
cohort was included by random selection (n= 352). In total, 3815 children were available for 
statistical analyses (Supplementary Figure 7.1).
Statistical methods
Student’s t test and chi-squared analyses were performed to examine differences between 
groups in 25(OH) vitamin D concentration. Logistic and linear regression analyses were 
performed for FeNO, Rint, physician diagnosed asthma ever, wheezing and eczema as 
dependent variables. FeNo was elog transformed to acquire normal distribution. Analyses 
were performed with FeNO as both continuous variable and as dichotomous variable using 
a threshold of 25 ppb, since it has been suggested that FeNO of ≥25 ppb indicates that 
eosinophilic inflammation is more likely [32]. 25(OH) vitamin D concentration at 6 years of 
age was analyzed categorically as independent variable (using sufficient 25(OH) vitamin 
D concentration as reference category) and adjusted for season of blood sampling and 
potential confounders. Additional analyses were performed with serum 25(OH) vitamin D 
concentration in quartiles based on the distribution of the cohort (using the first quartile as 
reference category). The selection of potential confounders was based on changes of 10% or 
greater on odds ratios (ORs) [33]. To assess whether the association between 25(OH) vitamin D 
concentration and asthma-related outcomes and eczema was different by gender, ethnicity, 
or children with and without a parental history of asthma or atopy, statistical interactions were 
assessed by adding the product term of independent variable and subgroup (independent 
variable × subgroup) as covariates to the univariate model. To account for potential reverse 
causality, sensitivity analyses were conducted in children without physician diagnosed 
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asthma ever. To prevent bias associated with missing data, missing values of the covariates 
were multiple imputed (n=20 imputations) based on the correlation between the variable 
with missing values with other patient characteristics [34]. Within the population for analyses 
the percentages of missing values were lower than 30%, except for folic acid intake (32%), 
breastfeeding (36%), vitamin D supplementation (39%), day care attendance (52%), history of 
cow’s milk allergy (53%). Both the results of the original dataset (Supplementary Table 3) and 
the pooled results of the 20 imputed data sets were reported in this article as ORs and 95% 
confidence interval (95% CI) for the analyses on FeNO (dichotomous), physician diagnosed 
asthma ever, wheezing, and eczema. The results for the analyses on FeNO (continuous) and 
Rint were reported as ratio of geometric means (EXP(ß)) and change in standardized z-score 
(ß) and 95% confidence interval (95% CI). A p-value  <0.05 was considered as statistically 
significant. IBM SPSS Statistics 22.0 for Windows (IBM Corp., Armonk, NY, USA) was used to 
carry out the statistical analyses.
RESULTS
Study population
Maternal and child characteristics of the study population are shown in Table 7.1 and 
Supplementary Table 7.1. In Supplementary Table 7.2 the prevalence of the outcomes 
of interest are shown. Of the 3815 children, 33%, were 25(OH) vitamin D sufficient, 37%, 
insufficient and 30% deficient. Mean 25(OH) vitamin D concentration for children with 
FeNO <25 ppb and FeNO ≥25 ppb, children with and without physician diagnosed asthma, 
wheezing, and eczema are shown in Figure 7.1.
 
 
Figure 7.1. Mean 25(OH)D concentration in children with and without asthma-related outcomes and eczema 
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25(OH) vitamin D concentration and asthma-related outcomes and eczema
Deficient 25(OH) vitamin D concentration, but not insufficient 25(OH) vitamin D 
concentration, was associated with elevated FeNO (OR: 2.54; 95% CI: 1.34-4.80) (Table 7.2; 
Supplementary Table 7.3). The association with continuous FeNO showed the same trend 
but became non-significant after adjustment for confounders (OR: 1.05; 95% CI: 0.98-1.12) 
(Table 7.2). In comparison with sufficient 25(OH) vitamin D concentration, deficient 
and insufficient 25(OH) vitamin D concentrations were associated with lower 
Rint (ß: -1.26; 95% CI: -1.66 to -0.85) (ß: -0.75; 95% CI: -1.08 to -0.42) (Table 7.2; 
Supplementary Table 7.3). Insufficient 25(OH) vitamin D concentration, but not deficient 
25(OH) vitamin D concentration, was associated with a decreased risk of physician 
diagnosed asthma ever (OR: 0.59; 95% CI: 0.38-0.94) (Table 7.2; Supplementary Table 7.3). 
For wheezing, no association with 25(OH) vitamin D concentrations was observed (Table 7.2; 
Supplementary Table 7.3). In addition, deficient and insufficient 25(OH) vitamin D 
concentrations were associated with increased risks of eczema (OR: 1.65; 95% CI: 1.13-2.41) 
(OR: 1.44; 95% CI: 1.06-1.95) (Table 7.2; Supplementary Table 7.3). Analyses with 25(OH) 
vitamin D concentration as continuous variable showed comparable results (Table 7.3).
Subgroup and sensitivity analyses
A significant interaction was found between 25(OH) vitamin D categories and ethnicity for 
eczema (p=0.048 and p=0.14 for deficient and insufficient 25(OH) vitamin D concentrations, 
respectively). After stratification by ethnicity an association was found between deficient 
and insufficient 25(OH) vitamin D concentrations and increased risk of eczema in Western 
children (OR: 2.01; 95% CI: 1.24-3.24) (OR: 1.61; 95% CI: 1.12-2.32). No significant association 
was found for Non-Western children (Supplementary Table 7.4). No interaction was 
found between 25(OH) vitamin D concentration and gender or parental history of atopy 
(p-interaction >0.17). In the sensitivity analyses in children without physician diagnosed 
asthma ever, we observed similar results for the association between 25(OH) vitamin D 
deficiency and insufficiency and Rint (ß: -1.09; 95% CI: -1.61 to -0.56) (ß: -0.48; 95% CI: -0.89 
to -0.07). Furthermore, in this subgroup the effect estimates for the association between 
25(OH) vitamin D deficiency and FeNO ≥25 ppb remained in the same direction but lost 
statistical significance (OR: 1.73; 95% CI: 0.62-4.80) (Supplementary Table 7.5).
DISCUSSION
We observed that lower vitamin D levels were associated with elevated FeNO levels, 
suggestive of eosinophilic airway inflammation. Remarkably, lower vitamin D levels were 
also associated with lower Rint values, reflecting better airway patency, and lower risk of 
asthma diagnosis ever. We found no effect on the risk for wheezing but found lower vitamin 
D levels to be associated with increased risk for eczema. 
At present, there is no agreement for optimal 25(OH) vitamin D concentrations [9]. 
The optimal vitamin D status for the prevention of allergic disease is unclear. Based on 
25-Hydroxyvitamin D concentrations, asthma and eczema
135
Table 7.2. Association between 25 hydroxyvitamin D and asthma-related outcomes and eczema at age 
6 years
n=3815 Crude modela Multivariate modelb
25(OH)D concentration n (%) FeNO ≥25 ppb aOR  (95% CI) 
Deficient (<50 nmol/L) 1156 (30) 2.90 (1.68-5.01) 2.54 (1.34-4.80)
Insufficient (≥50-75 nmol/L) 1393 (37) 1.30 (0.76-2.21) 1.25 (0.72-2.18)
Sufficient (≥75 nmol/L) 1266 (33) Reference Reference
FeNO EXP(ß) (95% CI)
Deficient (<50 nmol/L) 1156 (30) 1.08 (1.02-1.15) 1.05 (0.98-1.12)
Insufficient (≥50-75 nmol/L) 1393 (37) 1.04 (0.99-1.10) 1.03 (0.98-1.10)
Sufficient (≥75 nmol/L) 1266 (33) Reference Reference
Rint (ß) (95% CI)
Deficient (<50 nmol/L) 1156 (30) -1.09 (-1.44 to -0.75) -1.26 (-1.66 to -0.85)
Insufficient (≥50-75 nmol/L) 1393 (37) -0.73 (-1.05 to -0.41) -0.75 (-1.08 to -0.42)
Sufficient (≥75 nmol/L) 1266 (33) Reference Reference
Physician diagnosed asthma ever aOR (95% CI)
Deficient (<50 nmol/L) 1156 (30) 0.96 (0.60-1.52) 0.85 (0.49-1.45)
Insufficient (≥50-75 nmol/L) 1393 (37) 0.64 (0.42-0.98) 0.59 (0.38-0.94)
Sufficient (≥75 nmol/L) 1266 (33) Reference Reference
Wheezing aOR (95% CI)
Deficient (<50 nmol/L) 1156 (30) 1.19 (0.82-1.72) 1.15 (0.75-1.77)
Insufficient (≥50-75 nmol/L) 1393 (37) 1.03 (0.75-1.43) 0.99 (0.70-1.39)
Sufficient (≥75 nmol/L) 1266 (33) Reference Reference
Physician diagnosed eczema aOR (95% CI)c
Deficient (<50 nmol/L) 1156 (30) 1.64 (1.18-2.28) 1.65 (1.13-2.41)
Insufficient (≥50-75 nmol/L) 1393 (37) 1.34 (1.00-1.79) 1.44 (1.06-1.95)
Sufficient (≥75 nmol/L) 1266 (33) Reference Reference
OR: Odds ratio; 95% CI: 95% confidence interval. OR’s are compared to sufficient 25OHD concentration. EXP(ß): Ratio of 
geometric means and (ß): Regression coefficient indicating the change in standardized z-score compared to the reference 
group; 95% CI: 95% confidence interval.
Entries in bold are statistically significant.
a Adjusted for season at blood sampling. 
b Adjusted for season at blood sampling, smoking during pregnancy, alcohol use during pregnancy, caesarean section, 
day-care attendance first two years, ethnicity, household income per month, birth weight z-score, folic acid intake, marital 
status, breastfeeding, history of cow’s milk allergy first year, vitamin D supplementation age 6-12 months, respiratory tract 
infections, playing outside, walking and biking to school, TV watching and body fat percentage z-score at the age of 6 years. 
c Not additionally adjusted for respiratory tract infections age 6 years. 
Additional adjustment for gender, parity, maternal educational level, parental history of atopy, and age mother did not 
provide an alteration of ≥ 10% in OR.
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Table 7.3. Association between 25 hydroxyvitamin D and asthma-related outcomes and eczema at age 
6 years
n=3815 Crude modela Multivariate modelb
FeNO ≥25 ppb
OR (95% CI) 0.98 (0.97-0.99) 0.98 (0.97-0.99)
FeNO
EXP(ß) (95% CI) 0.99 (0.99-1.00) 0.99 (0.99-1.00)
Rint
(ß) (95% CI) 0.02 (0.01-0.02) 0.02 (0.01-0.02)
Physician diagnosed asthma ever
OR (95% CI) 1.00 (0.99-1.01) 1.00 (0.99-1.01
Wheezing
OR (95% CI) 1.00 (0.99-1.00) 1.00 (0.99-1.01)
Physician diagnosed eczema
OR (95% CI) 0.99 (0.99-1.00) 0.99 (0.99-1.00)c
OR: Odds ratio; 95% CI: 95% confidence interval. OR’s are compared to sufficient 25OHD concentration. EXP(ß): Ratio of 
geometric means and (ß): Regression coefficient indicating the change in standardized z-score compared to the reference 
group; 95% CI: 95% confidence interval.
Entries in bold are statistically significant.
a Adjusted for season at blood sampling. 
b Adjusted for season at blood sampling, smoking during pregnancy, alcohol use during pregnancy, caesarean section, 
day-care attendance first two years, ethnicity, household income per month, birth weight z-score, folic acid intake, marital 
status, breastfeeding, history of cow’s milk allergy first year, vitamin D supplementation age 6-12 months, respiratory tract 
infections, playing outside, walking and biking to school, TV watching and body fat percentage z-score at the age of 6 years. 
c Not additionally adjusted for respiratory tract infections age 6 years. 
Additional adjustment for gender, parity, maternal educational level, parental history of atopy, and age mother did not 
provide an alteration of ≥ 10% in OR.
skeletal health, the Institute of Medicine recommends 25(OH) vitamin D concentration of ≥50 
nmol/L and more to be sufficient [11]. Since it has been argued that the cut-off of 50 nmol/L 
for vitamin D deficiency may be too low, we additionally classified vitamin D insufficiency 
using the cut-off used in previous studies [15, 25]. In agreement with a meta-analysis, we 
found both vitamin D deficiency and insufficiency to be associated with asthma-related 
outcomes and eczema [35]. Comparison of our findings to those of other studies on vitamin 
D and allergic disease is difficult due to differences in study design, age of participants, 
and outcomes. Furthermore, studies on vitamin D and allergic disease are inconsistent [22, 
36]. For our findings on serum vitamin D concentrations and FeNO, only few studies were 
comparable. Similar to our results, a Taiwanese cohort study observed vitamin D deficiency 
(<50 nmol/L) and insufficiency (50-74.9 nmol/L) not to be associated with FeNO in children 
at the age of 6 years [25]. Checkley et al [26] also reported no association between 25(OH) 
vitamin D concentrations and FeNO. However, when using a cut-off of 25 ppb, we did 
find deficient 25(OH) vitamin D concentration to be associated with an increased odds of 
FeNO >25ppb. The threshold of 25 ppb has been suggested to indicate that eosinophilic 
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inflammation is likely [32]. To our knowledge no other study examined the association 
between vitamin D status and Rint. Therefore, we can only speculate about the association 
that was observed. Rint values reflecting airway resistance are generally increased in children 
with asthma [37, 38]. Therefore, our results that vitamin D insufficiency was associated with 
lower Rint values is surprising. Few studies report why Rint values may be reduced. First, Rint 
values may be lower when cheeks are not firmly supported, especially in younger children 
[38]. Nevertheless, we adjusted our Rint values for the technique during the measurement 
(eg. adequate breathing and support of cheeks). Another explanation may be potential 
treatment or interventions affecting airways resistance such as bronchodilators [37] since 
we also found a weak inverse association between insufficient, but not deficient, vitamin D 
concentrations and physician diagnosed asthma. Parents were asked to temporarily cease 
medication for respiratory conditions 24 hours before the visit to the research center in 
children without symptoms. Therefore, children who did experience symptoms prior to their 
visit might still have received medication. However, the results did not differ after exclusion of 
children with parent-reported physician diagnosed asthma. Last, Merkus et al [39] reviewed 
Rint values in different populations and found reduced values in children with recurrent 
rhinitis. Since previous studies have shown that low vitamin D levels are associated with 
a higher risk of rhinitis, this may have also been the case in our study [40]. This clearly deserves 
further elucidation. FeNO and Rint measurements both provide different information for 
the prediction of asthma. Caudri et al. showed that FeNO but not Rint is predictive for asthma 
[41].  In addition, after exclusion of children with parent-reported physician diagnosed 
asthma (Supplementary Table 7.5) the effect estimates for the association between 25(OH) 
vitamin D deficiency and FeNO ≥25 ppb remained in the same direction but lost statistical 
significance. Therefore, we speculate that the results on FeNO may be explained by airway 
inflammation due to uncontrolled asthma. Another Dutch birth cohort study reported 
higher serum vitamin D concentrations (median concentration 97nm and 68nm vs. 52nm) at 
the age of 4 years to be associated with a lower risk of parental reported asthma at age 4-8 
years [17]. A meta-analysis of published studies, including European studies, on vitamin D 
and childhood asthma suggests that low vitamin D levels might increase the risk of asthma 
[35]. In contrast, we found insufficient vitamin D concentration to be associated with a lower 
risk of physician diagnosed asthma. The possibility of a U-shaped association (<50 nmol/L 
and ≥75 nmol/l vs. 50-75 nmol/L) between vitamin D levels and respiratory health has been 
previously suggested by Niruban et al [15]. However, similar direction of the effect estimates 
were observed for the association between vitamin D deficiency and diagnosed asthma ever 
but not significant. This might be explained by the small number of children with vitamin 
D deficiency and physician diagnosed asthma. Contrary to our study, two other studies did 
find 25(OH) vitamin D levels to be associated with wheezing in children [15, 16]. Although 
the latter studies did adjust for multiple confounders, we also considered prenatal factors and 
factors during infancy as potential confounders in our analyses. Therefore, the inconsistency 
with our findings might be explained by residual confounding. In addition, Keet et al [42] 
found the association between vitamin D and wheezing to vary by age, suggesting an 
Chapter 7
138
age-dependent relationship. Our results show that lower vitamin D levels are associated 
with an increased risk of eczema, but only in Western children and not in non-Western 
children. A randomized placebo-controlled trial observed oral vitamin D supplementation 
to lead to an improvement in atopic dermatitis severity in children, supporting a causal role 
[43]. It has previously been suggested that the association between vitamin D levels and 
eczema might vary by race [44]. Wegienka et al [44] found prenatal vitamin D levels to be 
inversely associated with eczema and found this association to be stronger in white children 
than in black children, however not statistically significant. In children with a white skin, 
the prevalence of eczema is lower and vitamin D levels higher than in children with a dark 
skin [45-47]. Skin color might vary within ethnic groups [48]. Our cohort consists of children 
from many different but also mixed races, making it difficult to interpret our findings. Hence, 
it may be valuable to further study the interaction between race i.e. skin color, vitamin D 
status and eczema. 
An important strength of this study is the large study population drawn from the general 
population. Another strength is that we obtained data on several asthma-related outcomes 
including FeNO and Rint. We used FeNO and Rint measurements as an objective tool to 
support in the diagnosis of asthma in children [38, 49] in addition to self-administered 
questionnaire data.  Also, our study design provided information on multiple potential 
confounders including sedentary activity and time spent outdoors. However, residual 
confounding cannot be fully excluded. 
A limitation of this study is that the data on physician diagnosed asthma, wheezing, 
and eczema was collected by parent-reported questionnaires. This might have resulted 
in misclassification of the outcome as physician diagnosis is more precise. In a previous 
study in our cohort, we experienced that self-report mainly leads to overreporting of 
wheezing symptoms [50]. However, we believe it is unlikely that it would have influenced 
the directionality of our association with vitamin D since parents were not aware of their 
child’s vitamin D status. Another limitations is that we only had one measurement of 25(OH) 
vitamin D concentration. However, a population based study in adults found 25(OH) levels 
to be highly correlated over time, providing support for the use of a single measurement 
[51]. The cross-sectional design of this study precludes us to make causal inference. Also, 
reverse causality may have influenced our results. Parents of children with early symptoms 
of allergy may be more inclined towards a healthy life style including supplementation of 
vitamin D, which might explain the adverse association we found between insufficient (but 
not deficient) vitamin D status and physician diagnosed asthma ever and Rint. In addition, 
it has been suggested that chronic inflammation may reduce circulating 25(OH) vitamin D 
[52]. Therefore, an inadequate vitamin D status may indirectly indicate disease rather than 
associated with disease pathogenesis. 
 In conclusion, we found that lower 25(OH) vitamin D levels are cross-sectional associated 
with elevated FeNO levels, suggestive of eosinophilic airway inflammation, but lower Rint 
values, meaning a better airway resistance. Lower 25(OH) vitamin D levels are also associated 
with a decreased risk for asthma diagnoses but an increased risk for eczema. Further studies 
are  necessary to clarify the directionality of these observed associations.
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Supplementary Figure 7.1 Flowchart of the participants within the Generation R 
Study 
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Supplementary Figure 7.1. Flowchart of the participants within the Generation R Study
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Supplementary Table 7.2. Prevalence of outcomes
Outcome n %
FeNO Median (Range)
7.3 0.10-119
Missing 1051 28
FeNO
<25 2660 96
≥25 104 4
Missing 1051 28
Rint Mean (SD)
-0.11 3.55
Missing 1159 30
Physician diagnosed asthma ever
No 2191 94
Yes 136 6
Missing 1488 39
Wheezing
No 2505 92
Yes 233 8
Missing 1077 28
Physician diagnosed eczema
No 1859 85
Yes 326 15
Missing 1630 43
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Supplementary Table 7.3. Association between 25 hydroxyvitamin D and asthma-related outcomes and 
eczema at age 6 years (original data)
n=3815 Crude modela Multivariate modelb
25(OH)D concentration n (%) FeNO ≥25 ppb aOR (95% CI)
Deficient (<50 nmol/L) 1156 (30) 2.90 (1.68-5.01) 3.08 (0.31-30.47)
Insufficient (≥50-75 nmol/L) 1393 (37) 1.30 (0.76-2.21) 2.25 (0.51-10.05)
Sufficient (≥75 nmol/L) 1266 (33) Reference Reference
FeNO EXP(ß) (95% CI)
Deficient (<50 nmol/L) 1156 (30) 1.08 (1.02-1.15) 0.95 (0.79-1.14)
Insufficient (≥50-75 nmol/L) 1393 (37) 1.04 (0.99-1.10) 0.98 (0.86-1.11)
Sufficient (≥75 nmol/L) 1266 (33) Reference Reference
Rint (ß) (95% CI)
Deficient (<50 nmol/L) 1156 (30) -1.09 (-1.44 to -0.75) -1.04 (-2.09 to 0.01)
Insufficient (≥50-75 nmol/L) 1393 (37) -0.73 (-1.05 to -0.41) -0.57 (-1.28 to 0.14)
Sufficient (≥75 nmol/L) 1266 (33) Reference Reference
Physician diagnosed asthma ever aOR (95% CI)
Deficient (<50 nmol/L) 1156 (30) 0.96 (0.60-1.52) 0.58 (0.13-2.50)
Insufficient (≥50-75 nmol/L) 1393 (37) 0.64 (0.42-0.98) 0.34 (0.10-1.09)
Sufficient (≥75 nmol/L) 1266 (33) Reference Reference
Wheezing aOR (95% CI)
Deficient (<50 nmol/L) 1156 (30) 1.19 (0.82-1.72) 0.32 (0.08-1.24)
Insufficient (≥50-75 nmol/L) 1393 (37) 1.03 (0.75-1.43) 0.12 (0.04-0.38)
Sufficient (≥75 nmol/L) 1266 (33) Reference Reference
Physician diagnosed eczema aOR (95% CI)c
Deficient (<50 nmol/L) 1156 (30) 1.64 (1.18-2.28) 1.76 (0.67-4.65)
Insufficient (≥50-75 nmol/L) 1393 (37) 1.34 (1.00-1.79) 1.61 (0.80-3.23)
Sufficient (≥75 nmol/L) 1266 (33) Reference Reference
OR: Odds ratio; 95% CI: 95% confidence interval. OR’s are compared to sufficient 25OHD concentration. EXP(ß): Ratio of 
geometric means and (ß): Regression coefficient indicating the change in standardized z-score compared to the reference 
group; 95% CI: 95% confidence interval.
Entries in bold are statistically significant.
a Adjusted for season at blood sampling. 
b Adjusted for season at blood sampling, smoking during pregnancy, alcohol use during pregnancy, caesarean section, 
day-care attendance first two years, ethnicity, household income per month, birth weight z-score, folic acid intake, marital 
status, breastfeeding, history of cow’s milk allergy first year, vitamin D supplementation age 6-12 months, respiratory tract 
infections, playing outside, walking and biking to school, TV watching and body fat percentage z-score at the age of 6 years. 
c Not additionally adjusted for  respiratory tract infections age 6 years.
Additional adjustment for gender, parity, maternal educational level, parental history of atopy, and age mother did not 
provide an alteration of ≥ 10% in OR.
25-Hydroxyvitamin D concentrations, asthma and eczema
149
Su
pp
le
m
en
ta
ry
 T
ab
le
 7
.4
. A
ss
oc
ia
tio
n 
be
tw
ee
n 
25
(O
H
)D
 c
on
ce
nt
ra
tio
n 
an
d 
ec
ze
m
a 
st
ra
tifi
ed
 b
y 
et
hn
ic
ity
25
(O
H
)D
 c
on
ce
nt
ra
ti
on
W
es
te
rn
N
on
-W
es
te
rn
n 
(%
)
Cr
ud
e 
m
od
el
a
O
R 
(9
5%
 C
I)
M
ul
ti
va
ri
at
e 
m
od
el
b
O
R 
(9
5%
 C
I)
n 
(%
)
Cr
ud
e 
m
od
el
a
O
R 
(9
5%
 C
I)
M
ul
ti
va
ri
at
e 
m
od
el
b
O
R 
(9
5%
 C
I)
D
efi
ci
en
t (
<
50
 n
m
ol
/L
)
11
37
 (3
7)
1.
76
 (1
.1
3-
2.
75
)
2.
01
 (1
.2
4-
3.
24
)
12
9 
(1
7)
0.
88
 (0
.4
8-
1.
60
)
1.
04
 (0
.5
4-
1.
99
)
In
su
ffi
ci
en
t (
≥
50
-7
5 
nm
ol
/L
)
74
0 
(2
5)
1.
45
 (1
.0
3-
2.
04
)
1.
61
 (1
.1
2-
2.
32
)
41
6 
(5
4)
0.
83
 (0
.4
6-
1.
50
)
0.
93
 (0
.5
0-
1.
74
)
Su
ffi
ci
en
t (
≥
75
 n
m
ol
/L
)
11
64
 (3
8)
Re
fe
re
nc
e
Re
fe
re
nc
e
22
9 
(2
9)
Re
fe
re
nc
e
Re
fe
re
nc
e
O
R:
 O
dd
s 
ra
tio
; 9
5%
 C
I: 
95
%
 c
on
fid
en
ce
 in
te
rv
al
. O
R’
s 
ar
e 
co
m
pa
re
d 
to
 s
uffi
ci
en
t 2
5O
H
D
 c
on
ce
nt
ra
tio
n.
En
tr
ie
s 
in
 b
ol
d 
ar
e 
st
at
is
tic
al
ly
 s
ig
ni
fic
an
t.
a 
A
dj
us
te
d 
fo
r s
ea
so
n 
at
 b
lo
od
 s
am
pl
in
g.
 
b 
A
dj
us
te
d 
fo
r s
ea
so
n 
at
 b
lo
od
 s
am
pl
in
g,
 s
m
ok
in
g 
du
rin
g 
pr
eg
na
nc
y,
 a
lc
oh
ol
 u
se
 d
ur
in
g 
pr
eg
na
nc
y,
 c
ae
sa
re
an
 s
ec
tio
n,
 d
ay
-c
ar
e 
at
te
nd
an
ce
 fi
rs
t t
w
o 
ye
ar
s,
 h
ou
se
ho
ld
 in
co
m
e 
pe
r m
on
th
, b
ir
th
 
w
ei
gh
t z
-s
co
re
, f
ol
ic
 a
ci
d 
in
ta
ke
, m
ar
ita
l s
ta
tu
s,
 b
re
as
tf
ee
di
ng
, h
is
to
ry
 o
f c
ow
’s 
m
ilk
 a
lle
rg
y 
fir
st
 y
ea
r, 
vi
ta
m
in
 D
 su
pp
le
m
en
ta
tio
n 
ag
e 
6-
12
 m
on
th
s,
 p
la
yi
ng
 o
ut
si
de
, w
al
ki
ng
 a
nd
 b
ik
in
g 
to
 sc
ho
ol
, 
TV
 w
at
ch
in
g 
an
d 
bo
dy
 fa
t p
er
ce
nt
ag
e 
z-
sc
or
e 
at
 th
e 
ag
e 
of
 6
 y
ea
rs
. 
Chapter 7
150
Supplementary table 7.5. Association between 25 hydroxyvitamin D and asthma-related outcomes at 
age 6 years in children without asthma diagnosis
n=2191 Crude modela Multivariate modelb
n (%) FeNO ≥25 ppb aOR (95% CI) 
Deficient (<50 nmol/L) 821 (37) 1.76 (0.72-4.28) 1.73 (0.62-4.80)
Insufficient (≥50-75 nmol/L) 521 (24) 1.14 (0.57-2.25) 1.14 (0.55-2.34)
Sufficient (≥75 nmol/L) 849 (39) Reference Reference
FeNO EXP(ß) (95% CI)
Deficient (<50 nmol/L) 821 (37) 1.06 (0.92-1.10) 0.98 (0.89-1.08)
Insufficient (≥50-75 nmol/L) 521 (24) 1.03 (0.96-1.10) 1.02 (0.95-1.10)
Sufficient (≥75 nmol/L) 849 (39) Reference Reference
Rint (ß) (95% CI) 
Deficient (<50 nmol/L) 821 (37) -0.95 (-1.43 to -0.48) -1.09 (-1.61 to -0.56)
Insufficient (≥50-75 nmol/L) 521 (24) -0.48 (-0.88 to -0.09) -0.48 (-0.89 to -0.07)
Sufficient (≥75 nmol/L) 849 (39) Reference Reference
OR: Odds ratio; 95% CI: 95% confidence interval. OR’s are compared to sufficient 25OHD concentration. EXP(ß): Ratio of 
geometric means and (ß): Regression coefficient indicating the change in standardized z-score compared to the reference 
group; 95% CI: 95% confidence interval.
Entries in bold are statistically significant.
a Adjusted for season at blood sampling. 
b Adjusted for season at blood sampling, smoking during pregnancy, alcohol use during pregnancy, caesarean section, 
day-care attendance first two years, ethnicity, household income per month, birth weight z-score, folic acid intake, marital 
status, breastfeeding, history of cow’s milk allergy first year, vitamin D supplementation age 6-12 months, respiratory tract 
infections, playing outside, walking and biking to school, TV watching and body fat percentage z-score at the age of 6 years. 
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MAIN FINDINGS
The timing of introduction of complementary feeding
The transition from fluid-based nutrition to solid food is developmentally programmed but 
timing of developmental readiness differs by infant [1]. Infant feeding recommendations 
vary between countries but infants feeding practices have also been found to differ despite 
similar feeding recommendations [2, 3]. Infant feeding practices often do not follow infant 
feeding recommendations and early introduction of solid foods is common [1, 4]. Both early 
and late introduction of complementary feeding (solid foods and liquids other than breast 
milk or infant formula and follow-on formula) have been associated with health risks. Since 
the complementary feeding period accompanies a critical window of vulnerability, identifying 
maternal and infant factors associated with the timing of introduction of complementary 
feeding is of importance. Therefore, we aimed to identify determinants associated with 
the timing of introduction of complementary feeding (Chapter 2). Recommendations 
regarding the introduction of solid foods has changed significantly over the past years 
[1]. By the 1990s a delayed introduction of complementary feeding beyond the age of 6 
months was recommended. This recommendation was current in the Netherlands during 
the study period. In our study population we found that 62% of infants were introduced to 
complementary feeding before the age of 6 months. Our findings are in accordance with 
other studies. In a Danish study [5], about 70% of infants were introduced to complementary 
feeding before the recommended age of 6 months and about 80% of infants in a Canadian 
study [6]. We found that being a single parent and infant day care attendance were 
determinants for very early (<3 months) introduction of complementary feeding. Young 
maternal age, multiple parities, no infant family history of asthma, atopy and no infant 
history of allergy to cow’s milk were determinants for early (4-6 months) introduction of 
complementary feeding. Determinants for both very early and early introduction were low 
educational level and not fully breastfed for 4 months. Previous studies reported similar 
determinants for early introduction of complementary feeding including young maternal 
age, low maternal education, and short duration of breastfeeding [5, 7]. We found infants 
with a family history of asthma, atopy or a history of allergy to cow’s milk more likely to be 
introduced to complementary foods beyond the age of 6 months. Mothers of infants with an 
increased risk of allergic disease may be more aware of the introduction of complementary 
foods and less likely to introduce complementary feeding early. It has previously been 
suggested that in families with a history of allergy, the perceived risk of infants feeding 
recommendations is an important factor for parental action [8].   
The age of exposure to food allergens has been suggested to be important in 
the development of tolerance [9]. Formerly, a delayed introduction of solid foods beyond 
the age of 6 months was recommended and further delay in the introduction of allergenic 
foods was recommended for infants with a family history of allergy [1]. More recent guidelines 
recommend the introduction of solid foods >17 weeks of age for the prevention of allergies 
[9, 10]. Previous studies examining the association between the timing of introduction 
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of allergenic foods and the development of allergic diseases such as asthma and eczema 
have shown conflicting results. Therefore, we aimed to assess the effect of the timing of 
introduction of allergenic foods on the development of wheezing and eczema up to 4 years 
of age (Chapter 3). We found a delayed introduction of allergenic foods cow’s milk, hen’s egg, 
peanuts, tree nuts, soy, and gluten after the age of 6 months did not prevent wheezing and 
eczema in pre-school children. In addition, the association did not differ between children 
with and those without a history of cow’s milk allergy in the first year of life and those children 
with and those without a parental history of atopy. A review examining the association 
between the introduction of solid foods and allergic disease, including asthma and eczema 
in children, also found no convincing evidence that avoidance or delayed introduction of 
allergenic foods reduced the risk for allergy development in high-risk and non-risk infants [9]. 
Recently, two randomized controlled trials in the United Kingdom examined the role of early 
introduction of allergenic food in the development of allergic disease. The Enquiring About 
Tolerance (EAT) study found that early introduction from the age of 3 months of allergenic 
food in sufficient quantity may be able to help prevent food allergies in children [11]. The 
Learning about Peanut Allergy (LEAP) study found the introduction of peanut between 
the age of 4 to 11 months to significantly decrease the frequency of the development of 
peanut allergy in high risk children [12]. The findings of both randomized controlled trials 
support current evidence that delayed introduction of allergenic foods may not reduce 
allergies [9, 10].
The rapid increase in celiac disease prevalence might suggest that besides genetics, 
environmental factors also play a role in the loss of immune tolerance to gluten. It has 
been hypothesized that the introduction of gluten prior to maturation of the gut barrier 
may lead to an immune response [13]. Also, there may be a period during infancy when 
the immune system is predisposed to tolerance development. Exposure to a food during 
this time could lead to persistent tolerance to that food [14]. The timing of introduction of 
gluten and breastfeeding has long been thought to play a role in the development of celiac 
disease. Both early and late introduction of gluten have been suggested to increase the risk 
of celiac disease development [15, 16] whereas breastfeeding duration and exclusivity, and 
gradual introduction of gluten while breastfeeding has been proposed to be protective 
for the development of celiac disease [17, 18]. Yet, results of mainly retrospective studies 
lacked consistency [15, 16, 19-23]. Therefore, we prospectively studied whether the timing 
of introduction of gluten and breastfeeding duration were associated with celiac disease 
autoimmunity in 6 year old children (Chapter 4). We found a delayed introduction of 
gluten beyond the age of 6 months not to increase the risk of celiac disease autoimmunity. 
Also, we found breastfeeding for 6 months or longer not to decrease the risk of celiac 
disease autoimmunity. The results of our study are in agreement with the findings of two 
randomized controlled trials. The Risk of Celiac Disease and Age at Gluten Introduction 
(CELIPREV) trial compared early and delayed introduction of gluten on the prevalence of 
celiac disease autoimmunity and overt celiac disease among children at risk. The study 
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reported the introduction of gluten at age 6 months compared with the introduction at 12 
months to have no effect on the risk of celiac disease autoimmunity and overt celiac disease 
at 5 years of age. Also, breastfeeding had no effect on the development of celiac disease 
[24]. The PEVENTCD study, a randomized controlled trial in high-risk children, reported 
breastfeeding (exclusive or during gluten introduction) and early introduction (16-24 weeks) 
of small quantities of gluten not to influence the development of biopsy-confirmed celiac 
disease [25]. Therefore, the results of this latter study did not support the 2008 ESPGHAN 
Committee on Nutrition recommendation to avoid late (≥7 months) introduction of gluten 
and to introduce gluten gradually while the infant is still being breastfed to reduce the risk of 
celiac disease [10]. In addition, a recent updated systematic review reported breastfeeding 
and the age of gluten introduction to have no effect on the risk of celiac disease development 
in childhood [26]. Based on the new available evidence the ESPGHAN Committee on Nutrition 
recommendations now state that gluten may be introduced anytime between 4 (17 weeks) 
to 12 months of age. Breastfeeding should be promoted but neither any breastfeeding nor 
breastfeeding during gluten introduction reduces the risk of celiac disease [27]. Since gluten 
is central to the pathogenesis of celiac disease it remains the main environmental trigger. 
Based on previous available evidence it has been suggested that the window of 
vulnerability in infancy for allergic disease most likely be allocated between 4 to 7 months of 
age [10]. Although the timing of the window to prevent allergies is still not clear, evidence for 
delaying the introduction of complementary foods in the infant’s diet seems to be lacking. 
Nutrition and respiratory and allergic disease
It is well known that breastfeeding is the most desirable nutrition for infants [28, 29]. 
Especially during infancy breastfeeding has been found to protect against infectious 
diseases [29, 30]. Human milk offers passive protection against infections in the infant via 
secretory IgA antibodies and most likely via other immune components such as lactoferrin, 
oligosaccharides, cytokines and others [28]. It has been suggested that immune factors such 
as anti-idiotypic antibodies as well as T and B lymphocytes and others factors may also actively 
stimulate the immune system of the infants with lasting effects [31, 32]. Whether the effect 
of breastfeeding on the development of respiratory tract infections proceeds after infancy 
is still not clear as evidence on long-term effects is lacking. For this reason, we assessed 
whether breastfeeding is associated with lower and upper respiratory tract infections after 
infancy up to 4 years of age (Chapter 5). We found breastfeeding for 6 months or longer to 
be associated with a reduced risk of lower respiratory tract infections in children. We did 
not find an association between breastfeeding dose and lower respiratory tract infections. 
In agreement with our findings, a systematic review and meta-analysis reported lack of 
breastfeeding as a risk factor for severe acute lower respiratory infections in children under 
5 years of age [33]. When including studies in industrialized countries only, this latter study 
did not find an association between breastfeeding (lack of exclusive breastfeeding and no 
breastfeeding) and severe acute lower respiratory infections in children. However, only 2 
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case control studies from industrialized countries were included in this review [33]. We did 
not find the duration of breastfeeding and predominant breastfeeding to be associated with 
upper respiratory tract infections. Previous studies on breastfeeding and upper respiratory 
infections after infancy have shown conflicting results with some studies reporting 
an association [34, 35] and other studies a lack of [36, 37]. Comparison between studies 
examining the effect of breastfeeding on respiratory infections is difficult as the definition 
of breastfeeding varies. Also, studies focused on different outcomes with some studies 
examining the effect on respiratory tract infections in general and others specific respiratory 
infections. Whether the protective effect of breastfeeding on infectious diseases proceeds 
after infancy remains inconclusive. 
A potential environmental factor related to the rise in asthma prevalence might 
be the changes in diet. Oxidative stress and inflammation are central in the clinical 
manifestation of asthma. Some foods such as vegetables and fruits have been proposed to 
have antioxidant, anti-allergic and anti-inflammatory properties which may have a protective 
effect on the development of asthma [38, 39]. Therefore, diet might modulate the risk of 
asthma and other respiratory diseases. Previous studies have focused on either individual 
nutrients or individual food groups. An overview of systematic reviews showed a beneficial 
effect of fresh fruits and antioxidant vitamins (vitamins C, E and D) on asthma or wheeze for 
which the protective effect was more clear in children [39]. More recently, some studies have 
examined the association between overall diet and asthma in children [39, 40]. Most studies 
focused on the effect of a traditional Mediterranean diet on the development of asthma 
symptoms. It has been suggested that adherence to a Mediterranean diet during childhood 
might have a protective effect on the development of asthma [40]. The Mediterranean diet 
refers to dietary patterns low in saturated fatty acids and rich in complex carbohydrates, 
fiber, antioxidants, monounsaturated fatty acids and n-3 polyunsaturated fatty acids (PUFA). 
A Mediterranean diet might influence asthma development through its ability to reduce 
the effect of oxidative stress and inflammation. Contrary, a more modern/Western dietary 
pattern low in antioxidants and high in saturated fat might increase the risk of asthma 
symptoms [41]. We studied whether a “Western” dietary pattern, characterized by high 
intake of refined grains, soups and sauces, savoury and snacks, other fats, sugar-containing 
beverages and meat and a “Health conscious” dietary pattern, characterized by starchy 
foods, fruit, vegetables, potatoes, vegetable oils, fish, legumes and meat are associated with 
respiratory symptoms in pre-school children (Chapter 6). We found a high adherence to 
a “Western” diet to be associated with an increased risk of respiratory symptoms including 
wheezing, shortness of breath, and respiratory tract infections. A review examining 
the association between consumption of a Western dietary pattern and asthma in adults 
did not find an association between a Western diet and asthma. However, a possible link 
between a Western diet and asthma morbidity might exist [41]. We found no association 
between a “Health conscious” dietary pattern and reduction of respiratory symptoms. Two 
systematic reviews and meta-analyses reported that adherence to a Mediterranean dietary 
pattern may prevent respiratory outcomes including wheezing and asthma in childhood [40, 
42]. One of these latter studies did not observe this association in adults [42].
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It has been suggested that vitamin D has immunomodulatory effects on allergen-induced 
inflammatory pathways [43, 44]. Therefore, vitamin D may play a role in the development 
of asthma and allergies. The role of vitamin D in the prevention of asthma and allergies in 
children remains controversial as studies found both negative and positive results [44]. We 
aimed to examine whether serum 25-hydroxyvitamin D (25(OH) vitamin D) concentrations 
are associated with asthma symptoms including the fraction of exhaled nitric oxide (FeNO), 
airway interrupter resistance (Rint), physician diagnosed asthma ever, wheezing and eczema 
in 6 year old children (Chapter 7). We found that 33% of children had sufficient 25(OH)D levels 
whereas 37% had insufficient and 30% deficient. A systematic review examining the role of 
25 (OH) vitamin D in asthma found no association with asthma incidence in childhood (age 
4-20 years) [45]. However, the studies varied greatly in the way that asthma was defined and 
measured [45]. For example, parental reports included questions ranging from symptoms, 
medication use to doctor diagnosis of asthma. In addition to self-administered questionnaire 
data, we used FeNO, a biomarker of airway inflammation, and Rint measurements, reflecting 
airway resistance, as an objective tool to support in the diagnosis of asthma in children [46, 
47]. We found lower 25(OH) vitamin D levels to be associated with elevated FeNO levels, 
suggestive of eosinophilic airway inflammation. Few studies examining the association 
between vitamin D and FeNO found no association in children [48, 49]. In addition, 
a randomized controlled trial evaluating the effect of vitamin D treatment on fractional 
exhaled nitric oxide (FeNO) in children with mild asthma found no correlation between 
vitamin D and FeNO. However, the small sample size precludes conclusions [50]. We found 
lower vitamin D levels to be associated with lower Rint values. As lower Rint values reflect 
better airway patency an opposite effect was expected. To our knowledge no other study 
examined the association between vitamin D status and Rint and further studies are needed 
to elucidate our findings. Also, we found lower 25(OH) vitamin D levels to be associated 
with increased risk for eczema in Western children. A New Zealand cross-sectional study 
found no association between 25(OH) vitamin D concentration and eczema [51]. However, 
a randomized controlled trial found vitamin D supplementation to lead to an improvement 
in atopic dermatitis severity in children, supporting a causal role [52]. Despite the growing 
body of literature investigating the association between vitamin D and asthma and allergies 
in childhood, the role of vitamin D remains unclear as results are inconclusive.
METHODOLOGICAL CONSIDERATIONS
Study design 
The studies described in this thesis were performed in the Generation R study, a prospective 
cohort study. Cohort studies provide an opportunity to observe populations prospectively, 
thereby identifying factors associated with a disease of interest. It allows to examine 
the relationship between different variables and multiple outcome measures and relevant 
covariates. However, to appreciate the results of  this thesis, methodological considerations 
need to be taken into account. 
Cohort studies can be prone to selection bias due to loss of study subjects. Initially, this 
may occur if a portion of the target study population does not participate and is systematically 
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different from the original study population with regard to exposure and outcomes status. 
In the Generation R study participating mothers more often had a higher socioeconomic 
status than non-participating mothers. This may have influenced the external validity. 
Moreover, selection bias may also occur when subjects are lost to follow up. However, 
selection bias could have influenced our findings only if the association between early life 
nutrition and disease was different for those who participated compared with those who 
did not participate. 
Missing data are inevitable in epidemiological research and may also lead to biased 
results. The risk of bias depends on the reason for missing data. Missing data can be 
categorized as missing completely at random (MCAR), missing at random (MAR), and 
missing not at random (MNAR) [53]. Missing data is MCAR when the missing observations 
are unrelated to any study variable (observed and unobserved). Missing data is MAR when 
systematic differences can be explained by other observed variables, but not by the variable 
with missing data itself whereas data MNAR is related to the missing variable itself [53]. We 
used multiple imputation to deal with missing data under the assumption that our data are 
MAR. However, in this thesis it was not possible to distinguish between data MAR and MNAR. 
When data was MNAR this could have affected the prediction of the missing values and 
therefore the uncertainty of the effect estimates observed. 
Confounding and reverse causality
Epidemiological studies try to identify factors associated with  disease outcome. However, 
other factors may also be associated with the exposure and affect the risk of developing 
the disease, thereby distorting the observed association between the exposure and 
disease. Sociodemographic and lifestyle factors are potential confounding variables in 
the association between early life nutrition and respiratory and allergic disease. Adjustment 
for these potential confounders is particularly important since lifestyle factors including diet 
have been found to cluster and also to be associated with health outcomes [54]. Although we 
adjusted our studies for multiple potentially confounding variables, residual confounding 
cannot be fully excluded. This may be due to the fact that some potential confounders were 
not (sufficiently) measured during the process of data gathering or because variables were 
measured with error.  
We also considered the possibility of reverse causality. Reverse causality might influence 
the association between the timing of introduction of allergenic foods and wheezing and 
eczema, as parents with a family history of atopy or infants with early symptoms of allergy 
may delay the introduction of complementary feeding. Therefore, we evaluated whether 
the association was significantly different by history of cow’s milk allergy and parental 
history of atopy (by assessing effect-modification). Reverse causality has been minimized 
in the association between dietary patterns and respiratory outcomes since we examined 
the effect of dietary patterns prior to the outcomes. In contrast, reverse causality may have 
influenced the observed association between vitamin D status and asthma and eczema. 
General discussion
161
Parents of children with early symptoms of allergy may be more inclined towards a healthy 
life style including supplementation of vitamin D. Also, children with symptoms of asthma 
may be less likely to spend time outdoors and therefore have lower vitamin D levels due 
to their illness. In addition, it has been suggested that an inadequate vitamin D status may 
indirectly indicate disease rather than associated with disease pathogenesis. Therefore, 
reverse causality cannot be fully excluded. 
In observational research it is not possible to prove causality between early life nutrition 
and the reported outcomes. Only in a randomized controlled trial the risk of residual 
confounding and reverse causation can be excluded.  
Nutritional assessment
In this thesis, a food frequency questionnaire (FFQ) was used to assess dietary intake in 
children. FFQs are commonly used in epidemiological studies. It is a widely used method for 
quantitative assessment of usual intake of groups or individuals. FFQs enables the assessment 
of long-term dietary intakes in a relatively simple, cost-effective, and less time consuming 
manner. However, FFQs may be less accurate than 24-hours diet recalls, dietary records, and 
nutritional biomarkers [55]. As diet may be influenced by factors including ethnicity and 
culture, FFQs should be developed for a specific study group. FFQs to assess dietary intake 
in children should be made suitable especially in terms of the types of foods that children 
consume. The FFQ used in the Generation R study, was specifically designed for the study 
population consisting of 1 year old children. It was tailored to foods frequently consumed 
by children 9-18 months of age according to a Dutch National Food Consumption Survey in 
2002. The accuracy of information on dietary intake obtained by FFQ is highly dependent on 
the validity and reproducibility of the FFQ in the population it is intended for. The FFQ used 
in the Generation R study was validated against three day 24 hour recalls in Dutch children 
in the same age group. The intraclass-correlation coefficients were 0.4 for total energy, 
0.7 for protein, 0.4 for total fat, 0.4 for carbohydrates, and 0.7 for dietary fiber. Although 
these correlations are not ideal, other validations studies of dietary measurements showed 
comparable coefficients [56].  
Limitations of FFQs have to be considered in the interpretation of the results presented 
in this thesis. FFQs are self-reported measures of intake over an extended period of time. 
Because people may find it difficult to recall intake over a long period, FFQs may fail to truly 
reflect a person’s long-term average intake. Thus, the estimated intake has an error that is 
often substantial which may lead to biased disease risk estimates. Dietary measurement 
error is mostly non-differential which is independent of the outcome of interest [57]. 
Misclassification of dietary intake may lead to attenuation of the effect estimate and wider 
confidence intervals, meaning an underestimation of the association and reduced statistical 
power to detect an associations. A second type of dietary measurement error that may occur 
is differential, which is related to the outcome of interest [57]. Because in the majority of 
studies described in this thesis, dietary intake was measured prior to the development of 
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the disease of interest, differential measurement error and thus recall bias may have been of 
minimum concern. 
 In the Generation R study we assessed dietary patterns in 1 year old children. Dietary 
patterns analysis capture the relationship between overall diet and its constituent foods, 
beverages and nutrients in relation to the outcome of interest. It thereby overcomes 
the collinearity among single foods and nutrients and considers the interactions between 
foods and nutrients in disease risk. Different dietary pattern assessment methods have 
been suggested [58]. In this thesis, dietary patterns were obtained through an a posteriori 
approach that was outcome-independent. The relationship between the dietary patterns 
and health outcomes were examined once the patterns had been defined. Principal 
component analysis (PCA) is a popular method for deriving dietary patterns. It makes use 
of the underlying relationships between food intakes to identify underlying patterns within 
a population [58]. However, several arbitrary decisions are involved in identifying dietary 
patterns by PCA including combining food items into food groups, the number of factors to 
retain, type of rotation, and the labelling of components [58]. These decisions are important 
for the interpretation of the dietary patterns as they may influence the reproducibility.
In this thesis, we adjusted the study on dietary patterns and disease outcome for total 
energy intake. Adjustment for total energy intake is a standard procedure in nutritional 
epidemiology. It addresses for the fact that total energy requirements are related to body 
size, metabolic efficiency, and physical activity. Failure to account for energy intake can 
obscure associations between diet and disease risk. An association found between a dietary 
pattern that represents a diet high in energy-dense foods and a disease outcome, may not 
be a real effect of the food themselves, but an association with actual energy intake. In 
addition to adjustment for the potential confounding effect of total energy intake, energy 
adjustment is used to adjust for measurement error in diet, which is based on the assumption 
that individuals tend to misreport to a similar degree and in the same direction. Different 
methods for energy adjustment have been described such as the residual method. However, 
the residual method for energy adjustment has not been applied in this thesis as it may be 
more difficult to pick up energy-dense dietary patterns when using PCA [59]. Therefore, we 
adjusted for total energy intake in the regression models after dietary patterns were defined. 
It has been suggested that energy adjustment in a later stage in the analysis is sufficient and 
that adjustment for energy intake before entry into PCA analysis is not necessary [59].
To assess the effect of dietary patterns on the development of respiratory outcomes over 
time, including changes in dietary intake, measurements at multiple time-points are needed. 
However, repeated measures of childhood diet was not available for the study presented in 
this thesis. We assessed the association between diet at the age of 1 year and respiratory 
symptoms in early childhood. With repeated measures the association could be adjusted for 
diet through early childhood and provide a more accurate assessment. 
Specific biomarkers can be used to measure dietary intake of selected nutrients or 
dietary components. Nutritional biomarkers can provide an objective measure of dietary 
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intake or status that may provide more accurate measures than dietary intake estimates. We 
used vitamin D concentration as objective marker for nutrient status in children. However, 
measurement error may occur during processing, storage and laboratory assessment of 
the samples [60]. Since the measurement error is most likely to be random we do not expect 
this to have influenced our results.  
Respiratory and allergic disease outcome assessment
The outcomes in this thesis were primary obtained from parent-reported questionnaires. 
Questions from the age-adapted version of the International Study of Asthma and Allergies 
in Childhood (ISAAC) core questionnaires on asthma and atopic eczema were used [61]. 
The ISAAC questionnaire was developed for children 6-7 years and 13-14 years of age and 
used worldwide [61]. The questions used were made suitable for younger children between 
1-4 years of age but was not validated for this age group. Diagnosing asthma can be difficult 
in young children [62]. Wheezing, coughing and other asthma-like symptoms can occur with 
conditions other than asthma such as viral respiratory infections. Objective tests to support 
the diagnosis of asthma include spirometry and bronchoprovocation. In children under 
the age of 5 years, lung function testing is not reliable due to the child’s inability to perform 
reproducible expiratory maneuvers. Therefore, diagnoses are largely based on reported 
symptoms [62]. Since the outcomes of the studies in this thesis were mainly assessed by 
parent-reported questionnaires, misclassification could have occurred. However, we do not 
expect the misclassification to have influenced our results on the association between diet 
and the outcome of interest. Only when the misclassification was related to the exposure 
ie. breastfeeding, the timing of introduction of complementary feeding, and adherence to 
dietary patters would this have influenced the results.
In addition to parent-reported questionnaire data, we used the fraction of exhaled 
nitric oxide (FeNO) and the interrupter technique measuring airway resistance (Rint) during 
spontaneous breathing as objective measures to support asthma diagnosis. FeNO is a non-
invasive marker of eosinophilic airway inflammation, a hallmark of asthma. Unlike other 
lung function tests, FeNO can be successfully obtained in young children [63]. Eosinophilic 
inflammation develops and increases in childhood. An association between FeNO in early 
childhood and asthma later in life has been suggested [64]. Therefore, FeNO as a biomarker 
might help to identify children at risk for school age asthma. Measuring Rint is another method 
that is feasible in young children [46]. Rint measurements have been found to be associated 
with asthma symptoms in children [65, 66]. However, whether Rint is a useful measure to 
diagnose asthma in preschool children is unclear. Few studies assessed the additional value 
of Rint [46]. One study in preschool children with asthma-like symptoms found Rint not to 
improve the prediction of asthma symptoms in childhood [67]. 
To assess celiac disease autoimmunity, we measured anti-tissue transglutaminase (anti-
tTG) concentrations in venous serum. Clinical celiac disease can be diagnosed when anti-tTG 
concentrations ≥10 times the ULN in combination with positive anti-endomysial antibody 
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and symptoms are present [68]. Subclinical celiac disease is found by screening and must be 
verified by biopsy [68]. Since this is not the case in our study we examined the development 
of celiac disease autoimmunity and conclusions concerning celiac disease should be made 
with causation.
IMPLICATION FOR PUBLIC HEALTH AND FUTURE RESEARCH 
In the Generation R study the association between nutrition in early life and the development 
of childhood respiratory and gastrointestinal disease has been investigated. Based 
on the current literature and the studies presented in this thesis some public health 
recommendations and direction for future research will be given.
Breastfeeding is suggested to protect against a wide range of diseases during infancy 
but also later in life. Especially in infancy, breastfeeding is known to protect against 
respiratory tract infections. Previous research, including our study, found this protective 
effect to proceed in early childhood. Therefore, we support current recommendations on 
breastfeeding for the duration of at least 6 months to reduce the risk for respiratory tract 
infections in children. Recent randomized controlled trials confirmed our results that 
breastfeeding does not reduce the risk for celiac disease.
Recommendations regarding the timing of introduction of complementary feeding has 
changed considerably over the past years. There is no evidence, including the results of 
our study, that avoiding or delaying the introduction of allergenic foods beyond the age 
of 6 months reduces the risk for allergic or celiac disease. In addition, recent randomized 
controlled trials reported that the introduction of allergenic food i.e. peanut, before 6 months 
of age might even protect for allergic disease. Therefore, on the basis of recent studies 
recommendations in The Netherlands that complementary feeding may be introduced into 
a child’s diet as from 4 months of age may be valid. 
Health professionals need to provide counseling to  parents to follow infant feeding 
recommendations. In doing so, it is important that they are aware of groups and individuals 
who are less likely to follow these recommendations. Young mothers, mothers with a low 
educational level, and mothers of infants who attend day care may be appropriate targets 
for additional guidance and education. Also, mothers of children with a family history of 
asthma, atopy or a history of allergy to cow’s milk may need guidance to follow infants feeding 
recommendations as they may be more likely to delay the introduction of complementary 
feeding due to previous recommendations.
The timing of introduction of gluten is not associated with celiac disease autoimmunity 
in childhood. Future research on early nutrition may focus on the introduction of other 
types of gluten (for example different wheat preparations), the optimal amount of gluten 
to be introduced, and duration of gradual amounts of gluten. Since gluten is central to 
the pathogenesis of celiac disease it remains the main environmental trigger. However, as 
the introduction of gluten in infancy does not appear to influence celiac disease development, 
further studies on other environmental factors that may contribute to the development of 
celiac disease may be valuable. An environmental factor that has been suggested to play 
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a protective role in the development of celiac disease are infections in early childhood [69]. 
Future research on childhood infections and celiac disease might give more insight into 
the mechanisms underlying the development of this disease. 
We observed a unhealthy diet to be associated with respiratory symptoms. Different factors 
may influence food choices of mothers with young children. Most dietary interventions that 
have been implemented have focused on the prevention of childhood obesity as opposed 
to overall healthy diet behavior. Because dietary patterns are already present after the first 
year of life, and are likely to remain in childhood to adulthood, interventions improving 
dietary behavior may target mothers with young children [70]. The effect of additional 
dietary guidance for mothers of children from the age of 1 year on dietary behavior could be 
evaluated in a randomized controlled trial. Promoting healthy dietary practices could help 
to develop long-term positive eating behaviors and may contribute to the prevention of 
respiratory and other chronic diseases.      
Previous studies and our study found vitamin D status to be associated with asthma 
symptoms and eczema in young children. However, we observed inconsistent associations. 
In the Netherlands, it is recommended that all children till the age of 4 years receive 
400 IU of vitamin D daily [71]. Since vitamin D deficiency is still very common, health 
professionals should encourage parents to follow current recommendations on vitamin D 
supplementation in early childhood. Although vitamin D supplementation is advised for all 
children under the age of 4 years, this is especially important for children at risk of vitamin 
D deficiency [71]. Mothers of children with a darker skin type and children with limited sun 
exposure should be encouraged to continue the use of vitamin D supplementation after 
preschool age. Also, parents should be made aware that sun exposure is the main source of 
vitamin D and spending time outside could increase vitamin D levels. As the evidence is still 
inconclusive, well-designed clinical trials are warranted to examine the relation between 
vitamin D supplementation and the development of asthma and eczema in childhood. 
Diagnosing asthma can be difficult in children under the age of 5 years. In older children, 
spirometry can support the diagnosis of asthma. This lung function test has been performed 
in 9 year old children in the Generation R study. Replication of the analyses on early life 
nutrition and asthma symptoms with spirometry, may give new insight in whether diet in 
early childhood is associated with the development of asthma in later childhood. In addition, 
allergen-specific immunoglobulin E (IgE) were assessed by skin-prick test at the age of 9 
years. A positive skin test indicates sensitization which refers to the production of allergen-
specific IgE. Most allergic responses are mediated by IgE antibodies specific for a particular 
allergen [72]. Atopic individuals who have a tendency to become sensitized and produce IgE 
antibodies in response to a particular allergen may develop typical symptoms of asthma or 
eczema. Allergen-specific IgE in combination with symptoms of asthma and eczema could 
support the diagnoses of an allergic disease. 
Intestinal microbiome is an actively developing field. It has been suggested that the human 
intestinal microbiome is essential to the development of a healthy immune system. Early-
life exposures, including infant feeding, have the capacity to influence the microbiome 
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composition. It has been suggested that in early childhood a window might exist when 
the effects of gut microbial dysbiosis are most influential in the immune development, with 
lasting effects on health and susceptibility to disease. An altered intestinal microbiome has 
been associated with immune-mediated diseases, including allergic diseases and asthma 
[73]. The intestinal microbiome might also play a role in the development of celiac disease. 
Similar environmental factors have been suggested to influence both the composition of 
the intestinal microbiome and celiac disease development, including mode of delivery 
and infant feeding. Prospective longitudinal studies from birth such as the Celiac Disease 
Genomic, Environmental, Microbiome, and Metabolomic Study (CDGEMM), might give 
more insight into how microbiome composition and metabolomic profiles may influence 
the development of disease [74, 75].  
Nutrition in childhood has been linked to different health outcomes, but still much is 
unknown. In order to gain more insight in the influence of early nutrition on future respiratory 
and gastrointestinal health, further follow-up of the Generation R study cohort is valuable. 
Follow-up is needed to find out what the long term effects are of breastfeeding, the timing 
of introduction of complementary feeding, dietary patterns in young children, and nutrient 
deficiency in childhood.
CONCLUSION
Nutrition in early childhood may affect respiratory and allergic disease. We found 
breastfeeding for 6 months or longer to reduce the risk for respiratory tract infections 
in preschool children. Breastfeeding was not associated with a reduced risk for celiac 
disease autoimmunity. Delaying the introduction of allergenic foods beyond the age of 
6 months does not prevent wheezing and eczema nor does it increase the risk of celiac 
disease autoimmunity. We found an unhealthy diet in early childhood to be associated 
with respiratory symptoms. Furthermore, we found lower vitamin D levels to be associated 
with asthma outcomes, but we observed inconsistent associations. We support current 
recommendations on breastfeeding, the timing of introduction of allergenic foods, and 
vitamin D supplementation. Early childhood may offer a window of opportunity to prevent 
disease or to identify those children who are at risk for severe disease. Improving early life 
nutrition may provide a possibility for prevention.  
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SUMMARY
The first year of life includes many transitions in food consumption. After a period of milk 
feeding including breast and formula feeding, gradual introduction of complementary 
feeding takes place, after which in early childhood dietary behaviors develop. Nutrition 
may be a critical determinant of health at every age but especially during critical stages 
of early development. Exclusive breastfeeding for 6 months is a global public health 
recommendation. However, as of 4 months of age complementary feeding may be 
introduced with dietary patterns emerging after infancy. The period of nutritional transition 
and diet in early childhood may provide a window of opportunity for disease prevention.  
In this thesis we studied nutrition in early life and its association with allergic, respiratory 
and gastrointestinal health. We studied nutrition during different critical stages in infancy 
and early childhood and its effect on childhood health outcomes. Breastfeeding has been 
suggested to protect against respiratory tract infections in infancy for which its effect may 
proceed in early childhood. However, evidence for long-term effects of breastfeeding for 
the development of respiratory tract infections is limited. For the timing of introduction of 
complementary feeding a critical window has been suggested for the prevention of allergic 
and gastrointestinal disease. But, there is currently still much debate on optimal feeding 
recommendations in early life for the prevention of disease. Since children eat a variety 
of foods with complex combinations of nutrients, overall diet may be more predictive for 
disease risk. Yet, studies assessing the effect of dietary patterns in early childhood are few. 
Vitamin D deficiency is common in young children and has been linked to adverse health 
consequences, but a role of vitamin D in the prevention of disease is unclear. 
The studies presented in this thesis were conducted within the Generation R study. 
Information on early life nutrition was obtained by FFQ and information on the different 
health outcomes by parent-reported questionnaires. At the age of 6 years, all children were 
invited to the research facility in the Erasmus MC, Sophia children’s hospital, to participate 
in different health outcome measurements. Also, serum samples were taken during 
the visit to the research center and serum 25(OH) vitamin D concentration and anti-tissue 
transglutaminase (anti-tTG) concentration was assessed. 
The timing of introduction of complementary feeding
The studies on the timing of introduction of complementary feeding are described in 
chapter 2-4. First, in chapter 2 we identified determinants associated with the timing of 
introduction of complementary feeding. At the time the study was conducted delaying 
the introduction of complementary feeding beyond the age of 6 months was recommended. 
In our study population we found that 62% of infants were introduced to complementary 
feeding before the age of 6 months. We confirmed determinants for early introduction 
of complementary feeding that have been identified by previous studies such as young 
maternal age, low educational level, and not fully breastfeeding. In addition to these 
determinants, we found day care attendance to be a determinant for very early introduction 
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of complementary feeding. Health professionals may provide counseling to  parents to 
follow infant feeding recommendations. Young mothers, mothers with a low educational 
level, and mothers of infants who attend day care may be appropriate targets for additional 
guidance and education. Also, we found infants with a family history of asthma, atopy or 
a history of allergy to cow’s milk to be more likely to be introduced to complementary 
feeding after the recommended age of 6 months. Mothers of these children may need 
guidance to follow infants feeding recommendations as they may be more likely to delay 
the introduction of complementary feeding due to previous recommendations. Second, in 
chapter 3 we assessed the association between the timing of introduction of allergenic foods 
cow’s milk, hen’s egg, peanuts, tree nuts, soy, and gluten and the development of wheezing 
and eczema in children 4 years of age and younger. In agreement with previous studies, we 
demonstrated that the timing of introduction of allergenic foods was not associated with 
eczema and wheezing. Therefore, our findings do not support previous recommendation for 
delayed introduction of allergenic foods after age 6 months for the prevention of eczema 
and wheezing. Also, the association did not differ between children with and those without 
a history of cow’s milk allergy in the first year of life and those children with and those without 
a parental history of atopy. Third, in chapter 4 we examined whether the timing of gluten 
introduction and breastfeeding duration are associated with celiac disease autoimmunity in 
children at the age of 6 years. We observed a delayed introduction of gluten not to increase 
the risk of celiac disease autoimmunity. In addition, breastfeeding does not decrease the risk 
of celiac disease autoimmunity. Future research on other environmental factors that may 
contribute to the development of celiac disease may be valuable. 
Based on available evidence, current recommendations that complementary feeding 
may be introduced as of the age of 4 months may be valid since evidence for delaying 
the introduction of complementary foods in the infant’s diet seems to be lacking.
Nutrition and respiratory and allergic disease
We assessed the association between breastfeeding with lower and upper respiratory tract 
infections after infancy up to 4 years of age in chapter 5. We found breastfeeding duration for 
6 months or longer to be associated with a reduced risk of lower respiratory tract infections, 
but not upper respiratory tract infections, in pre-school children. Predominant breastfeeding 
until 4 months was not associated with respiratory tract infections. The results of this study 
suggest that the protection against respiratory tract infections may proceed after the first 
year of life. We support current recommendations on breastfeeding for the duration of at 
least 6 months to reduce the risk for respiratory tract infections in children. 
In chapter 6 we examined the association between dietary patterns in childhood and 
respiratory symptoms including wheezing, shortness of breath, and respiratory tract 
infections in pre-school children. In addition, we assessed whether this association could 
be explained by energy intake. We demonstrated that a Western diet, characterized by high 
intake of refined grains, soups and sauces, savoury and snacks, other fats, sugar-containing 
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beverages and meat,  may increase the risk of frequent respiratory symptoms at 3 and 4 
years of age. This association was in some measure explained by energy intake. We found 
no association between a “Health conscious” dietary pattern and reduction of respiratory 
symptoms. Because dietary patterns are already present after the first year of life, and 
are likely to remain in childhood to adulthood, interventions improving dietary behavior 
may target mothers with young children. Promoting healthy dietary practices could help 
to develop long-term positive eating behaviors and may contribute to the prevention of 
respiratory and other chronic diseases. 
In chapter 7 we aimed to examine the association between serum 25-hydroxyvitamin D 
(25(OH) vitamin D) concentrations and the fraction of exhaled nitric oxide (FeNO), airway 
interrupter resistance (Rint), physician diagnosed asthma ever, wheezing and eczema in 6 
year old children. We found that lower 25(OH) vitamin D levels are associated with elevated 
FeNO levels, but lower Rint values. Lower 25(OH) vitamin D levels are also associated with 
a decreased risk for asthma diagnoses but an increased risk for eczema. Since vitamin D 
deficiency is very common in childhood, health professionals should encourage parents 
to follow current recommendations on vitamin D supplementation. Although vitamin 
D supplementation is advised for all children under the age of 4 years, this is especially 
important for children at risk of vitamin D deficiency. As the evidence is still inconclusive, 
well-designed clinical trials are warranted to examine the relation between vitamin D 
supplementation and the development of asthma and eczema in childhood. 
Last, chapter 8 provides a general discussion of the studies described in this thesis. Also, 
the methodological considerations of our studies, and the implication for public health 
and future research are addressed. The findings of this thesis suggest that nutrition in early 
childhood may affect respiratory and allergic disease. Early childhood may offer a window 
of opportunity to prevent disease or to identify those children who are at risk for severe 
disease. Improving early life nutrition may provide a possibility for prevention. 
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SAMENVATTING
In het eerste levensjaar vindt er veel verandering plaats in voedingsconsumptie. Na een 
periode van melkvoeding waaronder borst en flesvoeding vindt geleidelijke introductie 
plaats van bijvoeding, waarna al op de vroege kinderleeftijd voedingspatronen ontstaan. 
Voeding is mogelijk een belangrijke determinant van gezondheid in elke levensfase, 
maar met name in de kritische fases van de vroege ontwikkeling. Het geven van exclusief 
borstvoeding tot de leeftijd van 6 maanden wordt wereldwijd voor de volksgezondheid 
aanbevolen. Echter kan volgens de richtlijnen vanaf de leeftijd van 4 maanden gestart 
worden met het introduceren van bijvoeding, waarna zich na het eerste levensjaar geleidelijk 
voedingspatronen ontwikkelen. De vroege kinderleeftijd waarin veel verandering in voeding 
plaats vindt kan mogelijk een kans bieden voor ziekte preventie.
In dit proefschrift onderzochten we voeding in de eerste levensjaren in relatie tot 
allergische, respiratoire en gastro-intestinale gezondheid. We onderzochten het effect van 
voeding in de verschillende kritische fases- in het eerste levensjaar en vroege kinderleeftijd- 
op gezondheidsuitkomsten van deze kinderen. Het geven van borstvoeding zou mogelijk 
een beschermend effect hebben op het ontwikkelen van luchtweginfecties in het 
eerste levensjaar, waarna dit effect zou continueren op de vroege kinderleeftijd. Bewijs 
voor beschermende effecten van het geven van borstvoeding op het ontwikkelen van 
luchtweginfecties op de lange termijn is echter beperkt. Een periode waarin de introductie 
van bijvoeding mogelijk voor preventie van allergische en gastro-intestinale ziekte zou 
kunnen zorgen wordt gesuggereerd. Tot op heden is er echter nog veel discussie gaande 
over de meest optimale voedingsadviezen voor de preventie van ziekten. Sinds kinderen 
een verscheidenheid aan voedsel consumeren met complexe combinaties van nutriënten, 
zou het gehele dieet mogelijk meer voorspellend kunnen zijn voor het risico op ziekten. 
Echter zijn er weinig studies verricht, die het effect van voedingspatronen op de vroege 
kinderleeftijd hebben onderzocht. Vitamine D deficiëntie komt veel voor bij jonge kinderen 
en is gerelateerd aan slechte gezondheidsuitkomsten. Echter de rol van vitamine D voor 
de preventie van ziekte is onduidelijk. 
De studies die in dit proefschrift worden gepresenteerd werden verricht in 
The Generation R Study. Informatie over voeding op de vroege kinderleeftijd werd 
verzameld door middel van voedselvragenlijsten, terwijl informatie over de verschillende 
gezondheidsuitkomsten door middel van de, door de ouders ingevulde vragenlijsten 
werden verkregen. Op zesjarige leeftijd werden alle kinderen uitgenodigd voor een 
bezoek aan het onderzoekscentrum in het Erasmus MC, Sophia kinderziekenhuis, voor 
deelname aan verschillende gezondheidsmetingen. Gedurende het bezoek aan het 
onderzoekscentrum werd er bloed afgenomen en werd er serum 25(OH) vitamine D 
concentratie en anti-tissue-transglutaminase (anti-tTG) concentratie bepaald. 
Het tijdstip van introduceren van bijvoeding
De studies over het tijdstip van introduceren van bijvoeding worden beschreven in 
hoofdstuk 2-4. In hoofdstuk 2 identificeren we determinanten die zijn geassocieerd met het 
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tijdstip van introduceren van bijvoeding. Op het moment van de studie werd geadviseerd 
het introduceren van bijvoeding uit te stellen tot na de leeftijd van 6 maanden. In onze 
studie populatie constateerden we dat 62% van de zuigelingen alreeds vóór de leeftijd van 6 
maanden aan bijvoeding waren geïntroduceerd. Onze studie vond dezelfde determinanten 
voor vroege introductie van bijvoeding die ook in eerdere studies zijn aangetoond, 
waaronder jonge leeftijd van moeder, laag educatie niveau van moeder, en het niet 
geven van volledige borstvoeding. Naast deze determinanten vonden we dat verblijf 
in een kinderopvang ook een determinant was voor vroege introductie van bijvoeding. 
Gezondheidsmedewerkers zouden ouders begeleiding kunnen bieden om zo 
voedingsadviezen voor zuigelingen op te volgen. Jonge moeders, moeders met een laag 
educatie niveau, en moeders van zuigelingen die naar een kinderopvang gaan, zouden een 
goede doelgroep kunnen zijn voor additionele begeleiding en educatie. Ook is gebleken 
dat het introduceren van bijvoeding bij zuigelingen met een familie geschiedenis van 
astma, atopie of geschiedenis van koemelk allergie, vaker wordt uitgesteld tot na de 
leeftijd van 6 maanden zoals voorheen werd geadviseerd. Moeders van deze kinderen 
hebben mogelijk begeleiding nodig om voedingsadviezen op te volgen, omdat zij meer 
geneigd zijn de bijvoeding uit te stellen vanwege voorgaande adviezen. In hoofdstuk 
3 onderzochten we de associatie tussen het tijdstip van introduceren van allergene 
voedingsmiddelen zoals koemelk, kippen-ei, pinda’s, noten, soja, en gluten, en het 
ontwikkelen van ‘wheezing’ en eczeem bij kinderen tot en met de leeftijd van 4 jaar. In 
overeenstemming met voorgaande studies laten we zien dat het tijdstip van introduceren 
van allergene voedingsmiddelen niet is geassocieerd met ‘wheezing’ en eczeem. 
De gevonden associatie verschilde niet tussen kinderen met en zonder een 
geschiedenis van koemelkallergie in het eerste levensjaar, en kinderen met en zonder 
familiegeschiedenis voor atopie. Onze resultaten ondersteunen hierin niet de voorgaande 
aanbeveling voor het uitstellen van het introduceren van allergene voedingsmiddelen 
tot na de leeftijd van 6 maanden, voor de preventie van ‘wheezing’ en eczeem. In hoofdstuk 
4 onderzochten we of het tijdstip van introduceren van gluten en de duur van borstvoeding, 
geassocieerd zou zijn met coeliakie auto-immuniteit bij kinderen op de leeftijd van 6 jaar. Wij 
vonden dat met het uitstellen van het introduceren van gluten het risico op coeliakie auto-
immuniteit niet wordt verhoogd. Ook vonden wij dat borstvoeding het risico op coeliakie 
auto-immuniteit niet verlaagd. Toekomstige studies naar andere omgevingsfactoren die 
kunnen bijdragen aan de ontwikkeling van coeliakie kunnen waardevol zijn.
Op basis van beschikbaar wetenschappelijke literatuur, en dat er geen bewijs is dat 
het uitstellen van bijvoeding bij zuigelingen gunstig is, is de huidige aanbeveling om 
de introductie van bijvoeding te starten vanaf de leeftijd van 4 maanden passend.  
Voeding en respiratoire en allergische ziekte
In hoofdstuk 5 onderzochten we de associatie tussen het geven van borstvoeding met 
hoge en lage luchtweginfecties na het eerste levensjaar tot en met de leeftijd van 4 jaar. Wij 
vonden dat het geven van borstvoeding voor 6 maanden en langer, geassocieerd is met een 
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lager risico van lage luchtweginfecties. Dit in tegenstelling tot bovenste luchtweginfecties. 
Voornamelijk borstvoeding tot de leeftijd van 4 maanden was niet geassocieerd met 
luchtweginfecties. De resultaten van deze studie suggereren, dat het beschermende effect 
van borstvoeding voor luchtweginfecties continueert tot na het eerste levensjaar. Wij 
ondersteunen de huidige aanbeveling dat borstvoeding voor 6 maanden of langer het risico 
op luchtweginfecties vermindert. 
In hoofdstuk 6 onderzochten we de associatie tussen voedingspatronen op 
de kinderleeftijd en respiratoire klachten zoals ‘wheezing’, kortademigheid en 
luchtweginfecties op jonge kinderleeftijd. Ook onderzochten we of deze associatie zou 
kunnen worden verklaard door energie inname. Wij vonden dat een ‘Westers’ dieet, 
gekarakteriseerd door hoge inname van geraffineerde granen, soep, sausen, snacks, andere 
vetten, suikerhoudende dranken en vlees het risico op frequente respiratoire klachten op 
de leeftijd van 3 en 4 jaar mogelijk doet toenemen. Deze associatie werd gedeeltelijk 
verklaard door energie inname. Wij vonden geen associatie tussen een “gezond” dieet 
patroon en respiratoire klachten. Omdat voedingspatronen na het eerste levensjaar al 
aanwezig, en mogelijk blijvend zijn van kinderleeftijd tot volwassenheid, zouden interventies 
gericht op het verbeteren van het eetgedrag zich moeten richten op moeders met jonge 
kinderen. Het promoten van een gezonde eetstijl kan bijdragen aan positief eetgedrag 
op de lange termijn en mogelijk bijdragen aan de preventie van respiratoire en andere 
chronische ziektes. 
In hoofdstuk 7 onderzochten we de associatie tussen 25(OH) vitamine D concentraties 
en de fractie van stikstofmonooxide (FeNO) in uitgeademde lucht, luchtweg weerstand 
(Rint), dokter gediagnostiseerde astma, ‘wheezing’ en eczeem op de leeftijd van 6 jaar. Wij 
vonden dat lage 25(OH) vitamine D levels geassocieerd zijn met verhoogde FeNO levels, 
maar met lagere Rint waardes. Lage 25(OH) vitamine D levels zijn ook geassocieerd met 
een lager risico op astma diagnose maar een verhoogd risico op eczeem. Omdat vitamine 
D deficiëntie veel voorkomt bij kinderen zouden gezondheidsmedewerkers ouders kunnen 
motiveren de huidige aanbevelingen voor vitamine D suppletie op te volgen. Hoewel 
vitamine D suppletie wordt aanbevolen voor alle kinderen beneden de leeftijd van 4 jaar, is 
dit met name belangrijk voor kinderen met een verhoogd risico op vitamine D deficiëntie. 
Omdat het bewijs niet eenduidig is zijn clinical trials nodig om de relatie tussen vitamine 
D suppletie en de ontwikkeling van astma en eczeem op de kinderleeftijd te onderzoeken.  
Tot slot geeft hoofdstuk 8 een algemene discussie van de studies beschreven in dit 
proefschrift. Ook de methodologische overwegingen van onze studies en de implicatie 
voor de volksgezondheid en vervolg onderzoek worden behandeld. De bevindingen van dit 
proefschrift suggereren dat voeding op jonge leeftijd mogelijk effecten heeft op respiratoire 
en allergische ziektes. De vroege kinderleeftijd zou daarom een kans bieden voor preventie 
van ziekte en het identificeren van kinderen met een verhoogd risico op ziekte. Het 
verbeteren van voeding op de kinderleeftijd biedt mogelijk een kans voor preventie. 
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